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“Science and opinion. 
The first begets knowledge, the latter ignorance” 
(Hippocrates) 
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Chapter 1 
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1.1 General introduction 
 
   Molecular chirality is one of the principal element governing natural processes 
and its importance is underscored by the fact that in nature it plays a key role in a 
wide range of biological and physical properties. Life itself depends on chirality, 
because living systems interact with enantiomers in different ways. A variety of 
functions occur because receptors, enzymes or binding sites recognize molecules 
having specific chirality. 
The discovery of chirality prompted chemists to develop methods to obtain 
enantiopure substances but, although many asymmetric reactions have been 
discovered so far, until the early 1970s resolution of racemates (spontaneous or with 
the aid of an enantiopure reagent) was the primary way to obtain optically active 
compounds. Many other methods, involving transformation of readily available 
natural chiral compounds (such as amino acids, carbohydrates or alkaloids), or 
forming enantiomerically pure molecule from prochiral substrates by use of 
enzymes or whole microorganisms, were used in this field. In the last decades 
synthetic chemists developed a variety of versatile stereoselective reactions that 
complement biological processes. Asymmetric catalysis is an ideal method to obtain 
chiral molecules. The chemical approach, which uses a small amount of a man-
made chiral catalyst (metal or metal-free), leads to the formation of naturally 
occurring and non-naturally occurring chiral material in large quantities.  
Recently combinatorial chemistry has appeared as an important methodology for 
the rapid synthesis of huge numbers of chemical compounds and the discovery and 
application of new catalysts has become an effective tool to overcome the 
drawbacks that hamper the use of enantioselective catalysis in an industrial 
environment.  
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1.2    Non-covalent interactions for supramolecular catalytic systems 
 
   The term “supramolecular” has been used for many years in the complex field of 
biological structures and ionic charges, and although the concept existed since the 
XIX century, an important contribute to rationalize the meaning of the word must 
be attributed to Jean-Marie Lehn, Nobel in chemistry in 1987, who introduced the 
definition “chemistry beyond the molecule”. According to this definition, a 
supramolecule is an organized complex entity created from the association of two 
or more chemical species held together by intermolecular additive and cooperative 
forces including hydrogen bonding, coordination, hydrophobic interactions, π-π 
interactions, electrostatic interactions and their properties are different than the sum 
of the properties of each individual component. To better understand the concept is 
worth using an analogy from daily life, and the best one is that “a strong team is 
greater than the sum of its parts”. 
Supramolecular chemistry can be split into two big categories which can be 
arbitrarily named host-guest chemistry and self-assembly chemistry. The difference 
between the two classes is peculiar. The first subtends the concept of molecular 
recognition, a molecule significantly larger than another can wrap around it, and the 
meaning of host and guest appears quite clear. This family includes many biological 
systems among which worth mentioning the system enzyme-substrate. Where there 
is no significant difference in size and no species is acting as a host for another, the 
non-covalent joining is named self-assembly. Specifically, the self-assembly is 
equilibrium between two or more molecular components to produce an aggregate 
with a structure dependent only on the characteristic of the chemical building 
blocks. 
Since the aim of this thesis is the use of this second type of interactions for the 
development of new catalytic systems, in this chapter only the concepts related to 
self-assembly processes will be analyzed. 
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1.3      Self-assembly 
 
   Self-assembly, in its most general sense, means the spontaneous association of 
two or more species to create a larger aggregate through the formation of reversible, 
and generally supramolecular, interactions. This generic definition has significantly 
broadened over time to incorporate many aspects of biology, biochemistry and 
nanotechnology which employ the basic principles of chemical self-assembly, albeit 
with subtle variations. 
Examples of such self-assembly processes are repeatedly found in nature. The DNA 
double-helix requires two complementary strands to become entwined via hydrogen 
bonds and π-π stacking in a self-assembly process. The strands recognize each other 
and join together to form the most thermodynamically stable assembly product. 
Protein folding and viral assembly operate in a broadly similar manner. 
Synthetic self-assembly systems are based on the ability of the chemists to design 
molecules containing complementary functionalities. The chemist has no direct 
control over the assembly process otherwise it would not be termed self-assembly, 
however, it is possible to induce the chemical system to rearrange to the most 
thermodynamically stable - and desired - product, by a careful and judicious choice 
of the different parts of the system. 
 
 
Self-assembly in nature 
   Processes that rely upon self-assembly are ubiquitous in nature and life could not 
exist without them. Vital biological processes are governed by countless weak 
interactions that cause highly complex architectures to form reliably and 
spontaneously. It is relatively easy to understand why self-assembly systems play 
such important biological and biochemical roles. If every biological process 
required strong chemical bonds to be formed or broken, then biological systems 
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would consume enormous amounts of energy and the synthesis of biological 
molecules would be extremely complex and time-consuming. 
Pairing of the two DNA helices is without doubt the best known self-assembly in 
biological systems. The double helix, and in particular the complementarity of the 
nucleobases, perfectly explains the basic concept of self-assembly. 
However, DNA pairing is not the only natural process involving non-covalent 
interaction. Nature uses self-assembly to build highly structured systems for 
specific functions. Examples include the folding process of proteins to give rise to 
secondary, tertiary and quaternary structures, hydrophobic effect in the formation 
and activity of lipid membranes, RNA interactions in the structure of Virus, 
functioning of molecular machines such as the system actin-myosin, tubulin 
assembly to give microtubules, biomineralization processes, and so on. 
Nature demonstrates an ability to outperform humans in efficiency of design and 
strength of materials, thus is therefore reasonable to assert that a better 
understanding of self-assembly processes in biological systems will lead chemist to 
develop systems even more efficient and will lead to an exploitation of their 
advantages. 
 
 
Self-assembly for developing new metal-based stereoselective catalysts 
   For many years synthetic chemists involved in catalysis focused on the research 
and development of new powerful and selective chiral ligands for new high 
selective metal-catalyzed asymmetric reactions. While bidentate C2-ligands were 
for more than thirty years the preferred structures for asymmetric catalysis, in the 
last decade a real renaissance of monodentate ligands was observed thanks to the 
pioneering studies independently performed by several groups including Reetz, 
Feringa and De Vries.
1
  These ligands showed themselves capable of excellent ees, 
                                                     
1 (a) M. T. Reetz, T. Sell, A. Meiswinkel, G. Mehler, Angew. Chem. Int. Ed. 2003, 42, 790. (b) M. T. 
Reetz, T. Sell, A. Meiswinkel, G. Mehler, DE-A 10247633.0, 2002. (c) M. T. Reetz, X. Li, Angew. 
Chem. Int. Ed. 2005, 44, 2959. (d) M. T. Reetz, G. Mehler, Tetrahedron Lett. 2003, 44, 4593. 
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particularly in enantioselective hydrogenations. Later, the same groups discovered 
that mixing different monodentate ligands often gave rise to comparable and 
sometimes even better results. Fascinated by these interesting results the groups 
developed numerous libraries of phosphonites, phosphites and phosphoramidites 
and investigated their applications in various asymmetric transformations, mainly 
hydrogenations.
2
 
This methodology is relevant whenever two different ligands are coordinated to the 
same metal center; therefore, the crucial point is the study the coordination process. 
In the simplest case La and Lb in the presence of a metal M, can generate three 
different species in equilibrium with each other: two homocomplexes [MLaLa] and 
[MLbLb] and the heterocomplex [MLaLb] (Scheme 1.1). In the absence of limiting 
agent or additional factors a statistical ratio (1:1:2) will be obtained, although in 
several cases the thermodynamic stability of the heterocomplex favoured its 
formation.  
 
Scheme 1.1 
 
The number of possible combinations in this approach can be calculated from the 
equation 
         
 
 
where n is the number of ligands although in some cases the equilibrium can be 
shifted towards the heterocomplex by varying the relative ligand ratio.
3
  
In this approach, enhancement of the ee can be obtained when the heterocomplex is 
more active and selective than the corresponding homocomplexes.
1
 
                                                     
2 For a review on monodentate ligands in combinatorial approach see M. T. Reetz,  Angew. Chem. Int. 
Ed. 2008, 47, 2556. 
3 C. Monti, C. Gennari, U. Piarulli, J. G. de Vries, A. H. M. de Vries L. Lefort, Chem. Eur. J., 2005, 
11, 6701. 
8 
 
More recently, the concept of supramolecular bidentate ligands emerged as a tool 
for the selective formation of heterocomplexes. This strategy requires that two 
ligands involved in the coordination process possess additional functionalities 
capable of interact each other shifting the equilibrium in the direction of the 
heterocomplex.
4
  
The systems thus created have fewer degrees of freedom, while still maintaining 
appeal for a combinatorial exploitation, compared to the analogues complexes with 
monodentate ligands; in fact, they combine the most peculiar qualities of 
monodentate ligands (ease and speed of synthesis) with a conformational behavior 
similar to the classic bidentate ligands.  
Depending on the nature of the non-covalent interaction, complementary or not, the 
formation of respectively heterocomplexes or homocomplexes will take place 
(Scheme 1.2). 
 
 
Scheme 1.2 
 
In this section, supramolecular bidentate ligands will be mentioned depending on 
the type of non-covalent interaction used. 
 
 
 
                                                     
4 (a) B. Breit, Angew. Chem. Int. Ed., 2005, 44, 6816. (b) M. J. Wilkinson, P. W. N. M. van Leeuwen, 
J. N. H. Reek, Org. Biomol. Chem., 2005, 3, 2371. (c) A. J. Sandee, J. N. H. Reek, Dalton Trans., 
2006, 3385; (d) P. E. Goudriaan, P. W. N. M. van Leeuwen, M.-N. Birkholz, J. N. H. Reek, Eur. J. 
Inorg. Chem., 2008, 2939; (e) G. Gasparini, M. Dal Molin, L. J. Prins, Eur. J. Org. Chem., 2010, 
2429; (f) J. Meeuwissen, J. N. H. Reek, Nat. Chem., 2010, 2, 615. 
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1.3.1   Self-assembly through hydrogen bonding 
 
Hydrogen bonding by peptides 
   Peptides are probably the best known functionalities capable of intermolecular 
interaction by hydrogen bonding and recently this ability has been used by Breit and 
coworkers in the development of a library of phosphines 1 and phosphites 2 that 
mimic the well known PhanePhos ligand.
5
 Meta-carboxypeptidyl-substituted 
triarylphosphines or phosphites were employed to construct PhanePhos-like 
structures by means of an inter-ligand helical hydrogen-bonding network (Scheme 
1.3). The latter, in turn, induces a planar π-stacking arrangement of the two meta-
substituted arene rings which resembles the planar stereogenic element present in 
PhanePhos, as it was demonstrated by X-ray and NMR analysis of Pt- and Rh-
complexes. The homocombinations of ligands 1 and 2, in the presence of 
[Rh(cod)2BF4], were tested in the enantioselective hydrogenation of methyl 2-
acetamido acrylate, methyl (Z)-2-acetamido cinnamate and dimethyl itaconate; the 
best combinations (involving ligands 69) gave enantioselectivity levels comparable 
with those of PhanePhos ligands (75–99% e.e.).  
 
                                                     
5 (a) P. J. Pye, K. Rossen, R. A. Reamer, N. N. Tsou, R. P. Volante and P. J. Reider, J. Am. Chem. 
Soc., 1997, 119, 6207; (b) P. J. Pye, K. Rossen, R. A. Reamer, R. P. Volante and P. J. Reider, 
Tetrahedron Lett., 1998, 39, 4441. 
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The concept of utilising peptide-functionalised P-ligands was further developed and 
expanded to the formation of heterocomplexes.
6
 Indeed, when C-linked peptides 1 
are combined with N-linked peptides 3 in the presence of platinum(II) and 
rhodium(I) salts, a two-stranded, antiparallel β-sheet structure forms (Scheme 1.3), 
which serves as basis for the generation of a heterobidentate ligand library. The 
latter was screened in the enantioselective hydroformylation of styrene; remarkably, 
the stereocentres of the peptide chains can induce a moderate selectivity, although 
they are remote from the catalytic metal centre. 
 
Scheme 1.3 
 
Recently our group and Gennari reported a new class of chiral monodentate 
phosphite ligands 4, named PhtalaPhos, which contain a phthalic acid primary 
diamide moiety.
7
 The phtalamidic group displays both donor and acceptor 
hydrogen-bonding properties that, in principle, can give rise to supramolecular 
interactions both between the ligands and with the reaction substrate (Scheme 1.4). 
Ligands were used in the rhodium catalyzed enantioselective hydrogenation of 
olefins with excellent results and enantioselectivities up to >99%.   
                                                     
6 C. Laungani, J. M. Slattery, I. Krossing, B. Breit, Chem.–Eur. J., 2008, 14, 4488. 
7 L. Pignataro, S. Carboni, M. Civera, R. Colombo, U. Piarulli, C. Gennari, Angew. Chem. Int. Ed. 
2010, 49, 6633. 
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Scheme 1.4 
 
Computational studies were also made to investigate the real structure of the 
precatalyst and an effective double hydrogen bond array (Scheme 1.5).  
 
 
Scheme 1.5 
 
Hydrogen bonding by heterocycles 
   The first example concerning the synthesis of supramolecular bidentate ligands 
using hydrogen bonding by heterocycles is attributed to Breit who developed a 
number of phosphines 5-9 using as hydrogen bond source the already known
8
 
                                                     
8 (a) K. Mashima, H. Nakano, A. Nakamura, J. Am. Chem. Soc. 1993, 115, 11632. (b) K. Mashima, M. 
Tanaka, K. Tani, H. Nakano, A. Nakamura, Inorg. Chem. 1996, 35, 5244. 
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equilibrium between the two tautomeric forms of 2-hydroxypyridine derivatives.
9
 
The general concept is shown in Scheme 1.6. 
 
 
Scheme 1.6 
 
Ligands were used in rhodium-catalyzed hydrogenations of olefins with 
enantioselections up to 99%. The importance of the tautomeric equilibrium was 
evidenced by poor result obtained with ligand 6, unable to self-assemble. 
Breit also explored the possibility to exploit “tautomeric interactions” in a 
combinatorial fashion. To overcome the problem of statistic mixtures, a DNA 
approach was used, or rather a non-tautomeric system based on Adenine-Thymine 
interplay (Scheme 1.7).
10
 A library of 8 building blocks were synthesized to obtain 
heterocomplexes which form stable hydrogen bonding even if in protic solvents like 
methanol.
10
 Tautomeric and non-tautomeric systems were then used in a various list 
                                                     
9 (a) B. Breit, W. Seiche, J. Am. Chem. Soc. 2003, 125, 6608. (b) W. Seiche, A. Schuschkowski, B. 
Breit, Adv. Synth. Catal. 2005, 347, 1488. (c) B. Breit, W. Seiche, Pure and Appl. Chem. 2006, 78, 
249. (d) B. Breit, W. Seiche, Angew. Chem. Int. Ed., 2005, 44, 1640. 
10 Waloch, C.; Wieland, J.; Keller. M.; Breit, B. Angew. Chem. Int. Ed. 2007, 46, 3037 
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of reactions like hydrogenation,
11,17
 anti-Markovnikov hydration of terminal 
alkynes,
12
 hydration of nitriles,
13
 allylic amination
14
 and hydrocyanation of 
alkenes.
15
 
 
Scheme 1.7 
 
Phosphonites 10 and 11 were then introduced using a BINOL moiety in order to 
create the chiral ligand donor group and tested in the hydrogenation of olefins.
16
 
 
 
 
                                                     
11 Birkholz, M.-N.; Dubrovina, N.V.; Jiao, H.; Michalik, D.; Holz, J.; Paciello, R.; Breit, B.; Borner, 
A. Chem. Eur. J., 2007, 13, 5896   
12 Chevallier, F.; Breit, B. Angew. Chem. Int. Ed., 2006, 45, 1599 
13 Smejkal, T.; Breit, B. Organometallics, 2007, 26, 2461 
14 (a) Birkholz, M.-N.; Dubrovina, N.V.; Shuklov, I.A.; Holz, J.; Paciello, R.; Waloch, C.; Breit, B.; 
Borner, A. Tetrahedon: Asymmetry, 2007, 18, 2055. (b) Usui, I.; Schmidt, S.; Keller, M.; Breit, B. 
Org. Lett., 2008, 10, 1207. 
15 De Greef, M.; Breit, B. Angew. Chem. Int. Ed., 2009, 48, 551 
16 M. Weis, C. Waloch, W. Seiche, B. Breit, J. Am. Chem. Soc. 2006, 128, 4188. 
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Hydrogen bonding by Urea functionalities 
   In this field two principal groups had a key-player role for the development of 
new efficient urea-based systems. Reek
17
 and Love
18
, independently, synthetized 
ligands 12 and studied the process of self-assembly in presence of a palladium 
source.  
Love observed with 12a the formation of polymeric species meanwhile Reek with 
12b the formation of trans complex. Both of them found completely symmetric 
specie in presence of Metal source and n-butyl ammonium chloride due to the 
interaction between chlorine and the four NH (Scheme 1.8). 
 
Scheme 1.8 
 
Subsequently, Reek developed a library of phosphite derivatives 13-18 called 
UREAPhos, with which were obtained high levels of enantioselection in Rhodium-
catalyzed hydrogenation of benchmark substrates.
12b 
In addition, the presence of 
stereocenters in the linker between the phosphate and the urea, seems to be useful to 
obtain higher selectivity. 
  
                                                     
17 (a) L. K. Knight, Z. Freixa, P. W. N. M. van Leeuwen, J. N. H. Reek, Organometallics 2006, 25, 
954. (b) A. J. Sandee, A. M. van der Burg, J. N. H. Reek, Chem. Commun. 2007, 864. (c) J. 
Meeuwissen, M. Kuil, A. M. Van der Burg, A. J. Sandee, J. N. H. Reek, Chem. Eur. J 2009, 15, 10272 
18 P. A. Duckmanton, A. J. Blake, J. B. Love, Inorg. Chem. 2005, 44, 7708. 
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1.3.2   Self-assembly through coordinative bonding 
 
   An attractive approach for the achievement of supramolecular bidentate ligands is 
the use of coordinative forces to direct the assembly.  
In general, one template component T is able to interact, by coordination, with two 
ligands La and Lb bearing a donor atom Do for the coordination to the catalytic 
metal M. (Scheme 1.9). The additional tunable center permits an excellent 
exploitability for a combinatorial approach, being the number of possible 
combinations nLa x nLb x nT. 
 
Scheme 1.9 
16 
 
The first system based on this strategy was 19 developed by Reek.
19
 The assembly 
was performed from a zinc(II)porphyrin, two (diphenylphosphino)pyridine ligands 
and [Rh(acac)(CO)2]. The system was used in the hydroformilation of 1-octene and 
styrene with high selectivity. 
 
 
Another interesting example of a template-direct bidentate ligand was introduced by 
Reek in 2006 and involved dimeric Zn(II)salen template 20. Ligands 21 and 22 
were used to obtained the catalytic systems which proved to be more selective in 
the heterobidentate form.
20
   
 
                                                     
19 Slagt, V.F.; van Leeuwen, P. W. N. M.; Reek, J. Chem. Commun. 2003, 2474.  
20 (a) Kuil, M.; Goudriaan, P. E.; van Leeuwen, P. W. N. M.; Reek, J. Chemm. Comm., 2006, 4679. (b) 
Kuil, M.; Goudriaan, P. E.; Kleij, A. W.; Tooke, D. M.; Spek, A. L.; van Leeuwen, P. W. N. M.; Reek, 
J. Dalton Trans., 2007, 2311. 
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Coordinative bonds can be used to promote the formation of supramolecular 
bidentate ligands also in the absence of a template. This kind of approach was 
pioneered by Reek who, in 2004, proposed a self-assembly strategy relying on the 
direct, complementary interaction between a zinc-porphyrin complex bearing a 
phosphite group 23 and a pyridyl phosphine or phosphite 24 (Scheme 1.10). A 
library of 48 supramolecular systems, called Supraphos, was prepared from smaller 
libraries of 23 and 24 and screened in the Pd-catalyzed allylic alkylation of 1,3-
diphenylallyl acetate with dimethyl malonate (Scheme 1.11-A).  
 
 
 
Scheme 1.10 
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The self-assembled systems proved significantly more active than the 
corresponding monodentate ligands, although their enantioselectivity (up to 70% 
e.e.) was inferior (a ligand of the series 39 alone gave 97% e.e.).  
The phosphite–phosphine heterocomplex was studied by UV–vis spectroscopy and 
it was demonstrated that the pyridine group of the phosphine selectively coordinates 
to the zinc(II) porphyrin moiety of the phosphite ligand. 
31
P-NMR spectroscopy 
showed the exclusive formation of the heterocomplex.  
The Supraphos systems were later screened in other reactions, such as the Rh-
catalysed hydroformylation of styrene, the Rh-catalysed hydrogenation of 
challenging enamides (Scheme 1.11-B) and the Pd-catalysed kinetic resolution of 
racemic cyclohexenyl acetate (Scheme 1.11-C). 
 
 
Scheme 1.11 
 
Probably the most impressive work in the field of self-assembly by coordination has 
been published by Takacs in 2004.
21
 In this beautiful study the catalytic systems 25 
                                                     
21 Takacs, J. M., Reddy, D. S., Moteki, S. A., Wu, D., Palencia, H, J. Am. Chem. Soc. 2004, 126, 4494.    
19 
 
had two different sets of chiral inducers. The proper template effect is due to the 
coordination to a Zinc atom by two different bisoxazolinic derivatives; whereas the 
catalytic metal coordinating group are TADDOL-derived phosphite unites. 
The strength of this system is that the heteroleptic Zinc(II)bisoxazoline assembly is 
thermodynamically more stable (and therefore more selective) than the homoleptic 
counterpart. In simple terms the two bisoxazolinic systems coordinating the Zinc(II) 
must have opposite configuration.  
 
 
1.4   Hydrogen bonding as supramolecular interaction in organocatalysis.  
 
   Over the years, the main strategy for asymmetric catalysis of electrophile-
nucleophile reactions has been based on the electrophile activation by Lewis 
acids,
22
 in which the rate acceleration is due to the decrease of LUMO orbital’s 
energy and their application is dated back to the 19
th
 century by the studies of 
Friedel and Crafts.
23
 The protic catalytic effect in cycloaddition reactions was 
                                                     
22 a) Lewis Acids in Organic Synthesis,  (Ed.: H. Yamamoto), Wiley, New York, 2000; b) M. Santelli, 
J.-M. Pons, Lewis Acids and Selectivity in Organic Synthesis, CRCs, Boca Raton, 1996. 
23 C. Friedel, J.-M. Crafts, C. R. Acad. Sci. 1884, 449. 
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already known since early 1940s by the studies of Wassermann;
24
 however for 
many decades the use of Lewis acids had a dominant role in this field. The better 
sort of Friedel-Craft’s approach was certainly not based on the inefficiency of 
Brønsted acid catalysis, but more probably on the higher variability of steric and 
electronic environment of catalysts. 
Nevertheless, in the last decades the electrophile activation by organic H-bond 
donors has emerged as powerful strategy for new applications and developments. 
Due to the aim of this thesis a brief overview of this area will be here below 
reported. 
The relatively strong intermolecular interactions between molecules capable of 
hydrogen bonding were first observed by Faraday in 1823 even if the real hydrogen 
bond definition will be introduced by Pauling in 1912 and can be summarized in 
Scheme 1.12 by a subdivision based on the strength interaction.   
 
 Weak Moderate Strong 
Bond type electrostatic 
mostly 
electrostatic 
mostly covalent 
Length [Å] 2.2-3-2 1.5-2.2 1.2-1.5 
Angle (°) 90-150 130-180 175-180 
Energy (kcal mol
-
1
) 
<4 4-15 14-40 
 
Scheme 1.12 
 
The massive number of works concerning this field has proven chemists 
understanding of catalysis by proton donors.
25
 Two principal mechanisms can 
accelerate reactions: (i) proton transfer in the transition state on the rate determining 
step or (ii) a reversible protonation of electrophile in a pre-equilibrium step. A more 
                                                     
24 a) A. Wassermann, J. Chem. Soc. 1942, 618; b)W. Rubin, H. Steiner, A. Wassermann, J. Chem. Soc. 
1946, 3046. 
25 (a) W. P. Jencks, Acc. Chem. Res. 1976, 9, 425 ; (b) E. Ciuffarin, A. Loi, M. Isola, A. Lupetti, L. 
Sagramora, L. Senatore, J. Org. Chem. 1983, 48, 1047; (c) S. Scheiner, Acc. Chem. Res. 1994, 27, 
402. 
21 
 
profound and effective classification is based on the nature of molecules, focusing 
the attention on the functional groups capable of H-bond donation. 
 
 
1.4.1   Catalysis by single hydrogen bond donation.  
 
   Highly enantioselective reactions involving molecules capable of only one H-
bond donation are not largely employed due to the little chance of having high 
directionality and strength of bonds and consequently a rigid catalyst-substrate 
complex. Nevertheless some interesting works have been reported on the use of 
chiral diols as asymmetric inducers. 
Chiral diols and diphenols are commonly used in catalysis but for years only as 
efficient ligands for enantioselective Lewis acid mediated processes.
26
 The 
application as real catalysts is more recent
27
 and has opened a new area of a metal-
free catalysis. Initially was commonly accepted that diols might act as double H-
bond donors,
28
 however more recent studies of enantioselective variants suggest 
that, at least in certain cases, mechanisms involving single H-bond activation may 
be operative.   
Pioneering studies in the latter field were undertaken by Toda in 1980s on the use of 
TADDOL derivatives as efficient resolving agents for a wide number of species 
such as sulfoxides, amines and alcohols.
29
 Toda reported X-ray structures clearly 
showing a single H-bond donation by diols (Scheme 1.13). 
                                                     
26 For useful review: (a) D. Seebach, A. K. Beck, A. Heckel, Angew. Chem. 2001, 113, 96; (b) J. M. 
Brunel, Chem. Rev. 2005, 105, 857. 
27 (a) J. Hine, S.-M. Linden, V. M. Kanagasabapathy, J. Am. Chem. Soc. 1985, 107, 1082; (b) T. R. 
Kelly, P. Meghani, V. S. Ekkundi, Tetrahedron Lett. 1990, 31, 3381. 
28 (a) J. Hine, S.-M. Linden, V. M. Kanagasabapathy, J. Am. Chem. Soc. 1985, 107, 1082; (b) J. Hine, 
S.-M. Linden, V. M. Kanagasabapathy, J. Org. Chem. 1985, 50, 5096; (c) T. R. Kelly, P. Meghani, V. 
S. Ekkundi, Tetrahedron Lett. 1990, 31, 3381. 
29 (a) F. Toda, K. Tanaka, L. Infantes, C. Foces-Foces, R. M. Claramunt, J. Elguero, J. Chem. Soc. 
Chem. Commun. 1995, 1453. 
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Scheme 1.13 
 
 These results led to an employment in enantioselective reactions among which is 
worth mentioning the asymmetric cyclization of cocrystal of N-allyl-3-
oxocyclohex-1-enecarboxamide and a TADDOL derivative (Scheme 1.14)
30
 with 
excellent results.  
 
 
Scheme 1.14 
 
BINOL has been more recently introduced by Schaus as a proficient catalyst in the 
Morita-Baylis-Hillman reaction. Catalyst 26 promoted the coupling between 3-
phenylpropanal and 2-cycloexenone with appreciable selectivity (Scheme 1.15-
A).
31
 
                                                     
30 K. Tanaka, F. Toda, J. Chem. Soc. Chem. Commun. 1983, 593. 
31 (a) N. T. McDougal, S. E. Schaus, J. Am. Chem. Soc. 2003, 125, 12094; ( b) N. T. McDougal, W. L. 
Trevellini, S. A. Rodgen, L. T. Kliman, S. E. Schaus, Adv. Synth. Catal. 2004, 346, 1231. 
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Product 27 was used by Sasai in the aza-Morita-Baylis-Hillman reaction (Scheme 
1.15-B). The author suggests a bifunctional role of the catalyst with electrophile 
activation by phenols and pyridine as group able to form the enolate.
32
  
 
Scheme 1.15 
 
 
1.4.2   Catalysis by double hydrogen bond donation.  
 
   The simultaneous donation of two H-bonds has proven to be a powerful strategy 
for the activation of a wide range of electrophiles including carbonyl compounds, 
nitro compounds and imine derivatives. 
The two principal categories of molecules having this employment are ureas (and 
thioureas) and guanidium ions. 
                                                     
32 K. Matsui, S. Takizawa, H. Sasai, J. Am. Chem. Soc. 2005, 127, 3680. 
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Ureas and thioureas  
   The notion that ureas and thioureas could act as chiral activators of electrophiles 
through H-bond donation has been known for years,
 
but the massive use of these 
molecules as real organocatalysts is more recent. 
Interesting studies were performed by Jacobsen in late 1990s concerning the use of 
ureas and thioureas as ligands for Lewis acid metal-catalyzed hydrocyanations of 
imines.
33
 The discovery that higher enantioselectivities were achieved in absence of 
metal additives was really unexpected. NMR, kinetic and computational studies 
highlighted the existence of a double H-bond between the acidic NH protons and 
the imine ion pair serving to activate the electrophile towards attack by cyanide.
34
  
Initially, achiral ureas and thioureas were synthesized as efficient catalytic systems 
for organic transformations. In many examples the maximum rate acceleration was 
observed with aromatic derivatives and consequently these results allowed to 
hypothesize a relationship between the NH acidity and catalytic ability. Curran and 
Schreiner developed products 28 and 29 and reported their use as catalyst 
respectively in Claisen rearrangements
35
 and Diels Alder reaction (Scheme 1.16).
36
 
 
 
 
                                                     
33 (a) M. S. Sigman, E. N. Jacobsen, J. Am. Chem. Soc. 1998, 120, 4901; (b) P. Vachal, E. N. 
Jacobsen, Org. Lett. 2000, 2, 867; (c) M. S. Sigman, P. Vachal, E. N. Jacobsen, Angew. Chem. 2000, 
112, 1336. 
34 P. Vachal, E. N. Jacobsen, J. Am. Chem. Soc. 2002, 124, 10012. 
35 (a) D. P. Curran, L. H. Kuo, J. Org. Chem. 1994, 59, 3259; (b) D. P. Curran, L. H. Kuo, 
Tetrahedron Lett. 1995, 36, 6647. 
36 (a) P. R. Schreiner, A. Wittkopp, Org. Lett. 2002, 4, 217; (b) A.Wittkopp, P. R. Schreiner, Chem. 
Eur. J. 2003, 9, 407. 
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Scheme 1.16 
 
Nevertheless, asymmetric induction has been the principal target of these studies, 
and during the years several catalysts were performed. Jacobsen has been one of the 
principal players in this field and recently introduced catalysts 30 with which 
performed numerous asymmetric reaction as allylations of imines, Mannich 
reactions and aza-Baylis-Hillman reactions
37
 whose transition state involve a double 
hydrogen bond between urea and enamine derivative (Scheme 1.17). 
 
 
 
 
Scheme 1.17 
                                                     
37 I. T. Raheem, E. N. Jacobsen, Adv. Synth. Catal. 2005, 347, 1701. 
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Chiral guanidinium ions  
   Guanidinium ions, structural relatives of ureas, are able of participate in H-bond 
processes as for example arginine in biological systems. The positive charge nature 
of these groups causes a higher H-bond donating ability than ureas and a related 
higher catalytic effect. 
Pioneering works were carried out by Corey in late 1990s, which performed 
catalysts based on bicyclic guanidine 31 and relative application in Strecker 
reaction of aromatic imines.
38
 
The mechanism proposed involves the generation of guanidinium cyanide, followed 
by an attack of the cyanide ion on the imine. H-bond should accelerate this last 
attack (Scheme 1.18). 
 
 
Scheme 1.18 
 
 
                                                     
38 E. J. Corey, M. J. Grogan, Org. Lett. 1999, 1, 157. 
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1.4.3   Bifunctional hydrogen-bond catalysts 
 
   This is without doubt the most attractive and studied field of H-bond catalysis. 
During the years many works have been reported on the development of systems 
capable of simultaneous activation of nucleophiles and electrophiles. Most of the 
first studies involved Lewis acids equipped with additional Brønsted or Lewis basic 
functionalities; however more systems proved to be highly exploitable to 
asymmetric metal-free catalysis. 
 
 
Proline and analogues  
   α-Amino acids are the simplest bifunctional molecules bearing both an acidic and 
basic groups and, in particular the 20 naturally occurring, of course are easily 
available in the enantiopure form.  
Despite the function of proline as organocatalyst was known from 1970s due to 
Hayos and Parrish’s research, it is surprising that chemists ignored the catalytic 
opportunities offered by amino acids, in particular by proline.  
In 2000 Lerner, List and Barbas introduced different proline-based systems for the 
direct asymmetric aldol reactions and since then, hundreds of publications have 
appeared in related topics.
39
 
Barbas in 2004 reported the synthesis and application of a number of proline 
derivatives and their application as catalyst in Michael addition of α,α-disubstituted 
aldehydes to nitrostyrene with good results.
40
 Some years later he reported the 
prolinol derivative 32 as efficient catalyst in presence of a thiourea as additive 
(Scheme 1.19).
41
 
                                                     
39 Brindle, C. S.; Trost, B. M. Chem. Soc. Rev. 2010, 39, 1600. 
40 Mase, N.; Thayumanavan, R.; Tanaka, F.; Barbas, C. Org. Lett., 2004, 6, 2527 
41 Albertshofer, K.; Thayumanavan, R.; Utsumi, N.; Tanaka, F.; Barbas, C. Terahedon Lett. 2007, 48, 
693. 
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Scheme 1.19 
 
In 2005 Gryko and Chimni independently synthesized products 33 and 34 and 
reported their use in asymmetric aldol reaction between acetone and electron-poor 
benzaldehydes with different results. These studies proved thioamides as more 
efficient catalysts with enantiomeric excesses up to >99.9%.
42,43 
 
 
A very interesting work was developed by Wennemers and coworkers who 
synthesized oligopeptides proline-containing and studied their role as catalyst 
having an high level of conformational rigidity. The power of these systems were 
proved by the tripeptide 35 which provided excellent levels of enantioselectivity (up 
to 98% ee) in a Michael addition of aldehydes to nitrostyrene.
44
  
The mechanism proposed involves a synergic contribution of the two different 
functionalities. Proline act as promoter of enamine catalysis while the carboxylic 
acid interact with the nitro moiety and makes the attack possible only on one face of 
enamine (Scheme 1.20). 
                                                     
42 D. Gryko and R. Lipinski, Adv. Synth. Catal., 2005, 347, 1948. 
43 S. S. Chimni, D. Mahajan and V. V. S. Babu, Tetrahedron Lett., 2005, 46, 5617. 
44 Wiesner, M.; Revell, J. D.; Wennemers, H. Angew. Chem. Int. Ed. 2008, 47, 1871.  
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Scheme 1.20 
 
Similar approach was undertaken by Tsogoeva in 2009 and small dipeptides Pro-
Phe were used in the same reaction but with lower selectivity.
45
  
Recently, Wang introduced some variations at the strategy with the development of 
chiral pyrrolidine–thiourea bifunctional catalysts 36-39 having a proline, a thiourea 
as electrophile activation moiety and non aminoacidic chiral linkers. Catalysts were 
tested in the benchmark Michael addition of aldehydes to nitroolefins with good 
levels of enantioselection.
46
 
 
 
 
 
                                                     
45 Freund, M.; Schenker, S.; Tsogoeva, S. B. Org. Biomol. Chem. 2009, 7, 4279. 
46 J.-F. Bai , X.Y. Xu, Q.-C. Huang, L. Peng, L.-X. Wang, Tetrahedron Lett. 2010, 51, 2803 
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Cinchona alkaloids and derivatives 
 
   Natural products isolated from the bark of trees belonging to Cinchona and 
Remijia species have been largely used in asymmetric synthesis as resolving 
agents.
47
 The hypothesis of their use as bifunctional organocatalyst was first 
suggested by Wynberg
48
 due to the observation that these alkaloids possess a free 
hydroxyl group and consequently can promote conjugate additions with higher rates 
and enantioselectivity. 
This theory was in part denied by Deng who in 2002 reported an highly 
enantioselective variant of an osmium-catalyzed dihydroxylation of alkenes
49
 in 
which the product were obtained with (DHQD)2PYR. The lack of free hydroxyl 
group suggested that this catalyst may operate by a different mechanism. 
Recently, Dixon reported the use of several chincona derivatives as efficient 
catalyst for different reactions. In particular, molecule 40 proved to be highly 
selective in Michael addition, Mannich and Krapcho reactions.
50
   
 
 
 
 
                                                     
47 (a) K. Kacprzak, J. Gawronski, Synthesis 2001, 961; (b) S.-K. Tian, Y. Chen, J. Hang, L, Tang, P. 
McDaid, L. Deng, Acc. Chem. Res. 2004, 37, 621. 
48 H. Hiemstra, H. Wynberg, J. Am. Chem. Soc. 1981, 103, 417. 
49 P. McDaid, Y. Chen, L. Deng, Angew. Chem. 2002, 114, 348; P. McDaid, Y. Chen, L. Deng, 
Angew. Chem. Int. Ed. 2002, 41, 338. 
50 J. Je, D. J. Dixon, P. Hynes, Chem Comm, 2005, 4481; A. L. Tillman, J. Je, D. J. Dixon, Chem 
Comm, 2006, 1181. 
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1.5   Aim and outline of this thesis 
 
   This thesis deals with the design of new catalytic systems involving non covalent 
interaction, in particular hydrogen-bonding, as basic principle on which they are 
developed and their application in asymmetric catalysis. 
In chapter 2 the preparation of a new class of chiral supramolecular (bis)oxazolines 
(SupraBox) for metal catalysis is described. The supramolecular system consists in 
two oxazoline-containg ligands that are linked by hydrogen bonding between urea 
functionalities. Attention will be focused on the modular strategy for the synthesis 
of ligands, the formation and characterization of metal-complexes and obviously on 
the catalytic reaction in which complexes have been tested. 
Chapter 3 deals with the development of a new bifunctional organocatalyst based 
on a diketopiperazinic backbone. The system is centered on a conformationally 
rigid scaffold functionalized with proline-containing and carboxylic-containing side 
arms. The synthesis will be reported and particular attention will be dedicated on 
the conformational studies of the molecules. Hydrogen bond interaction between 
the system and substrates has proved to be crucial to obtain high selectivity. 
  
32 
 
 
 
 
33 
 
 
 
 
Chapter 2 
 
Supramolecular chiral bis(oxazolines) 
for asymmetric metal catalysis 
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2.1   Oxazolines-containing chiral ligands 
 
   Oxazolines are five-membered cyclic aminoesters which were first synthesized at 
the end of XIX century. These molecules were initially used in organic synthesis as 
masked carboxylic acids, but their importance has grown over the years in 
particular from the moment they began to be used as ligands for metal catalysis.  
Because of their accessibility and applicability in a wide range of transformations, 
compounds containing chiral oxazolinic rings have become one of the most 
versatile, and commonly used classes of ligands for asymmetric catalysis.
1
 The 
majority of these ligands are derived from readily available chiral amino alcohols in 
a few synthetic steps. The enantiocontrol resides on the stereochemistry of the 
carbon atom neighboring the coordinating nitrogen atom of the ring and, therefore, 
in close proximity to the metal active site, thus having a direct influence on the 
stereochemical outcome of the reaction. 
Since the first report by Wimmer in 1986 of the use of chiral oxazolines as ligands 
in asymmetric catalysis,
2
 a wide range of ligands having one, two, or more 
oxazolines incorporating various heteroatoms, additional chiral motifs, and specific 
structural features have been used with great success in many asymmetric reactions.  
Here below will be listed the main, but not all, categories of oxazoline-containing 
ligands.  
Since the main part of the ligands mentioned will be bidentate, some brief on the 
bite-angle concept should be spent. Bite angle is easily defined as the angle formed 
by two bonds existing between a metal center and two ligand atoms, so it is strongly 
dependent on the linker between the two donor groups. Is well known that catalytic 
activity is depending on the bite angle, therefore bidentate ligands can have a 
                                                     
1 (a) Ghosh, A. K.; Mathivanan, P.; Cappiello, J. Tetrahedron: Asymmetry1998, 9, 1. (b) Helmchen, 
G.; Pfaltz, A. Acc. Chem. Res. 2000, 33, 336. (c) Sutcliffe, O. B.; Bryce, M. R. Tetrahedron: 
Asymmetry 2003, 14,2297. 
2 Brunner, H.; Obermann, U.; Wimmer, P. J. Organomet. Chem.1986, 316, C1. 
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preference for a specific geometry and reactivity. Many pioneering studies have 
been undertaken in order to understand how exactly reactions are affected by this.
3
  
Since a reaction can be steered by influencing of the initial state, transition state or 
final state of the metal complex involved, ligands that enforce a well-defined bite 
angle can be used to induce distortions of certain geometries. Not only this will 
have impact on activity and selectivity of a catalytic reaction, but even alternative 
reaction pathways can become accessible. Already in the late 1970s Hoffmann 
calculated that in the transition state of an insertion reaction of palladium-
bis(phosphine) complexes the bite angle P-Pd-P is larger than that in the starting 
complex.
4
 
 
 
2.1.1 Mono(oxazolines) 
 
Mono(oxazolines) N,N-Ligands 
   The first example of ligand with two nitrogen donor atoms 1 for catalytic 
applications appeared in 1986 with a success in Rhodium(I)-catalyzed 
hydrosilation.
2 
Since then, many modifications have been successfully used in a 
wide range of reactivity. 
 
Widenhoefer has reported the first examples of the asymmetric formation of 
functionalized carbocycles by the cyclization/hydrosilylation of functionalized 1,6-
                                                     
3 (a) S. Otsuka, J. Organomet. Chem. 1980, 200, 191; (b) J. J. Low, W. A. Goddard, J. Am. Chem. Soc. 
1984, 106, 6928; (c) P. Hofmann, H. Heiss, G. M_ller, Z. Naturforsch. B, 1987, 42, 395; (d) P. 
Dierkes, P. W. N. M. van Leeuwen, J. Chem. Soc. Dalton Trans. 1999, 1519; (e) Z. Freixa, P. W. N. 
M. van Leeuwen, Dalton Trans. 2003, 1890; (f) R. Fazaeli, A. Ariafard, S. Jamshidi, E. S. Tabatabaie, 
K. A. Pishro, J. Organomet. Chem. 2007, 692, 3984; (g) V. P. Ananikov, D. G. Musaev, K. 
Morokuma, Eur. J. Inorg. Chem. 2007, 5390. 
4 D. L. Thorn, R. Hoffmann. J. Am. Chem. Soc., 1978, 100, 2079. 
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dienes using palladium complexes of the pyridinyl- oxazoline ligands 1a-d (Scheme 
2.1).
5
 It was found that the palladium complex 2 of the ligand 1a was suitable for a 
wide range of substrates as diesters, diols and dienes with various trialkylsilanes.  
 
Scheme 2.1 
 
Studies on the nature of the complexes have been done using ruthenium salts and 
ligands 1; Davies found that ([(mesitylene)RuCl ((S)-1][SbF6]) exists as single 
diastereomer and catalyzes Diels-Alder reactions with high selectivity.
6
  
Ligands having optically active substituents at the 2- and 6-positions of the 
pyridinic ring were introduced to study the effect of bulky groups in proximity of 
the coordination site. Ligands 3-6 were tested in the rhodium-catalyzed 
hydrosylation of acetophenone with diphenylsilane.
7
 Product 3 gave higher 
selectivity compared to ligand 1a (80% vs. 63% ee) but the menthyl-substituted 
ligands 4-6 gave very low levels of selectivity compared to 1e, which may be a 
result of the inability of these molecules to coordinate the metal due to the high 
steric hindrance.  
                                                     
5 (a) Perch, N. S.; Widenhoefer, R. A. J. Am. Chem. Soc. 1999, 121, 6960. (b) Perch, N. S.; Pei, T.; 
Widenhoefer, R. A. J. Org. Chem. 2000, 65, 3836. (c) Pei, T.; Widenhoefer, R. A. J. Org. Chem. 
2001, 66, 7639. 
6 (a) Davenport, A. J.; Davies, D. L.; Fawcett, J.; Garratt, S. A.;  Russell, D. R. J. Chem. Soc., Dalton 
Trans. 2000, 4432. (b) Davies, D. L.; Fawcett, J.; Garratt, S. A.; Russell, D. R. Chem. Commun. 1997, 
1351. 
7 Brunner, H.; Sto¨riko, R.; Nuber, B. Tetrahedron: Asymmetry 1998, 9, 407. 
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The role of steric and electronic effects on pyridinyl-oxazoline ligand was 
investigated by the use of a library of ligands 7-9 in the Palladium-catalyzed 
asymmetric alkylation of 1,3-diphenyl-2-propenyl acetate with dimethyl malonate. 
8
 
The examination of catalytic results revealed that the enantioselectivity increased 
with increasing size of oxazoline substituent and with the introduction of electron-
donating groups at the 4-position of the pyridine. Ligand 7 (R1 = t-Bu, R3 = Me, and 
R2, R4 = H) proved to be the most selective (92% ee) whereas ligands with an 
electron-withdrawing chloro group afforded low-rate reaction with selectivity 
compared to unsubstituted pyridinic rings. 
Ligands 7-9 were also screened in the Cu(I)-catalyzed cyclopropanation of styrene 
with ethyl diazoacetate (Scheme 2.2).
9
 The results showed a trend completely 
comparable with the previous reactivity where enantioselectivity increases with the 
increase of steric bulk on the oxazoline even if in this case the effect of electro-
withdrawing groups seemed to be less important. 
 
                                                     
8 Chelucci, G.; Medici, S.; Saba, A. Tetrahedron: Asymmetry 1999, 10, 543. Chelucci, G.; Deriu, S. P.; 
Saba, A.; Valenti, R. Tetrahedron: Asymmetry 1999, 10, 1457. 
9 Chelucci, G.; Sanna, M. G.; Gladiali, S. Tetrahedron 2000, 2889. 
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Scheme 2.2 
 
In 2002 Zhou reported the synthesis of the tetrahydroquinolinic ligands 10 and their 
application in ruthenium-catalyzed asymmetric transfer hydrogenation of aromatic 
ketones.
10
 The aim of this study was to combine the selectivity induced by the 
ligand’s framework and the key role of the NH group in the mechanism of transfer 
hydrogenation (Scheme 2.3).
11
 The effect was demonstrated by results of ligand 10c 
compared with analogous ligand 11 (73% vs. 25% ee). 
                                                     
10 Zhou, Y.-B.; Tang, F.-Y.; Xu, H.-D.; Wu, X.-Y.; Ma, J.-A.; Zhou, Q.-L. Tetrahedron: Asymmetry 
2002, 13, 469. 
11 (a) Haack, K.-J.; Hashiguchi, S.; Fujii, A.; Ikariya, T.; Noyori, R. Angew. Chem., Int. Ed. Engl. 
1997, 36, 285. (b) Alonso, D. A.; Brandt, P.; Nordin, S. J. M.;  ndersson, P. G. J. Am. Chem. Soc. 
1999, 121, 9580. (c) Casey, C. P.; Johnson, J. B. J. Org. Chem. 2003, 68, 1998. 
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Scheme 2.3 
 
 
Mono(oxazolines) N,P-Ligands 
   This class of ligands has been applied over the years with great success in diverse 
range of asymmetric reactions. The first phosphinooxazoline 12 was introduced by 
Pfaltz in 1993 as efficient ligand for allylic alkylation
12
 but the ease of accessibility 
of these molecules from readily available starting materials has led to the 
development of a wide array of phosphinooxazoline ligands similar to 12.  
 
                                                     
12 (a) Matt, P.; Pfaltz, A. Angew. Chem., Int. Ed. Engl. 1993, 32, 566. (b) Sprinz, J.; Helmchen, G. 
Tetrahedron Lett. 1993, 34, 1769. (c) Dawson, G. J.; Frost, C. G.; Williams, S. J. Tetrahedron Lett. 
1993, 34, 3149. 
41 
 
Tietze applied a large library of benzothiophene, thiophene and benzofuran 
phosphinooxazoline ligands 13-17 in palladium-catalyzed alkylation of 1,3-
diphenyl-2-propenyl acetate with sodium dimethyl malonate (Scheme 2.4)
13
 with 
high yields and selectivity. 
Thiophene moiety has been used also by Cozzi in the development of ligands 18 
and 19 which proved to be highly active in the iridium-catalyzed asymmetric 
hydrogenation of olefins and imines. 
14
   
 
 
 
Scheme 2.4 
 
                                                     
13 Tietze, L. F.; Lohmann, J. K. Synlett 2002, 2083. 
14 Cozzi, P. G.; Menges, F.; Kaiser, S. Synlett 2003, 833. 
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The rule of the rigidity of the linker between N and P coordination atoms was 
investigated by Gilbertson with the development of chiral phosphinooxazolines 20 
and 21 based on (1S)-(+)-ketopinic acid and their application in the asymmetric 
palladium-catalyzed Heck reaction
15
. The two diastereomers 20b and 21 indicated 
that the asymmetry of the reaction is induced by the chirality of the oxazoline, 
however, the low enantioselectivity obtained by the corresponding acyclic analogue 
22 highlighted the importance of the rigid bicyclic system for high values of 
enantioselection.  
 
                                                     
15 Gilbertson, S. R.; Fu, Z. Org. Lett. 2001, 3, 161. 
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Alkylic chains were also used as linking motif and in 1998 Gilbertson reported the 
synthesis of ligands 23-25 with both one and two stereocenters and their application 
in allylic alkylations.
16
 In the benchmark palladium-catalyzed alkylation of 1-3-
diphenyl-2-propenyl acetate the introduction of a second stereocenter enhanced the 
asymmetric induction, attesting the effective importance of the linker’s rigidity. 
 
 
 
Interesting studies in this field were undertaken by Gilbertson and coworkers who 
synthesized ligands 39-42 to permit to study both the importance of the 
stereocenters in the linker and the activity of diarylphosphino groups directly 
bonded to a nitrogen atom. The ligands were proline-based and tested in palladium-
catalyzed asymmetric alkylation and amination
17
 and in the iridium-catalyzed 
enantioselective hydrogenation of aromatic olefins.
18
 The influence of the 
stereogenic proline in the asymmetric induction was demonstrated by the much 
lower ee achieved with the structurally similar ligand 42 which lacks the rigidity of 
the pyrrolidine ring. 
                                                     
16 Gilbertson, S. R.; Chang, C.-W. T. J. Org. Chem. 1998, 63, 8424. 
17 Xu, G.; Gilbertson, S. R. Tetrahedron Lett. 2002, 43, 2811. 
18 Xu, G.; Gilbertson, S. R. Tetrahedron Lett. 2002, 44, 953. 
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A characteristic variant of ligand 1 with a ferrocene substituent at the 4-position of 
the oxazoline was introduced by Patti. The ligand 43 was applied in the Palladium-
catalyzed allylic alkylation with good results
19
. Following this route Moyano 
reported an alternative synthesis of the enantiomeric ligand (S)-43 and the 
formation of a palladium-allyl complex [(Pd(η3-C3H5)-51)PF6] affording 
enantioselectivity up to 99.6% although with low catalytic activity.
20
 
 
Binaphthyl moiety is one the most largely used backbone for the synthesis of chiral 
ligands and over the years it has been used also for the development of new classes 
of phosphinooxazolines.  
Ligands 70, with an axial chirality, have been used independently by Hayashi
21
 and 
Ikeda
22
 for the palladium-catalyzed alkylation of 1,3-diphenyl-2-propenyl acetate 
                                                     
19 Patti, A.; Lotz, M.; Knochel, P. Tetrahedron: Asymmetry 2001, 12, 3375. 
20 Moreno, R. M.; Bueno, A.; Moyano, A. J. Organomet. Chem. 2002, 660, 62. 
21 Ogasawara, M.; Yoshida, K.; Kamei, H.; Kato, K.; Uozumi, Y.; Hayashi, T. Tetrahedron: 
Asymmetry 1998, 9, 1779. 
22 Imai, Y.; Zhang, W.; Kida, T.; Nakatsuji, Y.; Ikeda, I. Tetrahedron Lett. 1998, 39, 4343. 
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with dimethyl malonate; the best results was achieved by Ikeda using (S,aR)-44b. 
The most important feature of this work is the opposite enantioselectivity obtained 
by the two diastereomers (S,aR)-44a and (S,aS)-44a which indicates that the chiral 
binaphthyl skeleton is the more influential stereogenic unit in the structure.  
 
 
 
One of the few examples of a highly enantioselective rhodium-catalyzed allylic 
alkylation was instead reported by Hayashi, which obtained high enantio- and 
regioselectivities using ligand 44.
23
 
 
 
Mono(oxazolines) N,O-Ligands 
   Metal complexes bearing 2-(oxazolinyl)phenolato ligands have been used in a 
wide range of reactivity such as Baeyer-Villiger oxidations,
24
 cyclopropanations,
25
 
allylic functionalizations,
26
 and C-C bond formations.
27
  
In 2001 Feng reported the synthesis of ligands 45 and their application in titanium-
catalyzed oxidation of prochiral sulfides to chiral sulfoxides (Scheme 2.5)
28
 with 
                                                     
23 Hayashi, T.; Okada, A.; Suzuka, T.; Kawatsura, M. Org. Lett.2003, 5, 1713. 
24 (a) Bolm, C.; Schlingloff, G.; Weickhardt, K. Angew. Chem., Int. Ed. Engl. 1994, 33, 1848. (b) 
Bolm, C.; Schlingloff, G.; Weickhardt, K. Tetrahedron Lett. 1993,  4, 3405. (c) Bolm, C.; Schlingloff, 
G. Chem. Commun. 1995, 1247. 
25 Brunner, H.; Berghofer, J. J. Organomet. Chem. 1995, 501, 161. 
26 Yang, H.; Khan, M. A.; Nicholas, K. M. Organometallics 1993, 12, 3485. 
27  Cozzi, P. G.; Floriani, C. J. Chem. Soc., Perkin Trans. 1 1995, 2357. 
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good results. The same ligands were also tested in the copper-catalyzed oxidation of 
2-phenylcyclohexenone with lower selectivity.
29
 
 
 
 
Scheme 2.5 
 
Hydroxymethyl oxazolines 46 and 47 were introduced respectively by Williams
30
 
and Braga
31
 as efficient ligands for the asymmetric addition of diethylzinc to 
aldehydes. The best results were achieved by Braga in the addition of diethylzinc to 
substituted benzaldehydes with the less sterically hindered derivative 47a.  
                                                                                                                                        
28 Peng, Y.; Feng, X.; Cui, X.; Jiang, Y.; Chang, A. S. C. Synth. Commun. 2001, 31, 2287. 
29 Peng, Y.; Feng, X.; Yu, K.; Li, Z.; Jiang, Y.; Yeung, C.-H. J. Organomet. Chem. 2001, 619, 204. 
30 (a) Allen, J. V.; Frost, C. G.; Williams, J. M. J. Tetrahedron: Asymmetry 1993, 4, 649. (b) Allen, J. 
V.; Williams, J. M. J. Tetrahedron: Asymmetry 1994, 5, 277. 
31 Braga, A. L.; Rubim, R. M.; Schrekker, H. S.; Wessjohann, L. A.; de Bolster, M. W. G.; Zeni, G.; 
Sehnem, J. A. Tetrahedron: Asymmetry 2003, 14, 3291. 
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   Mono(oxazolines) N,S-Ligands 
This family of oxazolines, having an auxiliary sulfur donor atom, was developed 
first by Williams in 1993 as efficient ligand for a benchmark palladium-catalyzed 
alkylation of 1,3-diphenyl-2-propenyl acetate with dimethyl malonate with good 
selectivity.
32
 
A few years later, Christoffers synthetized tridentate ligands 48 and 49 having 
heteroaryl and thioether donor groups and screened them in the asymmetric Michael 
reaction of β-keto ester with methyl vinyl ketone using several metal salts. Best 
results were achieved with nickel(II) acetate and ligand 49d (Scheme 2.6).
33
  
 
                                                     
32 (a) Allen, J. V.; Coote, S. J.; Dawson, G. J.; Frost, C. G.; Martin, C. J.; Williams, J. M. J. J. Chem. 
Soc., Perkin Trans. 1 1994, 2065. (b) Dawson, G. J.; Frost, C. G.; Martin, C. J.; Williams, J. M. J. 
Tetrahedron Lett. 1993, 34, 7793. (c) Frost, C. G.; Williams, J. M. J. Tetrahedron Lett. 1993, 34, 
2015. 
33 Christoffers, J.; Mann, A.; Pickardt, J. Tetrahedron 1999, 55, 5377. 
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Scheme 2.6 
 
 
2.1.2 Bis(oxazolines)  
 
   In 1986, Pfaltz and co-workers developed semicorins 50,
34
 a new class of 
bidentate ligands having a rigid scaffold defined by the planar π system and the two 
heterocycles. This feature makes them attractive as ligand for asymmetric metal 
catalysis.  
These complexes showed a very high enantioselectivity in copper-catalyzed 
asymmetric cyclopropanation of olefins
35
 and the cobalt-catalyzed conjugate 
addition of α,β-unsaturated esters and amides.36 
The electron-rich vinylogous amidine group imparts an electron donating character 
to the ligands, reducing the electrophilicity of the metal center. For some reactivity, 
is preferable to have a weak electron donating character or even a π-acceptor 
ligand.
37
 In order to decrease this effect, neutral analogues of the semicorrins 50, 
(bis)oxazolines 51 and other ligands such as bi-oxazolines and aza-semicorrins 
were independently developed by several groups in the early 90’s.38 These 
bis(oxazolines), commonly called BOX, were then successfully applied with 
excellent results to a wide range of reactions including cyclopropanation of olefins 
and Diels-Alder reactions. 
                                                     
34 Fritschi, H.; Leutenegger, U.; Pfaltz, A. Angew. Chem. Int. Ed. 1986, 25, 1005. 
35 Pfaltz, A. Acc. Chem. Res. 1993, 26, 339. 
36 (a) Leutenegger, U.; Madin, A.; Pfaltz, A. Angew. Chem. Int. Ed. 1989, 28, 60. (b) von Matt, P.; 
Pfaltz, A. Tetrahedron: Asymmetry 1991, 2, 691. 
37 Leutenegger, U.; Umbricht, G.; Fahrni, C.; von Matt, P.; Pfaltz, A. Tetrahedron 1992, 48, 2143. 
38 (a) Evans, D. A.; Woerpel, K. A.; Hinman, M. M.; Faul, M; M. J. Am. Chem. Soc. 1991, 113, 726. 
(b) Corey, E. J.; Imai, N.; Zhang, H.-Y. J. Am. Chem. Soc. 1991, 113, 728. 
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Since then, the popularity of these ligands rapidly increased due to two factors: the 
ease of synthesis and the catalytic activity. Ligands 50 are readily obtained by a 
simple 2-3 step procedure. In this field a variety of options are available, among 
which, worth mentioning are Corey’s39 , Masamune’s40 and Evans’s.41 
Several hundred BOX ligands have been developed so far and used in various 
reactions such as Diels-Alder, aziridination, cyclopropanation, allylic substitution, 
Mukayama, Michael, and many others.
42
  
 
 
(Bis)oxazolines with a stereocenter 
   (Bis)oxazolines with a carbon spacer between the two oxazolinic rings are the 
most frequently used, affording high selectivity in a wide range of metal-catalyzed 
reactions. Modification on the nature, size and flexibility of the linker and 
substituents on the two oxazolines, have led to the development of numerous chiral 
ligands. 
In 1998 Desimoni developed ligand 53, having a bulky 2-naphthyl group at 4-
position of the oxazolines, in an attempt to increase the selectivity of 52a. The aim 
was achieved in the Lewis acid-catalyzed Diels-Alder reaction of cyclopentadiene 
                                                     
39 Corey, E. J.; Imai, N.; Zhang, H.-Y. J. Am. Chem. Soc. 1991, 113, 728. 
40 (a) Lowentahl, R. E.; Abiko, A.; Masamune, S. Tetrahedron Lett. 1990, 31, 6005. (b) Lowentahl, 
R.E.; Masamune, S. Tetrahedron Lett. 1991, 32, 7373. (c) Desimoni, G.; Faita, G.; Mella, M. 
Tetrahedron 1996, 52, 13649. 
41 Evans, D. A.; Woerpel, K. A.; Scott, M. J. Angew. Chem. Int. Ed. 1992, 31, 430. 
42 Desimoni, G.; Faita, G.; Jørgensen, K. A. Chem. Rev. 2006, 106, 3561. 
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and N-alkenoyl-oxazolidin-2-ones (Scheme 2.7) using different different metal 
salts. 
43
 
 
 
 
 
Scheme 2.7 
 
Product 54 was compared to ligands 52 by Rutjes using Cu(II) complexes in the 
Mukaiyama aldol reactions and Diels-Alder reactions obtaining enantioselections 
higher than that obtained with 52a but significantly lower than those achieved with 
tert-butyl-substituted ligand 52b.
44
 
In 2010 Fu performed the use of 52a in the nickel(II)-catalyzed asymmetric 
Kumada reaction of a wide variety of α-bromoketones45 with high enantioselectivity 
and more recently, Lu reported the use of Ligand 52c as efficient ligand for 
copper(II)-catalyzed enantioselective Friedel-Crafts reactions of substituted indoles 
with trifluoethylidene malonates.
46
 
                                                     
43 Crosignani, S.; Desimoni, G.; Faita, G.; Righetti, P. Tetrahedron 1998, 54, 15721. 
44 van Lingen, H. L.; van de Mortel, J. K. W.; Hekking, K. F. W.; van Delft, F. L.; Sonke, T.; Rutjes, 
F. P. J. T. Eur. J. Org. Chem. 2003, 317. 
45 Lou, S.; Fu, G. C. J. Am. Chem. Soc. 2010, 132, 1264. 
46 Wen, L.; Shen, Q.; Wan, X.; Lu, L. J. Org. Chem. 2011, 76, 2282. 
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Ligand 52d has recently been applied by Kim in the asymmetric Friedel-Crafts 
alkylations of indoles with α-phosphoric enones with excellent levels of 
enantioselectivity (up to 98%).
47
 
 (Bis)oxazolines ligands which possess hydroxy groups at the stereogenic 4-position 
of the oxazoline ring were deeply studied by Reiser, which developed ligands 55, 
suitable for both Copper and Zinc coordination. Ligands were tested in Copper(II)-
catalyzed conjugate addition of diethylzinc to cyclic enones and in Asymmetric 
addition of diethyl zinc to a range of aldehydes with good results (Scheme 2.8).
48
 
 
 
 
 
 
Scheme 2.8 
                                                     
47 Yang, H. T.; Kim, S. Org. Lett. 2007, 9, 1983  
48 Schinneri, M.; Seitz, M.; Kaiser, A.; Reiser, O. Org. Lett. 2001, 3, 4259.  
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In 2003 Reiser investigated the use of ligands 55 and 56, which possess secondary 
binding sites, in the Copper(I)-catalyzed cyclopropanation.
49
 In this work, the 
authors proposed that the hydrogen bond donor groups of the oxazolines 4-
substituents are able to form hydrogen bonding with the substrate, controlling the 
direction of the attack.   
An asymmetric version of ligands 52 has been synthesized by Orlandi in 2007. In 
his approach the two substituted 4-positions on the oxazolines bear different 
groups,
50
 and the ligand was applied to the Cu(II)-catalyzed Mukayiama aldol 
reaction with relatively low levels of selectivity (up to 55% ee).   
Reiser reported also an interesting variant of ligands 51 where the central atom, 
connecting the two oxazolines, was replaced by a nitrogen atom, giving rise at what 
are called aza-(bis)oxazolines. Ligands 57 were tested in the palladium-catalyzed 
allylic alkylation and copper catalyzed cyclopropanation with very interesting 
results. 
51
 
 
 
A recent work of Hong has introduced the concept of dual activation in the field of 
oxazolines. Hong developed a bifunctional aza-(bis)oxazoline 58 in which in 
addition to the two oxazolinic rings, a 1-benzyl-4-ethylpiperazine group is directly 
bounded to the nitrogen linker. This additional functionality causes a rate 
                                                     
49 Schinnerl, M.; Bo¨hm, C.; Seitz, M.; Reiser, O. Tetrahedron: Asymmetry 2003, 14, 765. 
50 Orlandi, S.; Benaglia, M.; Dell’Anna, G.; Celentano, G. J. Organomet. Chem. 2007, 692, 2120. 
51 Glos, M.; Reiser, O. Org. Lett. 2000, 2, 2045. 
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acceleration of 2.5 times and an increase of enantioselectivity (compared to the 
unsubstituted analogue) in the copper-catalyzed Henry reaction (Scheme 2.9).
52
 
 
 
Scheme 2.9 
 
(Bis)oxazolines with a stereoaxis 
   Ligands with biphenyl and binaphthyl backbone were the first stereoaxis-
containing (bis)oxazolines to be employed in a wide range of asymmetric 
reactions.
53,54
  
Rippert prepared a numerous library of (bis)phenyl analogues 59 and investigated 
their characteristics in the copper(I)-catalyzed cyclopropanation of styrene with 
ethyl diazoacetate
55
 finding a dependence of the enantioselectivity on the steric 
hindrance at the 5-position of the oxazoline. 
A binaphthyl skeleton was used by Hayashi to prepare ligands 60 and 61 for the 
application in Palladium(II)-catalyzed Wacker-type cyclizations.
56
  
                                                     
52 Lang, K.; Park, J.; Hong, S. J. Org. Chem. 2010, 75, 6424. 
53 (a) Uozumi, Y.; Kyota, H.; Kishi, E.; Kitayama, K.; Hayashi, T. Tetrahedron: Asymmetry 1996, 7, 
1603. (b) Gant, T. G.; Noe, M. C.; Corey, E. J. Tetrahedron Lett. 1995, 36, 8745. (c) Andrus, M. B.; 
Asgari, D.; Sclafani, J. A. J. Org. Chem. 1997, 62, 9365. 
54 (a) Uozumi, Y.; Kato, K.; Hayashi, T. J. Am. Chem. Soc. 1997, 119, 5063. (b) Uozumi, Y.; Kato, K.; 
Hayashi, T. J. Org. Chem. 1998, 63, 5071. 
55 Rippert, A. J. Helv. Chim. Acta 1998, 81, 676. 
56 Uozumi, Y.; Kyota, H.; Kato, K.; Ogasawara, M.; Hayashi, T. J. Org. Chem. 1999, 64, 1620. 
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An interesting class of (bis)oxazolines has been introduced by Sasai in 2004,
57
 and 
later refined by Zhou in the last years. In this area Zhou also reported the synthesis 
of ligands 62 and their application to the catalytic asymmetric N-H insertion of 
amines with diazoesters
58
 and in the enantioselective insertion of carbenoids into 
the O-H bonds of phenols.
59
 (Scheme 2.10) 
 
 
                                                     
57 Kato, T.; Marubayashi, K.; Takizawa, S.; Sasai, H. Tetrahedron: Asymmetry 2004, 15, 3693. 
58 (a) Liu, B.; Zhu, S.-F.; Wang, L.-X.; Zhou, Q.-L. Tetrahedron: Asymmetry 2006, 17, 634. (b) Liu, 
B.; Zhu, S.-F.; Chen, C.; Zhou, Q.-L. J. Am. Chem. Soc. 2007, 129, 5834. 
59 Chen, C.; Zhu, S.-F.; Liu, B.; Wang, L.-X.; Zhou, Q.-L. J. Am. Chem. Soc. 2007, 129, 12616. 
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Scheme 2.10 
 
Tridentate (bis)oxazolines  
   The introduction of a donor group into the link between the two oxazolines has 
led to the development of tridentate (bis)oxazolines ligands. The most important 
members of this category are ligands having a nitrogen atom in the linker. Other, 
less important, will not be mentioned here. 
“Pybox ligands” 63 are the best-known examples of this class of derivatives, 
developed first by Nishiyama. They have been used in a wide range of reactivity 
such as copper(I)-catalyzed oxidation of allylic and benzylic compounds,
60
 
copper(II)-catalyzed 1,3-dipolar cycloaddition of nitrones,
61
 palladium(II)-catalyzed 
resolution of racemic tosylaziridines,
62
 tin(II)- and copper(II)-catalyzed aldol 
reactions,
63,64
 scandium(III)-catalyzed Diels-Alder reaction,
65
 scandium(III)-
catalyzed and copper(II)-catalyzed Nazarov reaction,
66
 and even more.  
                                                     
60 Schulz, M.; Kluge, R.; Gelalcha, F. G. Tetrahedron: Asymmetry 1998, 9, 4341. 
61 Jensen, K. B.; Hazell, R. G.; Jørgensen, K. A. J. Org. Chem. 1999, 64, 2353. 
62 Leung, W.-H.; Mak, W.-L.; Chan, E. Y. Y.; Lam, T. C. H.; Lee, W.-S.; Kwong, H.-L.; Yeung, L.-L. 
Synlett 2002, 1688. 
63 Evans, D. A.; MacMillan, D. W. C.; Campos, K. R. J. Am. Chem. Soc. 1997, 119, 10859. 
64 Evans, D. A.; Murry, J. A.; Kozlowski, M. C. J. Am. Chem. Soc. 1996, 118, 5814. 
65 Fukuzawa, S.; Matsuzawa, H.; Metoki, K. Synlett 2001, 709. 
66 Tang, Y., et al. Angew. Chem. Int. Ed. 2010, 49, 4463. 
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Tridentate pybox 64 with trans-4,5-diphenyl substitution was developed by 
Desimoni and used in the Mukaiyama-Michael and Diels-Alder reaction.
67,68
 In both 
cases the selectivity proved to be excellent with quantitative yields and 
enantioselectivity up to 99% (Scheme 2.11). 
Zhang applied ligand 65 in the Ru(II)-catalyzed transfer hydrogenation of aromatic 
ketones
69
, demonstrating the importance of central NH comparing the excellent 
results of product 65 with the poor selectivity of the N-metylated analogue. 
 
 
Scheme 2.11 
 
                                                     
67Desimoni, G.; Faita, G.; Filippone, S.; Mella, M.; Zampori, M. G.; Zema, M. Tetrahedron 2001, 57, 
10203. 
68 Desimoni, G.; Faita, G.; Guala, M.; Pratelli, C. Tetrahedron 2002, 58, 2929. 
69 Jiang, Y.; Jiang, Q.; Zhang, X. J. Am. Chem. Soc. 1998, 120, 3817. 
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A successful application of 63c has been performed in the asymmetric nickel-
catalyzed Negishi cross-coupling of secondary α-bromo amides with organozinc 
reagents
70
, whereas ligand 63a proved to be suitable by Evans for the use in the 
Scandium-catalyzed asymmetric Sakurai-Hosomi additions.
71
 
Special mention is required for the studies of Willis, who recently reported the 
development of heterotridentate (bis)oxazoline 66 based on dibenzofuran moiety. 
The ligand was used in Mannich reaction
72
 and in the addition of nitrones to 
cyclopropanes
73
 with excellent enantioselectivity in both cases. 
 
 
 
2.1.3 Tris(oxazolines)  
 
   (Tris)oxazolines play in a marginal area in the world of oxazolines. However 
some works reported the synthesis of C3-symmetric ligands having mentionable 
results. 
Ligands 66 and 67 were developed by Katsuki and their efficiency was used in 
enantioselective oxidation of cycloalkenes with tert-butyl peroxybenzoate
74
 and in 
the copper(II)-catalyzed oxidative desymmetrization of racemic dicyclopentadiene 
derivatives.
75
   
                                                     
70 Fischer, C.; Fu, G. C. J. Am. Chem. Soc. 2005, 127, 4594. 
71 Evans, D. A.; Aye, Y.; Wu, J. Org. Lett. 2006, 8, 2071. 
72 Cutting, G. A.; Stainforth, N. E.; John, M. P.; Kociek-Ko¨hn, G.; Willis, M. C. J. Am. Chem. Soc. 
2007, 129, 10632. 
73 Sibi, M. P.; Ma, Z.; Jasperse, C. P. J. Am. Chem. Soc. 2005, 127, 16–5764. 
74 Kohmura, Y.; Katsuki, T. Tetrahedron Lett. 2000, 41, 3941. 
75 Kohmura, Y.; Katsuki, T. Synlett 1999, 1231. 
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Tripodal (tris)oxazolines 68 have been performed by Gade as ligand suitable for 
copper(I)-catalyzed asymmetric cyclopropanation of styrene.
76
  
 
 
 
2.2   Development and application of the catalytic system 
 
   As we discussed in the introduction, the concept of self-assembly of bidentate 
ligands through hydrogen bonding for combinatorial homogeneous catalysis was 
recently introduced, and several powerful ligands were described with outstanding 
reactivity and selectivity. Supramolecular ligands possess, besides the atom(s) 
coordinating the catalytic metal, additional functionalities capable of non-covalent 
interactions: mainly hydrogen or coordinative bonds. Hydrogen bond, is arguably 
the most practical and efficient, among the different kinds of non-covalent 
interaction that have been used so far. Several efficient and selective catalytic 
systems based on this strategy have recently been published, though containing 
exclusively phosphorus based ligands (i.e. phosphines, phoaphites, etc). 
In this chapter we will describe our idea to extend this approach to nitrogen ligands, 
and in particular to synthesize a new clad of supramolecular bis-oxazolines ligands 
which we called SupraBox. An urea functionality was introduced in the ligand 
through a linker moietry, to induce the self-assembly of the SupraBox ligands.  
                                                     
76 Bellemin-Laponnaz, S.; Gade, L. H. Angew. Chem., Int. Ed. Engl. 2002, 41, 3473. 
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2.2.1   Synthesis of the catalysts  
 
   In general terms a class of ligands suitable for a combinatorial exploitation should 
be accessed in a limited number of steps, through a highly modular synthesis which 
allows for the creation of a wide diversity from a limited number of building blocks. 
Our SupraBox ligands possess three possible tunable sites: i) the oxazoline moiety, 
ii) the linker, iii) the urea substituents which can be coupled in three straightforward 
synthetic steps involving only two chromatographic purifications (Scheme 2.12). 
 
Scheme 2.12 
 
Three different isocyanates (phenyl, cyclohexyl and 2-nitrophenyl isocyanate) were 
included in the screening to vary the H-bond forming properties of the ligands. The 
formation of the urea is probably the limiting step in terms of total yield of the 
60 
 
synthesis, the main problem being due to the low solubility of the different amino 
acids used in the reaction. In general THF proved to be a good solvent even if the 
solubility of products was not optimal. In one case the almost total insolubility of 
the 2-amino-isobutyric acid has necessitated the use of a 2M NaOH solution as 
solvent, anyway leading low yield.   
Four different linkers, namely β-alanine, 2-amino-isobutyric acid, L- and D-aspartic 
acid α-pyrrolidinamide and 3-aminobenzoic acid, were used to impart different 
conformational rigidity to the ligands and hence influence the global conformation 
of the complexes (Scheme 2.13). 
 
 
Scheme 2.13 
 
 Achiral linkers were readily available commercial products, whereas the chiral 
linker was synthesized ad hoc starting from aspartic acid (Scheme 2.14). In 
particular, the presence of stereocenters at the α-position of carboxylic groups (and 
hence of oxazolines) were deemed dangerous in terms of the stereo-integrity of the 
final ligand. Oxazolines in fact are known  to be susceptible of epimerization during 
the coupling of the starting carboxylic acid with the amino alcohols and the 
subsequent cyclization. On the other hand commercial enantiopure β3-homo amino 
acids are very expensive and, despite several published synthetic protocols, suffer 
from difficult availability in multigram quantities. 
61 
 
Scheme 2.14 
Coupling of the amino alcohols gave no particular problem, using standard 
procedures. On the other hand, chromatographic purification of the resulting amide 
was complicated by the use of DIPEA. An acidic work-up would be theoretically 
sufficient to remove the base, but the tendency of the product to be soluble in 
aqueous phases made this procedure not recommended.       
Different substituents on the oxazolinic ring lead obviously to a different chemical 
environment around the catalyst metal and consequently different levels of steric 
hindrance can modify the selectivity of the catalyst. Due to the synthetic strategy 
the stereochemistry and the nature of the substituent is related to the starting amino 
alcohol (Scheme 2.15). 
 
Scheme 2.15 
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Cyclization reactions to give oxazoline ring were carried out using 
diethylaminosulfur trifluoride (DAST) at -78°C. Due to the presence in the 
molecule of other nucleophilic oxygen atoms, an excess of DAST (2.2 equiv.) was 
necessary to obtain the cyclized product in considerable yields (Scheme 2.16). 
 
 
Scheme 2.16 
 
Due to this variables, a small library of 16 ligands Ox 1-16 was prepared for testing. 
In addition, one mono(oxazoline) Ox-0 devoid of functional group capable of 
hydrogen bond were added to validate the importance of the supramolecular 
interaction.  
63 
 
 
 
2.3.2   Complexation studies 
 
   Before screening the library in catalytic applications we decided to investigate the 
formation of transition metal complexes of our ligands. Bis(oxazolines) have 
developed into one of the most useful ligand classes also due to their ability to 
64 
 
coordinate to different metals
77
 and, also to impart specific coordination geometries 
to these metal ions. We will focus our attention on copper, which is known to be 
one of the metals with more coordination geometries, forming tri- tetra- penta- and 
hexacoordinate complexes. 
Tricoordinated complexes are almost exclusively prerogative of Cu(I), and in 
particular of copper(I)-carbene complexes as intermediates in cyclopropanations of 
alkenes with diazoacetates.
78
 
The two main geometries possible for tetracoordinated bis(oxazoline) complexes 
are square-planar and tetrahedral. These are indeed widely found for such 
complexes with varying degrees of distortion. Zinc (II), nickel (II) and iron(II) 
complexes have proven to form distorted tetrahedral complexes, meanwhile with 
copper(II) are considerably more distorted towards a square-planar geometry. Quite 
obviously, the chloride ligands, when present, orient themselves away from the 
ligand quadrants blocked by the sterically demanding substituent and in general is 
possible to say that the degree of distortion from the ideal thetrahedral geometry is 
increasing with the steric bulk of the oxazoline substitution (Scheme 2.17-A).
79
 A 
similar trend is present for square-planar Cu(II)-complexes, which prefer this 
geometry in presence of hydroxyl- or carbonyl-containing ligands. (Scheme 2.17-
B).
80
  
 
                                                     
77 S. Dagorne, S. Bellemin-Laponnaz, A. Maisse-François, Eur. J. Inorg. Chem. 2007, 913. 
78 R. Lowenthal, A. Abiko, S. Masamune, Tetrahedron Lett. 1990, 31, 6005; R.E. Lowenthal, S. 
Masamune, Tetrahedron Lett. 1991, 32, 7373; D.A. Evans, K.A.Woerpel, M.M. Hinman, M.M. Faul, 
J. Am. Chem. Soc. 1991, 113, 726. 
79 J. Thorhauge, M. Roberson, R.G. Hazell, K.A. Jørgensen, Chem. Eur. J. 2002, 8, 1888; D.A. Evans, 
S.J. Miller, T.v.M.P. Lectka, J. Am. Chem. Soc. 1999, 121, 7559; R. Rasappan, M. Hager, A. Gissibl, 
O. Reiser, Org. Lett. 2006, 8,  6099. 
80 D.A. Evans, G.S. Peterson, J.S. Johnson, D.M. Barnes, K.R. Campos, K.A. Woerpel, J. Org. Chem. 
1998, 63, 4541; D.A. Evans, T. Rovis, J.S. Johnson, Pure Appl. Chem. 1999, 71, 1407; D.A. Evans, T. 
Rovis, M.C. Kozlowski, C.W. Downey, J.S. Tedrow, J. Am. Chem. Soc. 2000, 122, 9134; D.A. Evans, 
T. Rovis, M.C. Kozlowski, J.S. Tedrow, J. Am. Chem. Soc. 1999, 121, 1994. 
65 
 
                                                                            
 
Metal R θ1/θ2  Metal R X θ1/θ2 
Cu Ph 45/38  Cu Ph H2O 79/66 
Cu tBu 45/45  Cu tBu H2O 52/50 
Cu iPr 31/25  Cu Ph PhCH=C(CO2Me)2 90/85 
    Cu tBu PhCH=C(CO2Me)2 79/75 
 
Scheme 2.17 
 
Hexacoordinate complexes are almost absent with bis(oxazolines), meanwhile 
pentacoordination is more widespread. The main part of examples are reported 
concerning square-pyramidal complexes (which moreover is the principal geometry 
recognizable with Py-BOX ligands) however also trigonal-bipyramidal geometry is 
possible. 
81
 
The copper (II) complex of ligand Ox-3 was obtained treating the ligand with CuCl2 
in CH2Cl2, followed by recrystallization from CH2Cl2/hexanes. Its molecular 
composition was assessed by ESI-MS spectroscopy and revealed one principal peak 
at m/z 613.3, corresponding to a copper atom coordinated to two molecules of 
ligand [CuL2]
+
 (Scheme 2.18). The reduction of Cu
2+
 to Cu
+
 has been reported to 
occur using ESI as ionization source.
82
  
                                                     
81 S. Hanessian, E. Jnoff, N. Bernstein, M. Simard, Can. J. Chem. 2004, 82,  306. 
82 Girault H., J. Am. Soc. Mass. Spectrom. 2008, 19, 560; Hoppiliard Y., J Am Soc Mass Spectrom 
1998, 9, 1217. 
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Scheme 2.18 
 
The presence of two ligands of Ox-3 coordinated to Cu
2+
 was further confirmed by 
a Job’s plot analysis of the absorbance of the complex as a function of the ligand 
stoichiometry (Scheme 2.19). Job’s plot technique exploits the correlation between 
a physical property and the amount of ligand in presence of a metal source,  
providing interesting information about the coordination processes of ligands to 
metal centers.
83
  
In our case, we measured the absorbance at 750nm as a function of the ligand/metal 
ratio, and a linear increase up to two equivalents of ligands added was observed, 
suggesting the presence of only one specie ascribable to one copper coordinated to 
two molecule of ligands. Some practical observations also suggested and 
anticipated the results of the experiment. The procedure requires multiple additions, 
directly in the quartz cuvette used for the analysis, of small amounts of ligand to the 
metal salt and in our case the solvent used was dichloromethane. Initially the 
solution was obviously clear and colorless due the insolubility of the salt and as the 
ligand was added it became greener. The important observation is that once one 
                                                     
83 Bühlmann, P., Olson, E. J., J. Org. Chem. 2011, 76, 8406. 
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equivalent of ligand was added, some unsolved copper chloride was still present on 
the bottom of the cuvette and some solid powder remained undissolved until the 
reaching of two equivalents of ligand globally added. 
This fact, in addition to the plot of absorbance values, led us to hypothesize the 
formation of only the desired product.  
 
Scheme 2.19 
 
Due to the paramagnetism of Cu(II), NMR spectroscopy could not be used to 
characterize the complex; therefore the formation of other complexes in solution 
was further studied. Palladium chloride was reacted with two equivalents of ligand 
Ox-3 in dichloromethane and the complex [Pd(Ox-3)2Cl2] was isolated by 
precipitation with hexanes and since in this case the complex is diamagnetic, the 
formation of the supramolecular bidentate specie was studied by 
1
H-NMR (Scheme 
2.20).  
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Scheme 2.20 
 
Our attention focused on the more representative signals of NH protons. In fact, 
while the coordination of the oxazoline to the metal ion is almost certain, the 
coordination of two ligands on the same atom and moreover an interaction between 
them is far from obvious. A study of the chemical shifts of protons, which should 
give rise to H-bonding, could therefore provide important information.  
The hydrogen bonding status of the NH protons for both the free ligand and the Pd-
complex was then studied by 
1
H NMR spectroscopy, and in particular the variation 
of the chemical shift of the N-H signals upon dilution was considered for both the 
ligand and the complex.  
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 NHA NHB 
conc (mM) 
free ligand 
δ (ppm) 
complex 
δ (ppm) 
free ligand 
δ (ppm) 
complex 
δ (ppm) 
5 5,6210 5,7430 6,803 7,029 
10 5,6530 5,7600 6,875 7,047 
20 5,7800 5,7990 7,185 7,086 
40 5,8940 5,8430 7,481 7,129 
 
 
 
 
Also important is the correlation between the variation of chemical shifts and the 
variation of the concentration in free ligand and complex. We chose the [5mM] 
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sample as reference. This trend, if present, is important to show an eventually 
chemically different behavior of the NH, that in our case would indicate the 
presence of hydrogen bonding. 
 NHA NHB 
conc (mM) 
free ligand 
Δδ / Δconc 
complex 
Δδ / Δconc 
free ligand 
Δδ / Δconc 
complex 
Δδ / Δconc 
5 0,0000 0,0000 0,0000 0,0000 
10 0,0320 0,0170 0,0720 0,0180 
20 0,1590 0,0560 0,3820 0,0570 
40 0,2730 0,1000 0,6780 0,1000 
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The results clearly show that free ligands and complex have a different behavior. 
The chemical shifts of both NH in the complex are less influenced by concentration 
and at the same time more deshielded compared to the free ligand. In particular 
NHB appears fairly independent from the concentration.  
What now seems to be curious is the lack of different sets of signals. Since one 
ligand act as donor the other as acceptor, two different sets of chemical shift should 
be present. Therefore we decided to investigate the behavior of complex depending 
on the temperature and we found that at temperature lower than 268K two signals 
appeared. This experiment, commonly used to differentiate between random-coil 
peptides and peptides in hydrogen bonded conformations, in addition to the 
previous observations, indicated that the two ligands coordinated to the metal atom 
interact intramolecularly via hydrogen bonds. 
 
 
2.3.3   Catalytic applications 
 
   Copper bis-oxazoline complexes have been shown to be efficient catalysts in the 
kinetic resolution of racemic diols and in particular hydrobenzoin. For this reason 
we decided to screen our small library of ligands in this reaction (Scheme 2.21). 
The reaction was carried out in dichloromethane using half equivalent of benzoyl 
chloride and 5 mol% of CuCl2 and 10 mol% of the chosen ligand.  
Isopropyl substitution on the oxazoline ring gives best results in term of 
enantioselectivity independently of linker and urea used in the ligand. Aromatic 
linker (entries 12-15) hampers enantioselectivity, probably because of the high 
rigidity does not allow the rapprochement of the two urea functionalities. Rigidity 
itself seems to thwart selectivity but probably is not the main cause (entries 7-8). 
Stereocenters on the linker don’t improve ee (entries 10-11 vs. entry 4). The 
absence of selectivity with the use of Ox-0 demonstrates the importance of the self-
assembled structure. 
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Entry Ligand Isolated Yield (%) er % (R,R:S,S) 
1 Ox-0 40 50 : 50 
2 Ox-1 45 7 : 93 
3 Ox-2 43 85 : 15 
4 Ox-3 44 93 : 7 
5 Ox-4 47 40 : 60 
6 Ox-5 45 51 : 49 
7 Ox-6 41 72 : 28 
8 Ox-7 44 82 : 18 
9 Ox-8 26 22 : 78 
10 Ox-9 37 61 : 39 
11 Ox-10 35 68 : 32 
12 Ox-11 35 50 : 50 
13 Ox-12 38 67 : 33 
14 Ox-13 17 56 : 44 
15 Ox-14 39 57 : 43 
16 Ox-15 28 43 : 57 
17 Ox-16 34 60 : 40 
 
Scheme 2.21 
 
To better investigate the role of the acylating agent the reaction was performed in 
the same conditions but using acetyl chloride, tosylchloride and pivaloyl chloride. 
The latter two proved to be not reactive under these conditions. The results with 
acetyl chloride are reported in Scheme 2.22. Unfortunately, acetyl chloride 
produced generally only low selectivity except Ox-8 which gave a moderate 48% 
ee. 
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Entry Ligand Conversion (%) er % (sx:dx) 
1 Ox-1 30 39 : 61  
2 Ox-3 29 56 : 44 
3 Ox-7 42 64 : 36  
4 Ox-8 43 26 : 74 
5 Ox-11 37 46 : 54  
6 Ox-12 31 54 : 46  
7 Ox-13 32 53 : 47  
8 Ox-14 34 53 : 47 
9 Ox-16 28 52 : 48 
  Scheme 2.22 
 
The scope of the reaction was then explored with the commercially available 
substrates S1-S5, which were screened in the selective benzoylation. Unfortunately 
lower ee’s were obtained in all cases, and only racemic dimethyl tartrate caused 
53% ee Here below (Scheme 2.23) are reported only the best results for each 
substrate.    
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Entry Substrate Ligand Yield (%) er % (sx:dx)  
1 S1 Ox-3 5 64 : 36 
2 S2 Ox-3 38 54.5 : 45.5 
3 S3 Ox-3 39 76.5 : 23.5 
4 S4 Ox-7 41 65 : 35 
5 S5 Ox-3 traces n.d. 
Scheme 2.23 
 
While the kinetic resolution of racemic substrates by acylation has found several 
solutions using both metal and organo-catalysis, the desymmetrization of meso-
diols and in particular meso-hydrobenzoin, was not reported with copper 
bis(oxazoline) complexes. Unexpectedly, reactivities were observed with 
enentioselectivities largely comparable, and in some cases even better, with respect 
to the racemic substrate (Scheme 2.24). Also in this screening the best result was 
achieved using ligand Ox-3 and Ox-1, while other ligands caused in general similar 
or poorer results (e.g. Ox-2 and Ox-10). 
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Entry Ligand Yield (%) er % (sx:dx) 
1 Ox-0 73 50 : 50 
2 Ox-1 97 11 : 89 
3 Ox-2 77 52 : 48 
4 Ox-3 92 94 : 6 
5 Ox-4 70 38 : 62 
6 Ox-6 89 69 : 31 
7 Ox-7 88 84 : 16 
8 Ox-8 99 27 : 63 
9 Ox-9 68 70 : 30 
10 Ox-10 62 60 : 40 
11 Ox-13 68 59 : 41 
12 Ox-15 74 48 : 52 
Scheme 2.24 
 
Pivaloyl chloride and tosyl chloride proved to be unreactive, while concerning other 
substrates, only dimethyl tatrtate was used obtaining the same enantioselectivity of 
S3 (54% ee vs. 53%). 
To extend the application of our ligands to different metals, we decided to 
investigate palladium catalyzed reactions. Several reactions were carried out but 
unfortunately only one gave interesting results. It was the Pd(II)-catalyzed 
asymmetric desymmetrization of meso-cyclopenten-2-ene-1,4-diol biscarbamate.
84
 
Different ligands and conditions were tested (Scheme 2.25) and best results were 
achieved in THF, with Ox-13. Triethylamine proved to be necessary to obtain good 
yield but deleterious for enantioselectivity. 
                                                     
84 Ruffo, F., Del Litto, R., De Roma, A., D’Errico, A., Magnolia, S., Tetrahedron: Asymmetry 2006, 
17, 2265. 
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Scheme 2.25 
 
To explore different copper-catalyzed reactivity our attention was focused on the 
insertion of carbenoids into N-H and O-H bonds. Indeed this reaction is known to 
take place in dichloromethane and is catalyzed by Cu(I). Moreover Zhou in 2007 
Entry Ligand Solvent Time (h) Additive Conv. % 
er % 
(S,R:R,S) 
1 none THF 24 - - - 
2 Ox0 THF 20 - - - 
3 Ox1 THF 6 - <5 40 : 60 
4 Ox1 THF 20 - 30 37.5 : 62.5 
5 Ox1 THF 20 TEA (1.0 equiv) 87 45 : 55 
6 Ox1 THF 48 - <5 38 : 62 
7 Ox1 DCM 20 - Traces - 
8 Ox1 DCM 20 TEA (1.0 equiv) 18 47.5 : 52.5 
9 Ox3 THF 20 - Traces 61 : 39 
10 Ox3 THF 20 TEA (1.0 equiv) 100 52 : 48 
11 Ox3 THF 48 - <5 63 : 37 
12 Ox7 THF 20 - 39 - 
13 Ox7 THF 48 - 19 - 
14 Ox8 THF 48 - 11 46 : 54 
15 Ox11 THF 20 - 18 26 : 74 
16 Ox11 THF 48 - 23 27.5 : 72.5 
17 Ox12 THF 48 - 36 54 : 46 
18 Ox13 THF 20 - 10 22.5 : 77.5 
19 Ox13 THF 20 TEA (1.0 equiv) 73 - 
20 Ox13 THF 48 - 25 75 : 25 
21 Ox14 THF 48 - <5 57.5 : 42.5 
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reported the use of chiral spiro bis(oxazolines) as efficient ligands for the reaction.
85
 
Unfortunately the tests gave only poor results (Scheme 2.26).  
 
 
Scheme 2.26 
 
 
2.2.4   Conclusions 
 
   In this chapter we have reported the synthesis of a new class of supramolecular 
bis(oxazolines) named SupraBox using urea moiety as self-assembly inducer. 
A library of 16 ligand, with different degree of structural diversity, has been 
prepared by a 3-step modular synthesis starting from readily available starting 
materials. Palladium- and Copper-complexes were characterized by NMR 
spectroscopy, UV spectroscopy and Mass spectrometry to investigate their 
structures and properties and used as catalysts in kinetic resolutions of racemic diols 
and in the desymmetrization of meso diols.  
Catalysts proved to give best results in the asymmetric benzoylation of 
hydrobenzoin and good enantiomeric excesses were achieved with both racemic 
and meso substrate. This unusual property, and the selectivity itself, proved to be 
correlate to the ligand's structure and in general more flexible ligands gave better 
results. We hypothesize that the above mentioned flexibility, peculiar of our system 
but not of classical Box and aza-Box, best fit to the structure of meso compounds, 
thus leading better results.  
 
                                                     
85 Zhou, Q. L., J. Am. Chem. Soc. 2007, 5834; Zhou, Q. L., J. Am. Chem. Soc. 2007, 12616. 
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2.2.5   Experimental part 
 
General Remarks  
   All reactions were carried out in flame-dried glassware with magnetic stirring 
under a nitrogen atmosphere, unless otherwise stated. Dry solvents (over molecular 
sieves in bottles with crown caps) were purchased from Sigma–Aldrich and stored 
under nitrogen. The reactions were monitored by analytical TLC using silica gel 60 
F254 precoated glass plates (0.25 mm thickness). Visualization was accomplished 
by irradiation with a UV lamp and/or staining with a potassium permanganate 
alkaline solution. Flash column chromatography was performed using silica gel 60 
Å, particle size 40–64 μm, following the procedure reported by Still and 
coworkers.
86
 
1
H NMR spectra were recorded with a spectrometer operating at 
400.13 MHz. Chemical shifts are reported in ppm with the solvent reference 
relative to tetramethylsilane (TMS) employed as the internal standard (CDCl3 δ = 
7.26 ppm). The following abbreviations are used to describe spin multiplicity: s = 
singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br. = broad signal, dd = 
doublet of doublets. 
13
C NMR spectra were recorded with a 400 MHz spectrometer 
operating at 100.56 MHz with complete proton decoupling. Chemical shifts are 
reported in ppm relative to TMS with the respective solvent resonance as the 
internal standard (CDCl3, δ = 77.23 ppm). Infrared spectra were recorded with a 
standard FTIR spectrometer. Optical rotation values were measured with an 
automatic polarimeter with a 1-dm cell at the sodium D line (λ = 589 nm). HPLC 
was performed with an instrument equipped with a diode array detector using a 
chiral column. HRMS were measured with a Fourier Transform Ion Cyclotron 
Resonance (FT-ICR) Mass Spectrometer APEX II & Xmass software (Bruker 
Daltonics)–4.7 T Magnet (Magnex) equipped with ESI source, available at CIGA 
(Centro Interdipartimentale Grandi Apparecchiature), c/o Università degli Studi di 
Milano. MS were acquired either with a Thermo- innigan LCQ Advantage mass 
spectrometer (ESI ion source) or a VG Autospec M246 spectrometer (FAB ion 
                                                     
86 W. C. Still, M. Kahn, A. Mitra, J. Org. Chem. 1978, 43, 2923. 
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source). Elemental analyses were performed with a Perkin–Elmer Series II 
CHNS/O Analyzer 2000.  
 
 
Materials 
   Commercially available reagents were used as received. 4-(allyloxy)-2-amino-4-
oxobutanoic acid
87
 (2) and (S)-4-isopropyl-2-phenyl-4,5-dihydrooxazole
88
 (Ox-0) 
were prepared according to literature procedures.  
 
 
Synthesis and characterization of the ligands 
 
3-(3-phenylureido)propanoic acid (1a) 
 
Phenylisocyanate (5.0mL, 44 mmol, 1.0 equiv.) was dissolved in 220 mL THF and 
then β-alanine (3.92 g, 44 mmol, 1.0 equiv.) was added and the reaction mixture 
stirred at room temperature for 3 days. The mixture was treated with cold Et2O to 
provide the precipitation of the product. After filtration the crude product was 
purified by flash chromatography eluting with 3→10% MeOH in DCM to yield 
product 1a as fine white powder (8.33g, 40 mmol, 91%). 
Rf = 0.24 (DCM/MeOH 95:5) ― m.p.160-161°C   ― 
1
H NMR (400 MHz, CD3OD, 
25°C): δ = 2.55 (t, 2H, J= 6.3 Hz), 3.47 (t, 2H, J= 6.3 Hz), 6.98 (t, 1H, J= 6.8 Hz), 
7.25 (dd, 2H, J= 8.4, 7.4 Hz), 7.33 (m, 2H). ― 13C NMR (100.6 MHz, CDCl3, 
25°C): δ = 34.1, 35.2, 119.0, 122.0, 128.4, 139.5, 156.8, 174.3. ― IR: ν = 3584, 
3329, 2725, 1694, 1638, 1571, 1108. ― C10H12N2O3 (208.21): calcd. C 57.68, H 
5.81, N 13.45; found C 57.73, H 5.57, N 13.81.  
                                                     
87 A. S. M. Ressurreicao, A. Bordessa, M. Civera, L. Belvisi, C. Gennari, U. Piarulli, J. Org. Chem. 
2008, 73, 652 
88 Focken, T., harette, A. B., Org. Lett, 2006, 14, 2985. 
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3-(3-(2-nitrophenyl)ureido)propanoic acid (1b) 
 
2-nitro-phenylisocyanate (1.000 g, 6.09 mmol, 1.0 equiv.) was dissolved in 30 mL 
THF and then β-alanine (1.085 g, 12.18 mmol, 2.0 equiv.) was added and the 
reaction mixture stirred at room temperature for 3 days. The mixture was treated 
with cold Et2O to provide the precipitation of the product. After filtration the crude 
product was purified by flash chromatography eluting with 3→5% MeOH in DCM 
to yield product 1b as fine yellow powder (1.077g, 4.25 mmol, 67%). 
Rf= 0.41 (DCM/MeOH 95:5) ― m.p.160-161°C ― 1H NMR (400 MHz, CDCl3, 
25°C): δ = 2.56 (t, 2H, J= 6.6 Hz), 3.48 (t, 2H, J= 6.6 Hz), 7.13 (ddd, 1H, J= 8.5, 
7.2, 1.3), 7.61 (ddd, 1H, J= 8.6, 7.2, 1.6), 8.12 (dd, 1H, J= 8.5, 1.6 Hz), 8.35 (dd, 
1H, J= 8.6, 1.3 Hz). ― 13C NMR (100.6 MHz, CD3OD, 25°C): δ = 33.8, 35.5, 
121.4, 122.1, 125.1, 134.6, 135.7, 137.1, 155.4, 174.0. ― IR: ν = 3583, 3393, 3330, 
2753, 2360, 1694, 1611, 1582, 1539, 1342, 1258, 1142, 1085, 798. ― C10H11N3O5 
(253.21): calcd. C 47.43; H 4.38; N 16.59; found C 47.62, 4.23, 16.2 
 
 
3-(3-cyclohexylureido)propanoic acid (1c) 
 
Cyclohexylisocyanate (2.86 mL, 22 mmol, 1.0 equiv.) was dissolved in 150 mL 
THF and then β-alanine (2.00 g, 22.4 mmol, 1.0 equiv.) was added and the reaction 
mixture stirred at room temperature for 3 days. The mixture was treated with cold 
Et2O to provide the precipitation of the product. After filtration the crude product 
was purified by flash chromatography eluting with 5→15% MeOH in DCM to yield 
product (1c) as fine white powder (3.60 g, 16.8 mmol, 76%). 
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Rf= 0.23 (DCM/MeOH 95:5) ― m.p.159-160°C  ― 1H NMR (400 MHz, DMSO, 
25°C): δ = 0.97-1.16 (m, 3H), 1.18-1.30 (m, 2H), 1.50 (m, 1H), 1.61 (m, 1H), 1.70 
(m, 1H), 2.31 (t, 2H, J= 6.5 Hz), 3.15 (q, 2H, J= 6.5 Hz), 5.74 (t, 1H, J= 5.8 Hz), 
5.83 (d, 1H, 7.9 Hz), 12.17 (s,1H).  
― 13C NMR (100.6 MHz, DMSO, 25°C): δ = 24.9, 25.8, 33.7, 35.5, 35.7, 48.1, 
157.7, 173.9. ― IR: ν = 3335, 1699, 1626, 1580, 1535, 1307, 1248, 1222, 1080, 
921. ― C10H18N2O3 (214.26): calcd. C 56.06; H 8.47; N 13.07; found C 55.87, H 
8.62, N 12.72. 
 
 
2-methyl-2-(3-phenylureido)propanoic acid (1d) 
 
2-aminoisobutyric acid (3.0 g, 29 mmol, 1.3 equiv) was suspended in 10 mL of 2M 
NaOH then phenylisocyanate (2.37 mL, 22 mmol, 1.0equiv) was added and the 
mixture reaction was stirred for 60 minutes at room temperature. The mixture was 
filtered and the product was precipitated from solution by slow addition of 1M HCl. 
The white solid was dissolved in 10 mL of 1M NaOH and the solution washed with 
DCM. Addition of 1M HCl provides the precipitation of product 1d as fine white 
powder (1.73 g, 7.78 mmol, 35%). 
Rf= 0.37 (DCM/MeOH 95:5) ― m.p.157-158°C ― 1H NMR (400 MHz, CD3OH, 
25°C): δ = 1.53 (s, 6H), 6.41 (s, 1H), 6.95 (m, 1H), 7.24 (m, 2H), 7.30 (m, 2H), 
8.19 (s, 1H). ― 13C NMR (100.6 MHz, CD3OD, 25°C): δ = 24.6, 55.3, 118.6, 
121.9, 128.3, 139.4, 155.7, 177.3. ― IR: ν= 3381, 2724, 1704, 1648, 1544, 1308, 
1158, 1069. ― C11H14N2O3 (222.24): calcd. C 59.45; H 6.35; N 12.60; found C 
59.55, H 5.55, N 12.61. 
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4-(allyloxy)-4-oxo-2-(3-phenylureido)butanoic acid (3a-3b) 
 
4-(allyloxy)-2-amino-4-oxobutanoic acid hydrochloride (1.20 g, 5.72 mmol, 1.0 
equiv.) was suspended in 57 mLTHF and triethylamine (0.79 mL, 5.72 mmol, 1.0 
equiv) added dropwise. The reaction mixture was vigorously stirred for 30 minutes 
then phenylisocyanate (0.65 mL, 5.72 mmol, 1.0 equiv) added and stirred for 3 days 
at room temperature. The mixture was treated with acold Et2O to provide the 
precipitation of a white powder. The solid was washed with KHSO4 1M to obtain 
product 3a and 3b as fine white powder (R-enantiomer: 1.394 g, 4.77 mmol, 83%. 
S-enantiomer: 1.407 g, 4.81 mmol, 84%). 
Rf= 0.28 (DCM/MeOH 95:5) ― m.p.186-187°C  ― 1H NMR (400 MHz, CDCl3, 
25°C): δ = 2.86 (bs, 2H), 4.54 (bs, 2H), 4.78 (bs, 1H), 5.19 (d, 1H, J= 10.4 Hz), 
5.26 (d, 1H, J= 17.1 Hz), 5.84 (m, 1H), 6.8 (bs, 1H), 6.96 (t, 1H, J= 6.8 Hz), 7.20 (t, 
2H, J= 7.1 Hz), 7.39 (d, 2H, J= 7.0 Hz), 8.46 (bs, 1H), 11.23 (bs, 1H). ― 13C NMR 
(100.6 MHz, CDCl3, 25°C): δ = 36.5, 49.9, 65.6, 118.4, 119.4, 122.6, 128.8, 131.8, 
139.1, 156.5, 170.9. ― IR: ν = 3311, 2738, 2603, 2531, 2496, 1716, 1702, 1596, 
1547, 1397, 1172, 1072, 1036, 851, 807. ― C14H16N2O5 (292.29): calcd. C 57.53; H 
5.52; N 9.58; found C 57.89, H 5.87, N 9.34. 
 
  
allyl 4-oxo-3-(3-phenylureido)-4-(pyrrolidin-1-yl)butanoate (4a-4b) 
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4-(allyloxy)-4-oxo-2-(3-phenylureido)butanoic acid (1.300 g, 4.45 mmol, 1.0 equiv) 
and N,N-diisopropylethylamine (1.90 mL, 11.1 mmol, 2.5 equiv.) were dissolved in 
45 mL DMF and the solution cooled at 0°C. HBTU (1.3equiv) was added and the 
solution stirred at the same temperature for 30 minutes, then pirrolidine (0.44 mL, 
5.34 mmol, 1.2 equiv.) was added and the reaction mixture stirred at 0°C for 60 
minutes and overnight at room temperature. 
The solvent was evaporated under reduced pressure and the mixture separated by 
flash chromatography eluting with MeOH (gradient from 2 to 6%) in DCM to yield 
the products 4a and 4b as pale yellow oil (R-enantiomer: 1.122 g, 3.24 mmol, 73%. 
S-enantiomer: 1.199 g, 3.47 mmol, 78%). 
Rf= 0.28 (DCM/MeOH 95:5) ― 1H NMR (400 MHz, CDCl3, 25°C): δ = 1.88 (m, 
2H), 1.99 (m, 2H), 2.68 (dd, 1H, J= 15.8, 6.7 Hz), 2.89 (dd, 1H, J= 15.8, 7.4 Hz), 
3.42 (m, 2H), 3.67 (m, 1H), 3.78 (m, 1H), 4.59 (t, 1H, J= 1.3 Hz), 4.61 (t, 1H, J= 
1.3 Hz), 5.01 (t, 1H, J= 7.0 Hz), 5.20 (ddd, 1H, J= 10.5, 2.7, 1.2 Hz), 5.31 (ddd, 1H, 
J= 17.2, 3.0, 1.6 Hz), 5.92 (m, 1H), 6.98 (m, 1H), 7.24 (m, 2H), 7.34 (dd, 2H, J= 
8.8, 1.0 Hz). ― 13C NMR (100.6 MHz, CDCl3, 25°C): δ = 23.7, 25.5, 36.6, 46.0, 
46.5, 48.2, 65.1, 117.2, 118.8, 122.3, 128.4, 132.1, 139.2, 155.7, 170.2, 170.4. ― 
IR: ν = 2721, 2656, 2512, 2345, 1721, 1678, 1600, 1329, 1178, 1109, 1074, 997, 
856. ― C18H23N3O4 (345.39): calcd. C 62.59; H 6.71; N 12.17; found C 62.33, H 
6.57, N 11.99. 
 
 
4-oxo-3-(3-phenylureido)-4-(pyrrolidin-1-yl)butanoic acid (1e-1f) 
 
allyl 4-oxo-3-(3-phenylureido)-4-(pyrrolidin-1-yl)butanoate (1.10g, 3.18mmol, 1.0 
equiv) was dissolved in 30mL DCM and the solution cooled at 0°C. Pyrrolidine 
(0.31 mL, 3.82 mmol, 1.2 equiv.), triphenylphosphane (0.149 g, 0.57 mmol, 0.18 
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equiv.) and tetrakis(triphenylphosphane)palladium(0) (0.147 g, 0.13 mmol, 0.04 
equiv.) were added and the reaction mixture stirred for 1 hour at 0°C. The mixture 
was poured into AcOEt (200mL) and extracted with satd. NHCO3 solution (5x 
30mL). Organic layers were acidified to pH 2 with 1M KHSO4 solution. The 
acidified aqueous solutions was extracted with DCM (3x 25mL) and the combined 
organic layers were dried with Na2SO4 and concentrated under reduced pressure. 
The crude product was purified by flash chromatography eluting with 6% MeOH in 
DCM to yield the product as yellow solid (R-enantiomer 0.754 g, 2.47 mmol, 77%. 
S-enantiomer 0.778 g, 2.55 mmol, 80%). 
Rf= 0.30 (DCM/MeOH 95:5) ― m.p.168-169°C ― 1H NMR (400 MHz, CDCl3, 
25°C): δ = 1.85 (m, 2H), 1.96 (m, 2H), 2.73 (dd, 1H, J= 15.7, 6.2 Hz), 2.84, (dd, 
1H, J= 15.7, 6.1 Hz), 3.44 (m, 2H), 3.62 (m, 1H), 3.80 (m, 1H), 5.13 (m, 1H), 6.75 
(d, 1H, J= 8.8 Hz), 6.97 (t, 1H, J= 7.5 Hz), 7.21 (t, 2H, J= 7.5 Hz), 7.34 (d, 2H, J= 
7.7 Hz), 8.08 (s, 1H). ― 13C NMR (100.6 MHz, CDCl3, 25°C): δ = 24.1, 25.9, 
37.5, 46.6, 47.1, 48.2, 119.5, 122.7, 128.8, 139.1, 155.4, 170.6, 173.7. ― IR: ν = 
3347, 3202, 3145, 1728, 1685, 1615, 1553, 1518, 1481, 1312, 1203, 1119, 1046, 
997. ― C15H19N3O4 (305.33): calcd. C 59.01; H 6.27; N 13.76; found C 59.34, H 
5.99, N 13.44. 
 
 
3-(3-phenylureido)benzoic acid (1g) 
 
Phenylisocyanate (1.59  mL, 14.5 mmol, 1.0 equiv.) and 3-aminobenzoic acid (2.0 
g, 14.5 mmol, 1.0 equiv) were dissolved in 80 mL THF and the reaction mixture 
stirred at room temperature for 3 days. The mixture was treated with cold Et2O to 
provide the precipitation of the product as fine white powder (2.34 g, 9.15 mmol, 
63%). 
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Rf= 0.35 (DCM/MeOH 95:5) ― m.p.152-153°C ― 1H NMR (400 MHz, CD3OD, 
25°C): δ = 7.03 (m, 1H), 7.30 (m, 2H), 7.37-7.46 (m, 3H), 7.68 (ddd, 1H, J= 7.7, 
1.5, 1.1 Hz), 7.73 (ddd, 1H, J= 8.0, 2.3, 1.1 Hz), 8.08 (t, 1H, J= 1.7 Hz). ― 13C 
NMR (100.6 MHz, CD3OD, 25°C): δ = 119.1, 119.9, 122.6, 123.2, 123.5, 128.4, 
128.6, 131.2, 139.0, 139.5, 151.1, 168.2. . ― IR: ν = 3354, 2724, 1738, 1680, 1649, 
1556, 1310, 1156, 1066. ― C14H12N2O3 (256.26): calcd. C 65.62; H 4.72; N 10.93; 
found C 63.38, 4.44, 10.81. 
 
 
3-(3-(2-nitrophenyl)ureido)benzoic acid (1h) 
 
2-nitrophenyl isocyanate (1.0 g, 6.09 mmol, 1.0 equiv.) and 3-aminobenzoic acid 
(0.84 g, 6.09 mmol, 1.0 equiv) were dissolved in 60 mL THF and the reaction 
mixture stirred at room temperature for 3 days. The mixture was treated with cold 
Et2O to provide the precipitation of the product as fine yellow powder (1.36 g, 4.50 
mmol, 74%). 
Rf= 0.26 (DCM/MeOH 95:5) ― m.p.174-175°C  ― 1H NMR (400 MHz, DMSO, 
25°C): δ = 7.22 (ddd, 1H, J= 8.4, 7.2, 1.2 Hz), 7.42 (t, 1H, J= 7.8 Hz), 7.59 (dt, 1H, 
J=7.7, 1.2 Hz), 7.66-7.73 (m, 2H), 8.09 (dd, 1H, J= 8.4, 1.6 Hz), 8.15 (t, 1H, J= 1.8 
Hz), 8.29 (dd, 1H, J= 8.5, 1.2 Hz), 9.61 (s, 1H), 10.03 (s, 1H), 12.93 (s, 1H). ― 13C 
NMR (100.6 MHz, DMSO, 25°C): δ = 119.7, 122.8, 123.0, 123.7, 125.8, 129.6, 
131.9, 135.2, 135.4, 138.3, 140.0, 152.3, 167.6. ― IR: ν = 3354, 3281, 2724, 1829, 
1739, 1652, 1543, 1310, 1155, 1073, 949. ― C14H11N3O5 (301.25): calcd. C 55.82; 
H 3.68; N 13.95; found C 55.54, H 3.34, N 14.30. 
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Synthesis of products (5) 
 
General procedure  
   Carboxylic acid (1.1 equiv) and N,N-Diisopropylethylamine (3 equiv) were 
dissolved in DCM (0.1M solution) and the solution cooled at 0°C. HBTU 
(1.3equiv) was added and the solution stirred at the same temperature for 30 
minutes, then the aminoalcohol (1.0 equiv) was added and the reaction mixture 
stirred at 0°C for 60 minutes and overnight at room temperature. 
The solvent was evaporated under reduced pressure and the mixture separated by 
flash chromatography eluting with MeOH (gradient from 2 to 10%) in DCM to 
yield the product.   
 
 
(R)-N-(1-hydroxybutan-2-yl)-3-(3-phenylureido)propanamide (5a) 
 
According to the general procedure product 5a was yielded as white solid (0.604 g, 
2.16 mmol, 99%) starting from acid 1a (0.500g, 2.4mmol) and coupled with (R)-2-
aminobutan-1-ol.. 
Rf= 0.23 (DCM/MeOH 94:6) ― m.p. 131-132°C ― [α]20D = +32.01(c = 0.1, 
CHCl3) ― 
  1
H NMR (400 MHz, CD3OD, 25°C): δ = 0.93 (t, 3H, J= 7.4 Hz), 1.42 
(m, 1H), 1.63 (m, 1H), 2.46 (m, 2H), 3.43-3.52 (m, 4H), 3.80 (m, 1H), 6.97 (m, 
1H), 7.23 (m, 2H), 7.33 (m, 2H). ― 13C NMR (100.6 MHz, CD3OD, 25°C): δ = 
18.6, 23.9, 36.5, 37.3, 53.9, 64.8, 119.8, 123.0, 128.9, 138.9, 157.0, 173.3. ― IR: ν 
= 3327, 3265, 2724, 1738, 1647, 1557, 1307, 1154, 1070. ― C14H21N3O3 (279.33): 
calcd. C 60.20; H 7.58; N 15.04; found C 60.42, H 7.59, N 14.79. 
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(S)-N-(1-hydroxy-3-phenylpropan-2-yl)-3-(3-phenylureido)propanamide (5b) 
 
According to the general procedure product 5b was yielded as white solid (0.802 g, 
2.35 mmol, 98%) starting from acid 1a (0.500 g, 2.4 mmol) and coupled with (S)-2-
amino-3-phenylpropan-1-ol. 
Rf= 0.30 (DCM/MeOH 95:5).  ― m.p. 131-132°C ― [α]20D = -34.68 (c = 0.1, 
CHCl3) ― 
  1
H NMR (400 MHz, CD3OD, 25°C): δ = 2.38 (t, 2H, J= 6.4 Hz), 2.71 
(dd, 1H, J= 13.8, 8.1), 2.90 (dd, 1H, J= 13.8, 6.2 Hz), 3.38 (m, 2H), 3.53 (m, 2H), 
4.12 (m, 1H), 6.97 (m, 1H), 7.15 (m, 1H), 7.21-7.27 (m, 6H), 7.33 (m, 2H). – 13C 
NMR (100.6 MHz, CD3OD, 25°C): δ= 35.9, 36.1, 36.6, 52.8, 62.9, 118.8, 122.1, 
125.9, 126.9, 127.9, 128.4, 128.9, 138.4, 139.5, 156.8, 172.5. ― IR: ν = 3320, 
2724, 2453, 1829, 1738, 1625, 1545, 1308, 1263, 1156, 1071, 1036. ― C19H23N3O3 
(341.40): calcd. C 66.84; H 6.79; N 12.31; found C 67.01, H 6.46, N 12.37. 
 
 
(S)-N-(1-hydroxy-3-methylbutan-2-yl)-3-(3-phenylureido)propanamide (5c) 
 
According to the general procedure product 5c was yielded as white solid solid 
(0.569 g, 1.94 mmol, 89%) starting from the acid 1a (0.500 g, 2.4 mmol) and 
coupled with L-valinol. 
Rf= 0.22 (DCM/MeOH 95:5). ― m.p. 121-122°C ― [α]20D = -31.01(c = 0.1, 
CHCl3) ― 
  1
H NMR (400 MHz, CDCl3, 25°C): δ = 0.89 (d, 3H, J= 6.8 Hz), 0.91 
(d, 3H, J= 6.8 Hz), 1.83 (m, 1H), 2.57 (m, 2H), 2.90 (bs, 1H), 3.47-3.59 (m, 3H), 
3.67 (dd, 1H, J= 11.6, 3.2 Hz), 3.75 (m, 1H), 6.85 (d, 1H, J= 8.5 Hz), 6.98 (m, 1H), 
7.21 (m, 2H), 7.28 (m, 1H), 7.44 (m, 1H), 7.55 (m, 1H), 7.86 (bs, 1H). – 13C NMR 
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(100.6 MHz, CDCl3, 25°C): δ = 18.9, 19.4, 29.1, 36.5, 37.2, 57.4, 63.3, 119.8, 
123.1, 128.9, 138.7, 156.9, 173.4. ― IR: ν = 3337, 3243, 3087,2478, 2419, 1670, 
1632, 1560, 1503, 1354, 1295, 1260, 1141, 1117, 1063, 1029, 970, 760. ― 
C15H23N3O3 (293.36): calcd. C 61.41; H 7.90; N 14.32; found C 61.21, H 8.02, N 
14.72. 
 
 
 (R)-N-(2-hydroxy-1-phenylethyl)-3-(3-phenylureido)propanamide (5d) 
 
According to the general procedure product 5d was yielded as white solid (0.505 g, 
1.54 mmol, 64%) starting from acid 1a (0.500 g, 2.4 mmol) and coupled with (R)-2-
amino-2-phenylethanol. 
Rf= 0.31 (DCM/MeOH 95:5).  ― m.p. 119-120°C ― [α]20D = -37.23 (c = 0.1, 
CHCl3) ― 
  1
H NMR (400 MHz, CD3OD, 25°C): δ = 2.53 (m, 2H), 3.47 (t, 2H, J= 
6.5 Hz), 3.77 (dd, 1H, J= 11.2, 7.7 Hz), 3.75 (dd, 1H, J= 11.2, 5.3 Hz), 5.01 (dd, 
1H, J= 7.7, 5.3 Hz), 6.97 (tt, 1H, J= 7.3, 1.2 Hz), 7.20-7.35 (m, 9H). – 13C NMR 
(100.6 MHz, CD3OD, 25°C): δ= 35.9, 36.0 55.6, 64.9, 118.8, 122.0, 126.6, 127.0, 
128.1, 128.4, 139.5, 139.9, 156.8, 172.5. ― IR: ν = 3382, 3308, 2462, 2364, 1644, 
1598, 1544, 1313, 1243, 1153, 1125, 1078, 1056, 905. ― C18H21N3O3 (327.38): 
calcd. C 66.04; H 6.47; N 12.84; found C 65.89, H 6.75, N 12.56. 
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(S)-N-(1-hydroxy-3-phenylpropan-2-yl)-3-(3-(2-
nitrophenyl)ureido)propanamide (5e) 
 
According to the general procedure product 5e was yielded as yellow solid (0.211 g, 
0.546 mmol, 46%) starting from acid 1c (0.300 g, 1.18 mmol) and coupled with (S)-
2-amino-3-phenylpropan-1-ol. 
Rf = 0.31 (DCM/MeOH 95:5). ― m.p. 146-147°C ― [α]20D = -43.40 (c = 0.1, 
CHCl3) ― 
  1
H NMR (400 MHz, CD3OD, 25°C): δ = 2.40 (t, 2H, J= 6.6 Hz), 2.72 
(dd, 1H, J= 13.7, 8.3), 2.90 (dd, 1H, J= 13.7, 6.1 Hz), 3.41 (m, 2H), 3.51 (dd, 1H, 
J= 11.1, 5.6 Hz), 3.56 (dd, 1H, J= 10.6, 5.1 Hz), 4.14 (m, 1H), 7.13 (m, 2H), 7.23 
(m, 4H), 7.61 (ddd, 1H, J= 8.7, 7.2, 1.6), 8.13 (dd, 1H, J= 8.4, 1.6 Hz), 8.35 (dd, 
1H, J= 8.6, 1.2 Hz). – 13C NMR (100.6 MHz, CD3OD, 25°C): δ= 35.9, 36.2, 36.6, 
52.8, 62.8, 121.4, 122.1, 125.1, 125.9, 127.8, 128.9, 134.6, 135.7, 137.1, 138.4, 
155.4, 172.2. ― IR: ν = 3371, 3329, 3282, 2368, 1676, 1649, 1585, 1556, 1155, 
1116, 1082, 960, 840. ― C19H22N4O5 (355.43): calcd. C 59.06; H 5.74; N 14.50; 
found C 59.23, H 6.00, 14.76. 
 
 
(S)-3-(3-cyclohexylureido)-N-(1-hydroxy-3-methylbutan-2-yl)propanamide (2f) 
 
According to the general procedure product 5f was yielded as white solid (0.688 g, 
2.19 mmol, 99%) starting from acid 1c (0.500 g, 2.3 mmol) and coupled with L-
Valinol. 
Rf = 0.44 (DCM/MeOH 95:5). ― m.p. 140-141°C ― [α]20D = -30. 12 (c = 0.1, 
CHCl3) ― 
  1
H NMR (400 MHz, CD3OD, 25°C): δ = 0.91 (d, 3H, J= 6.7 Hz), 0.94 
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(d, 3H, J= 6.7 Hz), 1.17 (m, 3H), 1.34 (m, 3H), 1.60 (dt, 1H, J= 12.6, 3.8 Hz), 1.72 
(dt, 1H, J= 13.3, 3.8 Hz), 1.85 (m, 3H), 2.42 (m, 2H), 3.39 (m, 2H), 3.53 (dd, 1H, 
J= 11.4, 6.6 Hz), 3.61 (dd, 1H, J= 11.3, 4.4 Hz), 3.71 (m, 1H).  – 13C NMR (100.6 
MHz, CD3OD, 25°C): δ= 17.4, 18.6, 24.6, 25.3, 28.6, 33.3, 36.1, 36.5, 56.6, 61.9, 
158.9, 172.9. ― IR: ν = 3312, 3278, 2409, 1623, 1578, 1545, 1345, 1214, 
1123,1076, 965. ― C15H29N3O3 (299.41): calcd. C 60.17; H 9.76; N 14.03; found C 
59.89, H 10.09, 14.33. 
 
 
(S)-N-(1-hydroxy-3-methylbutan-2-yl)-2-methyl-2-(3-
phenylureido)propanamide (5g) 
 
According to the general procedure product 5g was yielded as white solid (0.630 g, 
2.04 mmol, 100%) starting from acid 1d (0.500 g, 2.25 mmol) and coupled with L-
Valinol. 
Rf = 0.25 (DCM/MeOH 95:5) ― m.p. 135-136°C ― [α]20D = -38.27 (c = 0.1, 
CHCl3) ― 
 1
H NMR (400 MHz, CDCl3, 25°C): δ = 0.86 (d, 3H, J= 6.8 Hz), 0.89 
(d, 3H, J= 6.7 Hz), 1.52 (s, 3H), 1.53 (s, 3H), 1.70 (m, 1H), 3.39 (t, 1H, J= 10.2 
Hz), 3.70 (m, 2H), 3.98 (bs, 1H), 6.43 (s, 1H), 6.86 (d, 1H, J= 9.8 Hz), 6.94 (t, 1H, 
J= 7.2 Hz), 7.15 (t, 2H, 7.6 Hz), 7.28 (d, 2H, 7.7 Hz), 8.09 (s, 1H). – 13C NMR 
(100.6 MHz, CHCl3, 25°C): δ= 19.2, 19.7, 24.7, 26,9 29.1, 56.8, 57.9, 64.2, 120.1, 
123.0, 128.7, 138.7, 156.1, 177.4. ― IR: ν = 3358, 2724, 1649, 1578, 1542, 1310, 
1150, 1133, 1087, 965. ― C16H25N3O3 (307.39): calcd. C 62.52; H 8.20; N 13.67; 
found C 62.22, H 8.06, N 14.01. 
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(R)-N-(1-hydroxybutan-2-yl)-2-methyl-2-(3-phenylureido)propanamide (5h) 
 
According to the general procedure product 5h was yielded as white solid (0.630 g, 
2.04 mmol, 100%) starting from acid 1d (0.500 g, 2.25 mmol) and coupled with 
(R)-2-aminobutan-1-ol. 
Rf = 0.27 (DCM/MeOH 95:5). ― m.p. 137-138°C ― [α]20D = +39.99 (c = 0.1, 
CHCl3)  ― 
  1
H NMR (400 MHz, CD3OD, 25°C): δ = 0.94 (t, 3H, J= 7.6 Hz), 1.46 
(m, 1H), 1.50 (s, 6H), 1.62 (m, 1H), 3.52 (d, 2H, J= 5.4 Hz), 3.81 (m, 1H), 6.97 (t, 
1H, J= 7.3 Hz), 7.23 (m, 2H), 7.33 (dd, 2H, J= 8.5, 1.0 Hz). – 13C NMR (100.6 
MHz, CHCl3, 25°C): δ= 10.6, 23.4, 24.8, 26.9, 53.9, 56.7, 65.6, 120.0, 123.0, 128.7, 
138.7, 156.0, 177.4. ― IR: ν = 3382, 3271, 3133, 2724, 1648, 1598,1542, 1494, 
1312, 1253, 1220, 1168, 1062, 845. ― C15H23N3O3 (293.36): calcd. C 61.41; H 
7.90; N 14.32; found C 61.22, H 8.01, N 13.97. 
 
 
(S)-N-((S)-1-hydroxy-3-methylbutan-2-yl)-4-oxo-3-(3-phenylureido)-4-
(pyrrolidin-1-yl)butanamide (5i) 
 
According to the general procedure product 5i was yielded as yellow pale oil (0.154 
g, 0.39 mmol, 60%) starting from the acid 1e (0.200 g, 0.65 mmol) and coupled 
with L-valinol. 
Rf = 0.33 (DCM/MeOH 95:5). ― [α]20D = -78.04 (c = 0.1, CHCl3) ―
  1
H NMR 
(400 MHz, CD3OD, 25°C): δ = 0.91 (d, 3H, J= 6.8 Hz), 0.94 (d, 3H, 6.7 Hz), 1.82-
1.93 (m, 2H), 2.00 (m, 1H), 2.57 (dd, 1H, J= 14.4, 7.4 Hz), 2.72 (dd, 1H, J= 14.4, 
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6.7 Hz), 3.38-3.60 (m, 4H), 3.69 (m, 2H), 3.79 (m, 1H), 5.02 (t, 1H, J= 7.2 Hz), 
6.98 (m, 1H), 7.24 (m, 2H), 7.33 (m, 2H). – 13C NMR (100.6 MHz, CD3OD, 25°C): 
δ= 17.4, 18.6, 23.7, 25.5, 28.5, 38.4, 45.9, 46.5, 48.8, 56.7, 61.7, 118.8, 122.2, 
128.4, 139.2, 155.8, 170.7. ― IR: ν = 3310, 3259, 2767, 2456, 2412, 1665, 1565, 
1508, 1459, 1334, 1300, 1211, 1098, 980, 876. ― C20H30N4O4 (390.48): calcd. C 
61.52; H 7.74; N 14.35; found C 61.66, H 7.60, N 14.53. 
 
 
(R)-N-((S)-1-hydroxy-3-methylbutan-2-yl)-4-oxo-3-(3-phenylureido)-4-
(pyrrolidin-1-yl)butanamide (5j) 
 
According to the general procedure product 5j was yielded as yellow pale oil (0.144 
g, 0.37 mmol, 56%) starting from the acid 1f (0.200 g, 0.65 mmol) and coupled 
with L-valinol. 
Rf = 0.33 (DCM/MeOH 95:5). ― [α]20D = -12.35 (c = 0.1, CHCl3) ― 
 1
H NMR 
(400 MHz, CD3OD, 25°C): δ = 0.89 (d, 3H, J= 6.8 Hz), 0.93 (d, 3H, J= 6.7 Hz), 
1.80-1.92 (m, 3H), 2.00 (m, 2H), 2.58 (dd, 1H, J= 14.3, 6.8 Hz), 2.73 (dd, 1H, J= 
14.3, 7.4 Hz), 3.35-3.63 (m, 4H), 3.70 (m, 2H), 3.82 (m, 1H), 4.99 (t, 1H, J= 7.0 
Hz), 6.98 (m, 1H), 7.24 (m, 2H), 7.33 (dd, 2H, J= 8.8, 1.2 Hz). – 13C NMR (100.6 
MHz, CD3OD, 25°C): δ= 17.3, 18.6, 23.7, 25.5, 28.5, 38.3, 45.9, 46.5, 48.7, 56.7, 
61.7, 118.7, 122.2, 128.4, 139.2, 155.8, 170.6, 170.8. ― IR: ν = 3300, 3256, 2789, 
2481, 2426, 1656, 1599, 1548, 1499, 1315, 1224, 1100, 978, 856. ― C20H30N4O4 
(390.48): calcd. C 61.52; H 7.74; N 14.35; found C 61.84, H 7.70, N 14.39. 
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(R)-N-(1-hydroxybutan-2-yl)-3-(3-phenylureido)benzamide (5k) 
 
According to the general procedure product 5k was yielded as white solid (0.565 g, 
1.72 mmol, 97%) starting from acid 1g (0.500 g, 1.95 mmol) and coupled with (R)-
2-aminobutan-1-ol. 
Rf = 0.40 (DCM/MeOH 95:5). ― m.p. 146-147°C ― [α]20D = +42.58 (c = 0.1, 
CHCl3) ― 
  1
H NMR (400 MHz, CD3OD, 25°C): δ = 1.00 (t, 3H, J= 7.5 Hz), 1.56 
(m, 1H), 1.76 (m, 1H), 3.63 (dd, 2H, J= 5.6, 0.9 Hz), 4.03 (m, 2H), 7.03 (t, 1H, J= 
7.3 Hz), 7.29 (dd, 2H, J= 8.5, 7.5 Hz), 7.36 (t, 1H, J= 7.8 Hz), 7.44 (dd, 2H, J= 8.7, 
1.2 Hz), 7.48 (dt, 1H, J= 7.7, 1.3 Hz), 7.58 (ddd, 1H, J= 7.9, 2.2, 1.1 Hz), 7.88 (t, 
1H, J= 1.8 Hz), 8.05 (d, 1H, J= 8.3 Hz). – 13C NMR (100.6 MHz, CD3OD, 25°C): 
δ= 9.6, 23.66, 53.7, 63.43, 117.9, 119.1, 121.2, 121.9, 122.6, 128.5, 128.7, 135.6, 
138.9, 139.4, 153.9, 169.2. ― IR: ν = 3383, 2724, 1697, 1648, 1542, 1154, 1069. 
― C18H21N3O3 (327.38): calcd. C 66.04; H 6.47; N 12.84; found C 65.93, H 6.70, N 
12.58. 
 
 
(S)-N-(1-hydroxy-3-phenylpropan-2-yl)-3-(3-phenylureido)benzamide (5l) 
 
According to the general procedure product 5l was yielded as white solid (0.689 g, 
1.77 mmol, 100%) starting from acid 1g (0.500 g, 1.95 mmol) and coupled with 
(S)-2-amino-3-phenylpropan-1-ol. 
Rf = 0.34 (DCM/MeOH 95:5). ― m.p. 157-158°C ― [α]20D = -50.29 (c = 0.1, 
CHCl3) ― 
  1
H NMR (400 MHz, CD3OD, 25°C): δ = 2.87 (dd, 1H, J= 13.7, 8.6 
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Hz), 3.03 (dd, 1H, J= 13.7, 6.2 Hz), 3.66 (d, 2H, J= 5.5 Hz), 4.34 (m, 1H), 7.04 (t, 
1H, J= 7.5 Hz), 7.17 (m, 1H), 7.29 (m, 6H), 7.37 (m, 2H), 7.45 (dd, 2H, J= 8.6, 1.0 
Hz), 7.56 (dt, 1H, J= 7.0, 2.2 Hz), 7.79 (m, 1H). – 13C NMR (100.6 MHz, CD3OD, 
25°C): δ= 36.6, 53.6, 62.9, 117.8, 119.0, 121.1, 121.8, 122.6, 125.9, 128.0, 128.5, 
128.6, 129.0, 134.7, 135.5, 138.5, 139.0, 139.3, 153.9, 168.8. ― IR: ν = 3324, 
2724, 1739, 1648, 1543, 1310, 1265, 1155, 1069, 876, 840. ― C23H23N3O3 
(389.45): calcd. C 70.93; H 5.95; N 10.79; found C 70.88, H 6.18, N 7.78. 
 
 
(S)-N-(1-hydroxy-3-methylbutan-2-yl)-3-(3-phenylureido)benzamide (5m) 
 
According to the general procedure product 5m was yielded as white solid (0.578 g, 
1.69 mmol, 96%) starting from acid 1g (0.500 g, 1.95 mmol) and coupled with L-
Valinol 
Rf = 0.38 (DCM/MeOH 95:5). ― m.p. 167-168°C ― [α]20D = -44.37 (c = 0.1, 
CHCl3) ― 
  1
H NMR (400 MHz, CD3OD, 25°C): δ = 1.00 (d, 3H, J= 6.8 Hz), 1.03 
(d, 3H, J= 6.8 Hz), 2.00 (m, 1H), 3.67-3.76 (m, 2H), 3.91 (m, 1H), 7.03 (t, 1H, J= 
7.3 Hz), 7.30 (m, 2H), 7.39 (t, 1H, J= 7.9 Hz), 7.44 (dd, 2H, J= 8.7, 1.2 Hz), 7.48 
(dt, 1H, J= 7.7, 1.3 Hz), 7.58 (ddd, 1H, J= 8.1, 2.1, 1.0 Hz), 7.88 (t, 1H, J= 1.8 Hz). 
– 13C NMR (100.6 MHz, CD3OD, 25°C): δ= 17.8, 18.7, 28.9, 57.4, 61.7, 117.9, 
119.0, 121.2, 121.8, 122.6, 128.4, 128.6, 135.7, 138.9, 139.4, 153.9, 169.2. ― IR: ν 
= 3266, 3200, 2722, 1656, 1609, 1565, 1501, 1310, 1221, 1167, 1089, 989, 840. ― 
C19H23N3O3 (341.40): calcd. C 66.84; H 6.79; N 12.31; found C 66.62, H 7.14, N 
12.14. 
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(S)-N-(1-hydroxy-3,3-dimethylbutan-2-yl)-3-(3-phenylureido)benzamide (5n) 
 
According to the general procedure product 5n was yielded as white solid (0.552 g, 
1.55 mmol, 88%) starting from acid 1g (0.500 g, 1.95 mmol) and coupled with (S)-
2-amino-3,3-dimethylbutan-1-ol. 
Rf = 0.37 (DCM/MeOH 95:5). ― m.p. 97-98°C ― [α]20D = -49.69 (c = 0.1, CHCl3) 
―   1H NMR (400 MHz, CD3OD, 25°C): δ = 1.02 (s, 9H), 3.63 (dd, 1H, J= 11.4, 
8.8 Hz), 3.68 (dd, 1H, J= 11.4, 3.5 Hz), 4.04 (dd, 1H, J= 8.8, 3.5 Hz), 7.04 (m, 1H), 
7.30 (m, 1H), 7.40 (t, 1H, J= 7.7 Hz), 7.42-7.50 (m, 3H), 7.59 (ddd, 1H, J= 7.9, 2.2, 
1.1 Hz) 7.87 (t, 1H, J= 1.7 Hz) – 13C NMR (100.6 MHz, CD3OD, 25°C): δ= 26.0, 
33.9, 54.4, 60.9, 117.9, 119.1, 121.3, 121.8, 122.6, 128.5, 128.7, 136.0, 138.9, 
139.2, 153.9, 169.9. ― IR: ν = 3278, 3204, 2727, 1670, 1625, 1589, 1553, 1500, 
1310, 1233, 1134, 1088, 1047, 840. ― C20H25N3O3 (355.43): calcd. C 67.58; H 
7.09; N 11.82; found C 67.44, H 7.16, N 12.11. 
 
 
(R)-N-(2-hydroxy-1-phenylethyl)-3-(3-phenylureido)benzamide (5o) 
 
 
According to the general procedure product 5o was yielded as white solid (0.420 g, 
1.12 mmol, 98%) starting from acid 1g (0.320 g, 1.25 mmol) and coupled with (R)-
2-amino-2-phenylethanol. 
Rf = 0.39 (DCM/MeOH 95:5). ― m.p. 112-113°C ― [α]20D = -46.89 (c = 0.1, 
CHCl3) ― 
  1
H NMR (400 MHz, CD3OD, 25°C): δ = 3.87 (d, 2H, J= 6.6 Hz), 5.21 
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(t, 1H, J= 6.6 Hz), 7.02 (t, 1H, J= 7.3 Hz), 7.23-7.45 (m, 10H), 7.51 (d, 1H, J= 7.7 
Hz), 7.58 (dd, 1H, J= 8.0, 1.1 Hz), 7.90 (s, 1H). – 13C NMR (100.6 MHz, CD3OD, 
25°C): δ= 56.4, 64.7, 118.0, 119.1, 121.3, 122.0, 122.6, 126.6, 127.0, 128.1, 128.5, 
128.7, 135.3, 138.9, 139.4, 139.9, 153.9, 168.9. ― IR: ν = 3300, 3205, 2727, 1646, 
1621, 1599, 1563, 1348, 1298, 1235, 1175, 1065, 844. ― C22H21N3O3 (375.42): 
calcd. C 70.38; H 5.64; N 11.19; found C 70.37, H 5.73, N 12.11. 
 
 
(S)-N-(1-hydroxy-3-phenylpropan-2-yl)-3-(3-(2-nitrophenyl)ureido)benzamide 
(5p) 
 
According to the general procedure product 5p was yielded as yellow solid (0.568 
g, 1.47 mmol, 97%) starting from acid 1h (0.500 g, 1.66 mmol) and coupled with L-
Valinol. 
Rf = 0.36 (DCM/MeOH 95:5). ― m.p. 140-141°C ― [α]20D = -47.64 (c = 0.1, 
CHCl3) ― 
  1
H NMR (400 MHz, CD3OD, 25°C): δ = 1.00 (d, 1H, J= 6.8 Hz), 1.03 
(d, 1H, J= 6.8 Hz), 2.01 (m, 1H), 3.71 (m, 2H), 3.92 (m, 1H), 7.19 (ddd, 1H, J= 8.4, 
7.4, 1.3), 7.42 (t, 1H, J= 7.8 Hz), 7.51 (dt, 1H, J= 7.8, 1.3 Hz), 7.67 (m, 2H), 7.97 
(t, 1H, J= 1.8 Hz), 8.19 (dd, 1H, J= 8.4, 1.4 Hz), 8.48 (dd, 1H, J= 8.6, 1.2 Hz). – 
13
C NMR (100.6 MHz, CD3OD, 25°C): δ= 17.8, 18.7, 28.9, 57.4, 61.7, 118.2, 
121.6, 122.0, 122.3, 125.2, 128.7, 134.7, 135.2, 135.8, 153.2, 169.2. ― IR: ν = 
3296, 3205, 1722, 1697, 1628, 1604, 1565, 1340, 1252, 1194, 1141, 1074, 1028, 
846. ― C19H22N4O5 (355.43): calcd. C 59.06; H 5.74; N 14.50; found C 59.27, H 
6.09, 14.83. 
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General procedure for cyclization of products (5) to oxazolines 
 
   Peptidic precursor 5 (1.0 equiv) was dissolved in THF (0.1M solution) and cooled 
at -78°C; than DAST (2.2 equiv) was added dropwise and the reaction stirred at the 
same temperature for 90 minutes. The mixture was filtered and the solvent 
evaporated under reduced pressure. The product was purified by flash 
chromatography eluting with MeOH (gradient from 1 to 5%) in DCM. 
 
 
(R)-1-(2-(4-ethyl-4,5-dihydrooxazol-2-yl)ethyl)-3-phenylurea (Ox-1) 
 
According to the general procedure product Ox-1 was yielded as pale yellow solid 
(0.410 g, 1.57 mmol, 77%) starting from precursor 5a (0.570 g, 2.04 mmol). 
Rf = 0.57 (DCM/MeOH 95:5). ― m.p. 68-69°C ― [α]20D = +29. 07 (c = 0.1, 
CHCl3) ― 
  1
H NMR (400 MHz, CHCl3, 25°C): δ = 0.91(t, 3H, J= 7.3 Hz), 1.56 (m, 
1H), 1.67 (m, 1H), 2.69 (t, 1H, J= 5.6 Hz), 3.57 (m, 2H), 4.06-4.20 (m, 2H), 4.63 (t, 
1H, J= 8.8 Hz), 6.38 (bs, 1H), 7.02 (t, 1H, J= 7.7 Hz), 7.25 (m, 2H), 7.39 (d, 2H, J= 
7.3 Hz), 7.75 (bs, 1H). – 13C NMR (100.6 MHz, CDCl3, 25°C): δ= 9.8, 24.0, 36.5, 
37.3, 53.6, 64.6, 119.6, 122.8, 128.9, 139.2, 156.8, 173.0. ― IR: ν = 3321, 2725, 
1640, 1556, 1309, 1243, 1156, 1070. ― C14H19N3O2 (261.32): calcd. C 64.35; H 
7.33; N 16.08; found C 64.44, H 7.43, N 15.41. 
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(S)-1-(2-(4-benzyl-4,5-dihydrooxazol-2-yl)ethyl)-3-phenylurea (Ox-2) 
 
According to the general procedure product Ox-2 was yielded as pale yellow solid 
(0.175g, 0.541mmol, 53%) starting from precursor 5b (0.350 g, 1.03 mmol). 
Rf = 0.51 (DCM/MeOH 95:5). ― m.p. 130-131°C ― [α]20D = -44.65 (c = 0.1, 
CHCl3) ― 
  1
H NMR (400 MHz, CHCl3, 25°C): δ = 2.44 (t, 2H, J= 5.8 Hz), 2.64 
(dd, 1H, J= 13.7, 7.8 Hz), 2.96 (dd, 1H, J= 13.7, 5.6 Hz), 3.43-3.62 (m, 2H), 3.98 (t, 
1H, J= 7.4 Hz), 4.20 (t, 1H, 8.4 Hz), 4.29 (m, 1H), 6.06 (bs, 1H), 7.03 (t, 1H, J= 7.3 
Hz), 7.13 (m, 2H), 7.16-7.40 (m, 8H), 7.63 (bs, 1H). – 13C NMR (100.6 MHz, 
CDCl3, 25°C): δ = 28.8, 36.6, 41.6, 66.7, 71.9, 120.5, 123.3, 126.6, 128.6, 129.1, 
129.2, 137.7, 139.0, 156.2, 167.4. ― IR: ν = 3331, 2724, 1679, 1632, 1595, 1565, 
1497, 1444, 1349, 1311, 1242, 1191, 1084, 975, 924. ― C19H21N3O2 (323.39): 
calcd. C 70.57; H 6.55; N 12.99; found C 70.78, H 6.32, N 13.04. 
 
 
(S)-1-(2-(4-isopropyl-4,5-dihydrooxazol-2-yl)ethyl)-3-phenylurea (Ox-3) 
 
According to the general procedure product Ox-3 was yielded as white solid 
(0.519g, 1.88mmol, 99%) starting from precursor 5c (0.560 g, 1.91 mmol) 
Rf = 0.59 (DCM/MeOH 95:5). ― m.p. 81-81°C ― [α]20D = -29.80 (c = 0.1, CHCl3) 
―   1H NMR (400 MHz, CD3OD, 25°C): δ = 0.89 (d, 3H, J= 6.8 Hz), 0.94 (d, 3H, 
J= 6.7 Hz), 1.74 (m, 1H), 2.52 (m, 2H), 3.49 (m, 2H), 3.91 (m, 1H), 4.07 (t, 1H, J= 
7.9 Hz), 4.31 (dd, 1H, J= 9.8, 8.7 Hz), 6.97 (m, 1H), 7.24 (m, 2H), 7.33 (dd, 2H, J= 
8.7, 1.2 Hz). – 13C NMR (100.6 MHz, CD3OD, 25°C): δ= 17.4, 18.6, 28.6, 36.1, 
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36.2, 56.6, 61.8, 118.8, 122, 128.4, 139.5, 156.8, 172.8. ― IR: ν = 3205, 2728, 
1694, 1639, 1594, 1527, 1380, 1353, 1168, 1077, 1029, 920, 832. ― C15H21N3O2 
(273.35): calcd. C 65.43; H 7.69; N 15.26; found C 65.61, H 7.99, 14.61. 
 
 
(R)-1-phenyl-3-(2-(4-phenyl-4,5-dihydrooxazol-2-yl)ethyl)urea (Ox-4) 
 
According to the general procedure product Ox-4 was yielded white solid (0.257g, 
0.83 mmol, 77%) starting from precursor 5d (0.500 g, 1.54 mmol). 
Rf = 0.59 (DCM/MeOH 95:5). ― m.p. 122-123°C ― [α]20D = +38.08 (c = 0.1, 
CHCl3) ― 
  1
H NMR (400 MHz, CHCl3, 25°C): δ = 2.51 (t, 2H, J= 5.8 Hz), 3.54 
(m, 2H), 4.06 (t, 1H, J= 8.3 Hz), 4.56 (dd, 1H, J= 10.1, 8.6 Hz), 5.09 (t, 1H, J= 9.2 
Hz), 6.18 (t, 1H, J= 6.0 Hz), 6.97 (m, 1H), 7.13-7.36 (m, 10H). – 13C NMR (100.6 
MHz, CDCl3, 25°C): δ= 28.9, 36.6, 67.7, 69.4, 120.1, 122.9, 127.8, 128.8, 129.0, 
139.1, 141.8, 156.4, 171.8 ― IR: ν = 3310, 2726, 1678, 1620, 1567, 1541, 1310, 
1245, 1180, 1076, 978, 845. ― C18H19N3O2 (309.36): calcd. C 69.88; H 6.12; N 
13.58; found C 69.58, H 6.34, N 13.89. 
 
 
(S)-1-(2-(4-benzyl-4,5-dihydrooxazol-2-yl)ethyl)-3-(2-nitrophenyl)urea (Ox-5) 
 
According to the general procedure product Ox-5 was yielded as yellow solid 
(0.101 g, 0.274 mmol, 50%) starting from precursor 5e (0.210 g, 0.543 mmol). 
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Rf = 0.34 (DCM/MeOH 95:5). ― m.p. 154-155°C ― [α]20D = -42.12 (c = 0.1, 
CHCl3) ―   1H NMR (400 MHz, CDCl3, 25°C): δ = 2.56 (t, 2H, J= 5.7 Hz), 2.78 
(dd, 1H, J= 13.7, 7.9 Hz), 3.08 (dd, 1H, J= 13.7, 5.4 Hz), 3.61 (m, 2H), 4.10 (dd, 
1H, J= 8.3, 7.4 Hz), 4.33 (t, 1H, J= 8.9 Hz), 4.49 (m, 1H), 6.17 (bs, 1H), 7.04 (m, 
1H), 7.20-7.35 (m, 5H), 7.58 (ddd, 1H, J= 8.7, 7.3, 1.6 Hz), 8.16 (dd, 1H, J= 8.4, 
1.5 Hz), 8.58 (d, 1H, J= 8.6 Hz), 9.72 (s, 1H). – 13C NMR (100.6 MHz, CDCl3, 
25°C): δ= 28.1, 36.6, 41.5, 66.6, 71.9, 121.3, 121.5, 125.7, 126.7, 128.6, 129.3, 
134.7, 135.8, 137.0, 137.4, 153.9, 172.2. ― IR: ν = 3353, 2724, 1651, 1613, 1543, 
1309, 1264, 1140, 1104, 794. ― C19H20N4O4 (368.38): calcd. C 61.95 ; H 5.47, N 
15.21; found C 61.66, H 5.78, N 14.99. 
 
 
(S)-1-cyclohexyl-3-(2-(4-isopropyl-4,5-dihydrooxazol-2-yl)ethyl)urea (Ox-6) 
 
According to the general procedure product Ox-6 was yielded as white solid (0.402 
g, 1.42 mmol, 62%) starting from precursor 5f (0.688 g, 2.30 mmol). 
Rf = 0.54 (DCM/MeOH 95:5). ― m.p. 103-104°C ― [α]20D = -39.45 (c = 0.1, 
CHCl3) ―   1H NMR (400 MHz, CDCl3, 25°C): δ = 0.90 (d, 3H, J= 6.8 Hz), 0.98 
(d, 3H, J= 6.8 Hz), 1.08-1.39 (m, 6H), 1.59 (dt, 1H, J= 12.8, 3.8 Hz), 1.71 (m, 2H), 
1.77 (m, 1H), 1.92 (m, 2H), 2.50 (m, 2H), 3.51 (m, 2H), 3.92 (m, 1H), 4.02 (t, 1H, 
J= 8.1 Hz), 4.32 (dd, 1H, J= 9.5, 8.5 Hz), 4.61 (d, 1H, J= 7.5 Hz), 5.49 (bs, 1H). – 
13
C NMR (100.6 MHz, CDCl3, 25°C): δ= 18.1, 18.7, 24.9, 25.6, 28.6, 32.5, 33.9, 
36.6, 49.4, 70.3, 71.3, 157.6, 167.4. ― IR: ν = 3351, 3305, 2350, 1669, 1624, 1579, 
1532, 1309, 1251, 1167, 1082, 982, 939, 891, 791. ― C15H27N3O2 (281.39): calcd. 
C 64.02 ; H 9.67, N 14.93; found C 63.89, H 9.90, N 14.79. 
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 (S)-1-(2-(4-isopropyl-4,5-dihydrooxazol-2-yl)propan-2-yl)-3-phenylurea (Ox-7) 
 
According to the general procedure product Ox-7 was yielded as white solid (0.501 
g, 1.73 mmol, 84%) starting from precursor 5g (0.635 g, 2.06 mmol). 
Rf = 0.50 (DCM/MeOH 95:5). ― m.p. 189-190°C ― [α]20D = -43.12 (c = 0.1, 
CHCl3) ― 
  1
H NMR (400 MHz, CD3OD, 25°C): δ = 0.89 (d, 3H, J= 6.7 Hz), 0.95 
(d, 3H, J= 6.8 Hz), 1.56 (s, 3H), 1.59 (s, 3H), 1.82 (m, 1H), 4.00 (ddd, 1H, J= 9.8, 
7.2, 5.5 Hz), 4.12 (dd, 1H, J= 8.6, 7.2 Hz), 4.32 (dd, 1H, J= 9.8, 8.6 Hz), 6.96 (m, 
1H), 7.23 (dd, 2H, J= 8.6, 7.5 Hz), 7.31 (dd, 2H, J= 8.6, 1.2). – 13C NMR (100.6 
MHz, CD3OD, 25°C): δ= 16.4, 17.5, 25.5, 25.7, 31.9, 51.5, 70.0, 71.2, 118.6, 121.9, 
128.9, 139.4, 155.5, 172.2. ― IR: ν = 3338, 2725, 1646, 1600, 1557, 1543, 1310, 
1264, 1152, 1071, 800. ― C16H23N3O2 (289.37): calcd. C 66.41; H 8.01, N 14.52; 
found C 66.53, H 8.11, 14.77. 
 
 
(S)-1-(2-(4-ethyl-4,5-dihydrooxazol-2-yl)propan-2-yl)-3-phenylurea (Ox-8) 
 
According to the general procedure product Ox-8 was yielded as white solid (0.441 
g, 1.60 mmol, 74%) starting from precursor 5h (0.636 g, 2.17 mmol).  
Rf = 0.49 (DCM/MeOH 95:5). ― m.p. 122-123°C ― [α]20D = +40.82 (c = 0.1, 
CHCl3) ― 
  1
H NMR (400 MHz, CD3OD, 25°C): δ = 0.94 (t, 3H, J= 7.3 Hz), 1.55 
(s, 3H), 1.56 (m, 1H), 1.57 (s, 3H), 1.66 (m, 1H), 4.01 (t, 1H, J= 7.6 Hz), 4.08 (m, 
1H), 4.39 (dd, 1H, J= 9.0, 7.8 Hz), 6.96 (t, 1H, J= 7.3 Hz), 7. 23 (t, 2H, J= 7.9 Hz), 
7.30 (dd, 2H, J= 8.8, 1.2 Hz). – 13C NMR (100.6 MHz, CD3OD, 25°C): δ= 8.3 25.5, 
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25.6, 27.6, 51.3, 66.8, 72.3, 118.6, 122.0, 128.3, 139.3, 155.4, 172.2. ― IR: ν = 
3321, 2725, 1661, 1641, 1596, 1587, 1500, 1302, 1250, 1218, 1132, 1082, 1068, 
979, 955, 924, 843. ― C15H21N3O2 (275.35): calcd. C 65.43; H 7.69, N 15.26; 
found C 65.57, H 7.66, N 15.37. 
 
 
1-((S)-3-((S)-4-isopropyl-4,5-dihydrooxazol-2-yl)-1-oxo-1-(pyrrolidin-1-
yl)propan-2-yl)-3-phenylurea (Ox-9) 
 
According to the general procedure product Ox-9 was yielded as yellow solid 
(0.083 g, 0.22 mmol, 58%) starting from precursor 5i (0.150 g, 0.38 mmol). 
Rf = 0.43 (DCM/MeOH 95:5). ― m.p. 122-123°C ― [α]20D = -71.70 (c = 0.1, 
CHCl3) ―   1H NMR (400 MHz, CDCl3, 25°C): δ = 0.84 (d, 3H, J= 6.7 Hz), 0.92 
(d, 3H, J= 6.7 Hz), 1.66 m, 1H), 1.87 (m, 2H), 1.96 (m, 2H), 2.68 (dd, 1H, J= 15.2, 
6.4 Hz), 2.82 (dd, 1H, J= 15.2, 8.0 Hz), 3.49 (m, 2H), 3.78-3.92 (m, 4H), 4.20 (dd, 
1H, J= 9.4, 8.2 Hz), 5.20 (m, 1H), 6.88-6.96 (m, 2H), 7.22 (t, 2H, J= 7.6 Hz), 7.36 
(d, 2H, J= 7.6 Hz), 8.26 (s, 1H). – 13C NMR (100.6 MHz, CDCl3, 25°C): δ= 18.3, 
18.7, 24.3, 25.9, 31.8, 32,6, 46.3, 47.1, 48.3, 70.3, 72.2, 118.8, 122.1, 128.7, 139.6, 
155.2, 163.7, 170.9. ― IR: ν = 3330, 3223, 2721, 1656, 1623, 1567, 1504, 1398, 
1311, 1214, 1200, 1178, 1123, 1083, 1034, 970. ― C20H28N4O3 (372.46): calcd. C 
64.49 ; H 7.58, N 15.04; found C 64.67, H 7.30, N 14.99. 
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1-((R)-3-((S)-4-isopropyl-4,5-dihydrooxazol-2-yl)-1-oxo-1-(pyrrolidin-1-
yl)propan-2-yl)-3-phenylurea (Ox-10) 
 
According to the general procedure product Ox-10 was yielded as yellow solid 
(0.074 g, 0.20 mmol, 58%) starting from precursor 5j (0.134 g, 0.34 mmol). 
Rf = 0.43 (DCM/MeOH 95:5). ― m.p. 126-127°C ― [α]20D = -13.76 (c = 0.1, 
CHCl3) ―   1H NMR (400 MHz, CDCl3, 25°C): δ = 0.83 (d, 3H, J= 6.7 Hz), 0.87 
(d, 3H, J= 6.7 Hz), 1.65 (m, 1H), 1.88 (m, 2H), 1.97 (m, 2H), 2.67 (dd, 1H, J= 15.6, 
6.6 Hz), 2.81 (dd, 1H, J= 15.6, 8.3 Hz), 3.42-3.55 (m, 2H), 3.83-3.93 (m, 4H), 4.19 
(dd, 1H, J= 8.7, 7.9 Hz), 5.23 (m, 1H), 6.89 (d, 1H, J= 9.5 Hz), 6.94 (t, 1H, J= 7.3 
Hz), 7.21 (t, 2H, J= 7.7 Hz), 7.35 (d, 2H, 7.8 Hz), 8.35 (s, 1H). – 13C NMR (100.6 
MHz, CDCl3, 25°C): δ= 18.2, 18.4, 24.3, 25.9, 31.9, 32.4, 46.3, 47.1, 48.0, 70.2, 
72.1, 118.8, 122.0, 128.7, 139.8, 155.1, 163.9, 171.0. ― IR: ν = 3312, 2729, 1678, 
1634, 1603, 1593, 1549, 1334, 1212, 1150, 1115, 1084, 1065, 991, 840.― 
C20H28N4O3 (372.46): calcd. C 64.49 ; H 7.58, N 15.04; found C 64.71, H 7.44, N 
14.81. 
 
 
(R)-1-(3-(4-ethyl-4,5-dihydrooxazol-2-yl)phenyl)-3-phenylurea (Ox-11) 
 
According to the general procedure product Ox-11 was yielded as white solid 
(0.370 g, 1.20 mmol, 78%) starting from precursor 5k (0.500 g, 1.53 mmol). 
Rf = 0.46 (DCM/MeOH 95:5). ― m.p. 147-148°C ― [α]20D = +43.30 (c = 0.1, 
CHCl3) ―   1H NMR (400 MHz, CD3OD, 25°C): δ = 0.99 (t, 3H, J= 7.3 Hz), 1.63 
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(m, 1H), 1.74 (m, 1H), 4.14 (t, 1H, J= 7.7 Hz), 4.24 (m, 1H), 4.54 (dd, 1H, J= 9.4, 
8.2 Hz), 7.02 (m, 1H), 7.29 (m, 2H), 7.37 (t, 1H, J= 8.2 Hz), 7.43 (dd, 2H, J= 8.7, 
1.1 Hz), 7.58 (dt, 1H, J= 7.7, 1.3 Hz), 7.68 (ddd, 1H, J= 8.1, 2.3, 1.0 Hz), 7,96 (t, 
1H, J= 2.0 Hz). ). – 13C NMR (100.6 MHz, CD3OD, 25°C): δ= 8.52, 28.0, 67.1, 
72.0, 118.4, 119.0, 122.1, 122.6, 127.8, 128.5, 128,7, 138.9, 139.6, 153.8, 164.6. ― 
IR: ν = 3309, 3281, 1644, 1612, 1592, 1572, 1448, 1311, 1298, 1237, 1168, 1080, 
1059, 973, 926. ― C18H19N3O2 (309.36): calcd. C 69.98; H 6.19, N 13.58; found C 
70.01, H 6.15, N 13.54. 
 
 
(S)-1-(3-(4-benzyl-4,5-dihydrooxazol-2-yl)phenyl)-3-phenylurea (Ox-12) 
 
According to the general procedure product Ox-12 was yielded as white solid 
(0.518 g, 1.39 mmol, 78%) starting from precursor 5l (0.693 g, 1.78 mmol). 
Rf = 0.52 (DCM/MeOH 95:5). ― m.p. 106-107°C ― [α]20D = -37.89 (c = 0.1, 
CHCl3) ― 
  1
H NMR (400 MHz, CHCl3, 25°C): δ = 2.64 (dd, 1H, J= 13.7, 9.0 Hz), 
3.12 (dd, 1H, J= 13.7, 5.1 Hz), 4.02 (t, 1H, J= 7.8 Hz), 4.22 (t, 1H, J= 8.8 Hz), 4.47 
(m, 1H), 6.95 (t, 1H, J= 7.1 Hz), 7.11-7.27 (m, 11H), 7.54 (d, 1H, J= 7.1 Hz), 7.94 
(d, 2H, J= 8.1 Hz), 8.04 (s, 1H). – 13C NMR (100.6 MHz, CDCl3, 25°C): δ=41.8, 
67.6, 72.0, 119.8, 120.5, 123.0, 123.1, 123.6, 126.6, 128.1, 128.6, 128.9, 129.0, 
129.1, 137.8, 138.2, 138.7, 154.0, 164.4. ― IR: ν = 3353, 2724, 2360, 1649, 1597, 
1555, 1310, 1264, 1201, 1154, 1074, 896, 845. ― C23H21N3O2 (371.43): calcd. C 
74.37 ; H 5.70, N 11.31; found C 77.37, H 5.68, N 10.95. 
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(S)-1-(3-(4-isopropyl-4,5-dihydrooxazol-2-yl)phenyl)-3-phenylurea (Ox-13) 
 
According to the general procedure product Ox-13 was yielded as white solid 
(0.458 g, 1.42 mmol, 91%) starting from precursor 5m (0.530 g, 1.55 mmol).  
Rf = 0.49 (DCM/MeOH 95:5). ― m.p. 138-139°C ― [α]20D = -35.05 (c = 0.1, 
CHCl3) ―   1H NMR (400 MHz, CD2Cl2, 25°C): δ = 0.92 (d, 3H, J= 6.8 Hz), 1.01 
(d, 3H, J= 6.7 Hz), 1.84 (m, 1H), 2.15 (bs, 1H), 4.09 (ddd, 1H, J= 9.5, 8.2, 6.4 Hz), 
4.16 (t, 1H, 8.2 Hz), 4.43 (dd, 1H, J= 9.5, 8.3 Hz), 7.10 (m, 1H), 7.14 (bs, 1H), 7.25 
(bs, 1H), 7.28-7.37 (m, 5H), 7.50 (ddd, 1H, J= 8.0, 2.1, 0.9 Hz), 7.60 (dt, 1H, J= 
7.7, 1.1 Hz), 7.95 (t, 1H, J= 1.7 Hz). – 13C NMR (100.6 MHz, CDCl3, 25°C): δ= 
17.6, 18.8, 32.4, 70.6, 71.2, 119.4, 120.8, 123.2, 123.6, 123.9, 128.9, 129.1, 129.3, 
138.0, 138.8, 139.0, 153.6, 165.0. ― IR: ν = 3319, 2725, 1743, 1646, 1595, 1567, 
1309, 1262, 1155, 1069, 801. ― C19H21N3O2 (323.39): calcd. C 70.57; H 6.55, N 
12.99; found C 70.19, H 6.41, N 12.83. 
 
 
 (S)-1-(3-(4-tert-butyl-4,5-dihydrooxazol-2-yl)phenyl)-3-phenylurea (Ox-14) 
 
According to the general procedure product Ox-14 was yielded as white solid 
(0.436 g, 1.29 mmol, 83%) starting from precursor 5n (0.552 g, 1.55 mmol). 
Rf = 0.48 (DCM/MeOH 95:5). ― m.p. 170-171°C ― [α]20D = -47.13 (c = 0.1, 
CHCl3) ―   1H NMR (400 MHz, CD3OD, 25°C): δ = 1.02 (s, 9H), 3.63 (dd, 1H, J= 
11.5, 8.9 Hz), 3.88 (dd, 1H, J= 11.5, 3.4 Hz), 4.04 (dd, 1H, J= 8.9, 3.4 Hz), 7.03 (t, 
106 
 
1H, J= 7.4 Hz), 7.30 (dd, 2H, J= 8.4, 7.4 Hz), 7.40 (t, 1H, J= 7.7 Hz), 7.44 (m, 2H), 
7.48 (ddd, 1H, J= 7.7, 1.7, 1.1 Hz), 7.59 (ddd, 1H, J= 8.2, 2.2, 1.1 Hz), 7.82 (t, 1H, 
J= 1.7 Hz) – 13C NMR (100.6 MHz, CDCl3, 25°C): δ= 25.8, 33.9, 68.8, 75.9, 119.8, 
120.6, 123.0, 123.1, 123.6, 128.3,129.0, 138.1, 138.6, 154.0, 163.7. ― IR: ν = 
3352, 2724, 2360, 1740, 1647, 1596, 1560, 1309, 1264, 1204, 1154, 1073, 897, 799. 
― C20H23N3O2 (337.42): calcd. C 71.19 ; H 6.87, N 12.45; found C 71.44, H 7.10, 
N 12.47. 
 
 
(R)-1-phenyl-3-(3-(4-phenyl-4,5-dihydrooxazol-2-yl)phenyl)urea (Ox-15) 
 
According to the general procedure product Ox-15 was yielded as white solid 
(0.103 g, 0.29 mmol, 30%) starting from precursor 5o (0.400 g, 1.06 mmol). 
Rf = 0.45 (DCM/MeOH 95:5). ― m.p. 134-135°C ― [α]20D = -51.78 (c = 0.1, 
CHCl3) ―   1H NMR (400 MHz, CDCl3, 25°C): δ = 4.25 (t, 1H, J= 8.3 Hz), 4.90 
(dd, 1H, J= 10.1, 8.3 Hz), 5.45 (dd, 1H, J= 10.1, 8.3 Hz), 6.98 (t, 1H J= 7.3 Hz), 
7.24-7.31 (m, 3H), 7,34-7.41 (m, 5H), 7.55 (dd, 2H, J= 8.7, 1.1 Hz), 7.65 (dt, 1H, 
J= 7.7, 1.3 Hz), 7.73 (ddd, 1H, J= 8.2, 2.3, 1.1 Hz), 8.23 (t, 1H, J= 1.9 Hz), 8.36 (s, 
1H), 8.52 (s, 1H). – 13C NMR (100.6 MHz, CDCl3, 25°C): δ= 69.5, 74.9, 118.2, 
118.5, 118.6, 121.5, 121.6, 121.9, 122.1, 126.7, 127.3, 128.1, 128.5, 128.7, 128.9, 
139.9, 140.4, 142.9, 152.5, 164.3. ― IR: ν = 3321, 3278, 2725, 1709, 1656, 1611, 
1561, 1311, 1223, 1189, 1063, 970, 840. ― C22H19N3O2 (357.41): calcd. C 73.93 ; 
H 5.36, N 11.76; found C 73.57, H 5.63, N 11.46. 
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 (S)-1-(3-(4-isopropyl-4,5-dihydrooxazol-2-yl)phenyl)-3-(2-nitrophenyl)urea 
(Ox-16) 
 
According to the general procedure product Ox-16 was yielded as yellow solid 
(0.441 g, 1.20 mmol, 82%) starting from precursor 5p (0.565 g, 1.46 mmol). 
Rf = 0.38 (DCM/MeOH 95:5). ― m.p. 166-167°C ― [α]20D = -49.37 (c = 0.1, 
CHCl3) ―   1H NMR (400 MHz, CD2Cl2, 25°C): δ = (d, 3H, J= 6.7 Hz), 1.05 (d, 
3H, J= 6.7 Hz), 1.84 (m, 1H), 4.07-4.18 (m, 2H), 4.45 (dd, 1H, J= 9.2, 7.8 Hz), 7.10 
(bs, 1H), 7.15 (ddd, 1H, J= 8.4, 7.2, 1.3 Hz), 7.43 (t, 1H, J= 7.7 Hz), 7.64 (ddd, 1H, 
J= 7.9, 2.1, 1.0 Hz), 7.68 (ddd, 1H, J= 8.7, 7.1, 1.6 Hz), 7.72 (dt, 1H, J= 7.7, 1.2 
Hz), 8.04 (t, 1H, J= 2.0 Hz), 8.22 (dd, 1H, J= 8.6, 1.6 Hz), 8.68 (dd, 1H, J= 8.7, 1.1 
Hz), 9.94 (bs, 1H). – 13C NMR (100.6 MHz, CH2Cl2, 25°C): δ= 17.8, 18.6, 32.8, 
70.3, 72.5, 119.7, 121.9, 122.1,122.9, 123.4, 125.5, 128.8, 129.1, 135.4, 136.0, 
136.7, 138.4, 151.8, 163.1. ― IR: ν = 3339, 3281, 2724, 1650, 1591, 1557, 1309, 
1278, 1155, 1066, 823. ― C19H20N4O4 (368.39): calcd. C 61.95 ; H 5.47, N 15.21; 
found C 61.71, H 5.84, N 13.47. 
 
 
General procedure for kinetic resolution of 1,2 diols 
 
Ligand (0.1 equiv.) was solved in CH2Cl2 (0.15 M solution respect the substrate) 
and CuCl2 (0.05 equiv.) added and the mixture stirred until the solution became 
clear and then cooled at 0°C. Substrate (1.0 equiv.), diisopropylethylamine (1.0 
equiv.) and acyl chloride (0.5 equiv.) were added and the reaction stirred for 3 hours 
at 0°C. The reaction mixture was filtered on silica gel washing with CH2Cl2 and the 
solvent evaporated under reduced pressure. Monobenzoylated product was purified 
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by flash chromatography on silica gel eluting with Hexane-Ethyl acetate (variable 
from 6:1 to 3:1). Spectroscopical datas of products were in agreement with the 
literature and enantiomeric excesses were determined by HPLC equipped with 
chiral column Chiracel AS-H. 
 
 
General procedure for selective desymmetrization of meso-1,2 diols 
 
   Ligand (0.1 equiv.) was solved in CH2Cl2 (0.15 M solution respect the substrate) 
and CuCl2 (0.05 equiv.) added and the mixture stirred until the solution became 
clear and then cooled at 0°C. Substrate (1.0 equiv.), diisopropylethylamine (1.0 
equiv.) and acyl chloride (1.0 equiv.) were added and the reaction stirred for 3 hours 
at 0°C. The reaction mixture was filtered on silica gel washing with CH2Cl2 and the 
solvent evaporated under reduced pressure. Monobenzoylated product was purified 
by flash chromatography on silica gel eluting with Hexane-Ethyl acetate (variable 
ratios from 6:1 to 3:1). Spectroscopical data of products were in agreement with the 
literature and enantiomeric excesses were determined by HPLC equipped with 
chiral column Chiracel AS-H. 
 
 
General procedure for selective desymmetrization of meso-1,4-diols 
   To a solution of cis-2,4-cyclopentenediol (10 mg, 0.099 mmol, 1.0 equiv) in 1.0 
mL of dry THF (or DCM) was added tosyl isocyanate (35 μL, 0.23 mmol, 2.3 
equiv) and the colorless solution was stirred at 55°C for 1 hour and then was 
allowed to cool a room temperature. Triethylamine was added (if required) and the 
reaction mixture cooled to 0°C, and then added dropwise to an orange solution of 
[Pd(dba)2] (0.05 equiv) and ligand (0.1 equiv.) in 1.0 mL of dry THF. The orange 
reaction mixture was stirred at room temperature for 6-48 hours. The solvent was 
removed under vacuum and column chromatography on silica gel (1:10 ethyl 
109 
 
acetate–hexane) gave the desired product as a white solid. The enantiomeric 
excesses were determined by chiral HPLC equipped with Chiralcel OD-H 
(hexane:iPrOH 10:1, flux 0.5 mL/min., rt (R,S)= 23 min, rt (S,R)= 31 min). 
Spectroscopic data were in agreement with literature. 
 
 
Characterization of metal complexes 
 
Job’s plot 
   4.88mg CuCl2 (0.0363 mmol) were transferred in a quartz cuvette and 3.5mL 
CH2Cl2 were added. (S)-1-(2-(4-isopropyl-4,5-dihydrooxazol-2-yl)ethyl)-3-
phenylurea (Ox-3) was then sequentially added in accurately weighed portions of 
~1mg (0.00363 mmol) up to 2.3 equivalents of ligand, performing UV absorption 
spectrum after each addition. 
UV absorption value at 750 nm (λmax) and the amount of ligand added were plotted 
in a 2D graph. 
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NMR evaluations 
(S)-1-(2-(4-isopropyl-4,5-dihydrooxazol-2-yl)ethyl)-3-phenylurea (Ox-3) (100mg, 
0.363mmol) and PdCl2(CH3CN)2 (47.1mg, 0.181mmol) were dissolved in 5mL 
DCM and stirred for 1 hour at room temperature. Complex was achieved by 
precipitation with hexane.  
1
H NMR experiments were carried out focusing on the variation of chemical shift of 
the NH signals upon different concentrations (5, 10, 20 and 40 mM) both in the 
complex and in the free ligand.  
 
 
 NHA NHB 
conc (mM) free ligand 
δ (ppm) 
complex 
δ (ppm) 
free ligand 
δ (ppm) 
complex 
δ (ppm) 
5 5,6210 5,7430 6,803 7,029 
10 5,6530 5,7600 6,875 7,047 
20 5,7800 5,7990 7,185 7,086 
40 5,8940 5,8430 7,481 7,129 
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Chapter 3 
 
Bifunctional organocatalysts for 
asymmetric conjugate additions 
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3.1   Enamine catalysis 
In the last decade the potential of organocatalysis has successfully been 
demonstrated. In particular primary and secondary amines have emerged as a 
broadly applicable class of organocatalysts for many types of reactions. The 
catalysis of electrophilic substitutions in the α-position of carbonyl compounds and 
related reactions via enamine intermediates is called enamine catalysis.
1
 
In general an enamine is generated by reaction of a carbonyl compound with an 
amine under dehydrating conditions. Reaction of the enamine can proceed via an 
addition (route i) or substitution (route ii) depending on the nature of the reaction 
partner (electrophile). In either case, iminium ions are usually formed, which are 
then hydrolyzed to afford the products (Scheme 3.1). During the years many 
variants have been introduced in enamine chemistry; therefore, a catalytic version 
of this chemistry was highly desirable.  
 
Scheme 3.1  
                                                     
1 List, B. Synlett 2001, 1675; List, B. Acc. Chem. Res. 2004, 37, 548. 
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In recent years an exponential growth in the field of enamine catalysis occurred 
and, particularly, asymmetric enamine catalysis. This happened because, in addition 
to being almost ideally atom-economic and step-economic, the scope of the 
catalytic version exceeds those of the stoichiometric approach (Scheme 3.1). The 
basis of enamine catalysis is the reversible generation of enamines from a catalytic 
amount of an amine and a carbonyl compound. The key step of the process is the 
LUMO lowering effect and the resulting increase in C-H acidity upon initial 
conversion of the carbonyl compound into an iminium ion.  
Two different mechanisms can be identified (Scheme 3.2) depending on the nature 
of electrophiles used. On the one hand, the double bond containing electrophiles 
such as aldehydes, imines, Michael acceptors, etc. are inserted into the α-C‒H bond 
of the carbonyl compound via a nucleophilic addition reaction of the enamine 
intermediate. On the other hand single bond containing electrophiles such as alkyl 
halides react in a nucleophilic substitution reaction. 
 
Scheme 3.2 
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The asymmetric induction naturally is due to the structure of catalyst and initial 
carbonyl compound. The selectivity could be simplistically explained with the 
figures shown in Scheme 3.3 where is clear that, in the transition state, the geometry 
of enamine and the presence of interaction between catalyst and the electrophile 
govern the configuration of the product. 
 
Scheme 3.3 
Summarizing, enamine catalysis has developed into a powerful strategy for 
asymmetric synthesis and many studies are coming up in amazing pace, in this 
extremely active area. Here below the principal enamine-catalyzed reactions will be 
reported, in particular Michael reaction which will be widely used in this chapter. 
 
 
3.1.1   Enamine-catalyzed Aldol reaction 
 
The aldol reaction is among the most commonly applied C-C bond forming 
reactions.
2
 The versatility of this reaction stems from its utility in constructing 
chiral building blocks (via the stereoselective formation of C-C bonds) for the 
synthesis of structurally complex molecules, namely natural products or non-natural 
drug molecules. Aldol reactions combine a nucleophilic addition, which is acid-
catalyzed, with an enolization, which is catalyzed by both acids and bases.
3
 These 
properties make it possible for the aldolization to be catalyzed by both Lewis and 
Brønsted acids and bases (Scheme 3.4). 
                                                     
2 Heathcock, C. H. In ComprehensiVe Organic Synthesis; Trost, B. M., Fleming, I., Heathcock, C. H., 
Eds.; Pergamon: Oxford, 1991; Vol. 2, pp 133. 
3 Tanaka, F.; Barbas, C. F., III. In EnantioselectiVe Organocatalysis; Dalko, P. I., Ed.; Wiley-VCH: 
Weinheim, 2007; pp 19. 
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The direct aldol reaction between two unmodified carbonyl compounds has a great 
importance, especially for practical reason since it does not require the isolation of 
the reactive enolates.
4
 
Scheme 3.4 
Chemists became inspired by nature and developed catalysts that mimic the 
functional concept of aldolases for this purpose. One such approach includes 
antibody-catalyzed direct asymmetric aldol reactions developed by Barbas
5
 and 
Reymond.
6
 Purely chemical direct catalytic asymmetric aldol reactions were 
achieved by multifunctional heterobimetallic complexes reported by Shibasaki
7
 and 
by dinuclear Zn complexes reported by Trost
8
 and Shibasaki.
9
 Both aldolases and 
even more so Knoevenagel-like chemistry may have stimulated chemists to employ 
amino acids for the catalysis of the aldol reaction. Initial efforts in asymmetric 
catalysis have concentrated on Proline-catalyzed enantiogroup differentiating 
intramolecular aldolizations.  
The first example of an asymmetric aldol reaction catalyzed by secondary amines 
was the intramolecular Proline-catalyzed aldolization of di- and triketones, reported 
by Hajos-Parrish-Eder-Sauer-Wiechert. Discovered in the early 1970s, this reaction 
                                                     
4 Alcaide, B.; Almendros, P. Eur. J. Org. Chem. 2002, 1595; Alcaide, B.; Almendros, P. Angew. 
Chem., Int. Ed. 2003, 42, 858. 
5 Tanaka, F.; Barbas, C. F., III In Modern Aldol Reactions; Mahrwald, R., Ed.; Wiley-VCH Verlag 
GmbH & Co. KGaA: Weinheim, 004; Vol. 1, pp 273. 
6 Reymond, J.-L.; Chen, Y. J. Org. Chem. 1995, 60, 6970. 
7 Yamada, Y. M. A.; Yoshikawa, N.; Sasai, H.; Shibasaki, M. Angew. Chem., Int. Ed. 1997, 36, 1871; 
Yoshikawa, N.; Yamada, Y. M. A.; Das, J.; Sasai, H.; Shibasaki, M. J. Am. Chem. Soc. 1999, 121, 
4168; Kumagai, N.; Matsunaga, S.; Yoshikawa, N.; Ohshima, T.; Shibasaki, M. Org. Lett. 2001, 3, 
1539; Yoshikawa, N.; Kumagai, N.; Matsunaga, S.; Moll, G.; Ohshima, T.; Suzuki, T.; Shibasaki, M. 
J. Am. Chem. Soc. 2001, 123, 2466; Shibasaki, M.; Matsunaga, S.; Kumagai, N. In Modern Aldol 
Reactions; Mahrwald, R., Ed.; Wiley-VCH Verlag GmbH & Co. KGaA: Weinheim, 2004; Vol. 2, pp 
197. 
8 Trost, B. M.; Ito, H. J. Am. Chem. Soc. 2000, 122, 12003; Trost, B. M.; Silcoff, E. R.; Ito, H. Org. 
Lett. 2001, 3, 2497. 
9 Kumagai, N.; Matsunaga, S.; Kinoshita, T.; Harada, S.; Okada, S.; Sakamoto, S.; Yamaguchi, K.; 
Shibasaki, M. J. Am. Chem. Soc. 2003, 125, 2169. 
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was the first example of a highly enantioselective organocatalytic process, although 
at that time neither its mechanism was well understood nor its potential for other 
reactions was realized. The Hajos-Parrish-Eder-Sauer-Wiechert reaction is a 6-enol-
endo aldolization. Hajos and Parrish discovered that Proline is an effective catalyst 
for the intramolecular aldol reaction of triketones, furnishing aldols in good yields 
and in one case with high enantioselectivity (Scheme 3.5). Acid-catalyzed 
dehydration of the aldol addition products gave condensation products.
10
 
Independently in the same year, Eder, Sauer, and Wiechert directly isolated the 
aldol condensation products when the same cyclizations were conducted in the 
presence of Proline and an acid cocatalyst.
11
  
Scheme 3.5 
 
Despite its enormous potential, this methodology remained almost neglected for 
more than two decades and it was only towards the end of the millennium that a real 
burgeoning of this approach was observed with hundreds of examples being 
reported in very few years.
12
 List’s group, over the years, proved to be one of the 
most active in the field of proline catalysis and in the last decade reported numerous 
                                                     
10 Hajos, Z. G.; Parrish, D. R. J. Org. Chem. 1974, 39, 1615. 
11 Eder, U.; Sauer, G. R.; Wiechart, R. German Patent DE 2014757, 1971. 
12 Trost, B. M., Brindle, C. S. Chem. Soc. Rev. 2010, 39, 1600. 
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works. Several versions of the reaction were performed to obtain different adducts 
and a small selection of these are reported in Scheme 3.6.
13
 
 
 
Scheme 3.6 
 
MacMillan also reported very interesting works on aldol, in particular concerning 
the first enantioselctive cross-aldol reaction of aldehydes
14
 and α-thioacetal 
aldehydes (Scheme 3.7).
15
 
 
Scheme 3.7 
                                                     
13 List, B., Lerner, R. A., Barbas III C., F., J. Am. Chem. Soc., 2000, 122, 2395; Notz, W., List, B., J. 
Am. Chem. Soc., 2000, 122, 7386; List, B., Pojarliev, P., Castello, C., Org. Lett. 2001, 4, 573; 
Bahmanyar, P, Biller, W. T., Martin, H., J., List, B., J. Am. Chem. Soc. 2003, 9, 2475. 
14 Northrup, A. B., MacMillan, D. W. C., J. Am. Chem. Soc. 2002, 124, 6798.  
15 Storer, I., R., MacMillan D. W. C., Tethtahedron 2004, 60, 7705. 
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Wennemers in 2003 reported the exploitation of oligopeptides as efficient 
organocatalysts for asymmetric aldol reactions (Scheme 3.8).
16
 Oligopeptides 
proved highly suitable for a rapid modification of the catalyst’s structure and, more 
important, conformation, the latter proving the importance of the nature and 
arrangement of the functional groups for a simultaneous activation of the 
nucleophile and of the electrophile. The tripeptide Pro-Pro-Asp-NH2 emerged as 
best asymmetric catalyst, for aldol reaction, from a library of 3375 tripeptides 
generated by the split-mix methodology and screened by “catalyst-substrate 
coimmobilization”.17 
 
Scheme 3.8 
 
In 2010 Juaristi reported the use of the dipeptide Pro-Phe as efficient organocatalyst 
for aldol reaction between cyclic ketones and electron-poor aromatic aldehydes in 
solvent-free conditions with good results (ees up to 95%).
18
 The peculiarity of this 
work is the transition state proposed in which the dipeptide acts as bifunctional-like 
catalyst interacting with the aldehyde by π-π interaction (Scheme 3.9). 
 
                                                     
16 Revell, J. D., Wennemers, H., Adv. Synth. Catal. 2008, 350, 1046 and references therein. 
17(a) P. Krattiger, C. McCarthy, A. Pfaltz, H. Wennemers, Angew. Chem. Int. Ed. 2003, 42, 1722;( b) 
J. D. Revell, H. Wennemers, Adv. Synth. Catal. 2008, 350, 1046; (c) M. Messerer, H. Wennemers, 
Synlett 2011, 499. 
18 Hernandez, J. G., Juaristi, E., J. Org. Chem. 2011, 76, 1464.  
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Scheme 3.9 
 
Reiser has recently reported a novel kind of proline catalyzed aldol reaction.
19
 
While proline itself is able to act as asymmetric catalyst, an improvement of 
efficiency was observed in presence of cobalt chloride as co-catalyst. 
The system was tested with a wide range of ketones and aldehydes with excellent 
results in terms of diastereo- (up to 45:1 anti/syn) and enantioselectivity (up to 
>99%). The mechanism proposed involves two prolines coordinated to the cobalt 
ion to form a C2-simmetric complex. Due to the symmetry, both prolines give rise 
to the same enamines and consequently the same aldol product (Scheme 3.10). 
 
 
Scheme 3.10 
 
 
 
                                                     
19 Karmakar, A., Maji, T., Wittmann, S., reiser, O., Chem. Eur. J. 2011, 17, 11024. 
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3.1.2   Enamine-catalyzed Mannich reaction 
 
The Mannich reaction, developed by Carl Mannich more or less 100 years ago, is a 
highly useful transformation for the construction of nitrogenous molecules.
20
 In this 
transformation three components, two carbonyl compounds and an amine, react to 
form a β-amino-carbonyl compound. The key element in Mannich reactions is an 
iminium intermediate, which is susceptible to nucleophilic attack by a variety of 
nucleophiles such as enolized ketones or equivalents thereof, resulting in carbon–
carbon bond formation adjacent to the nitrogen atom. 
The increasing popularity of the Mannich reaction has been fueled by the 
ubiquitous nature of nitrogen in drugs and natural products as well as by the 
potential of this multicomponent reaction to generate diversity. Both direct variants 
with unmodified ketone donors and indirect variants utilizing preformed enolate 
equivalents have been described. In addition, the imine intermediate may be 
preformed or its amine and aldehyde precursors may be used directly (Scheme 
3.11).  
 
 
Scheme 3.11 
 
                                                     
20 Mannich, C.; Krosche, W. Arch. Pharm. 1912, 250, 647. 
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Enantioselective variants are especially attractive and over the years many groups 
have been involved in the development of asymmetric version of Mannich 
reaction
21
 and some of the most interesting works are reported in Scheme 3.12 even 
if many others could worth mention.  
 
Scheme 3.12 
 
.Based on important contributions by Gellman,
22
 Cordova and co-workers reported 
the asymmetric R-aminomethylation of cyclohexanone with dibenzyl aminomethyl 
ether using (S)-proline as catalyst.
23
 The results proved that (S)-proline gives the 
corresponding R-aminomethylated ketones in generally modest yields (32-75%) 
with high enantioselectivities (75-99% ee). A possible transition state was also 
suggested (Scheme 3.13). 
                                                     
21 Rutjes, F. P. J. T. Chem. Soc. Rev., 2008, 37, 29. 
22 Chi, Y.; Gellman, S. H. J. Am. Chem. Soc. 2006, 128, 6804. 
23 Ibrahem, I.; Dziedzic, P.; Cordova, A. Synthesis 2006, 23, 4060. 
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Scheme 3.13 
 
More recently Toma reported that Proline-derived N-sulfonylcarboxamides C 
efficiently catalyze the asymmetric Mannich reaction of cyclic ketones with N-(p-
methoxyphenyl)-protected iminoglyoxylate. The reaction proceeded with high 
enantioselectivity (99% ee).
24
 Enamine intermediates were investigated by DFT 
calculations and a transition state was hypothesized (Scheme 3.14). 
 
Scheme 3.14 
 
 
3.1.3   Enamine-catalyzed Michael reaction 
 
The Michael reaction, developed by Arthur Michael in the late 19
th
 century, is one 
of the most common C-C bond forming reactions used in organic synthesis. In 
broad terms, the Michael reaction may be most readily summarized as a “1,4 
                                                     
24 Veverková, E., Štrasserová, J., Šebesta, R., Toma, Š., Tetrahedron: Asymmetry, 2010, 21, 58. 
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addition”, or “conjugate addition”, of a nucleophile to the β-position of an α,β-
unsaturated carbonyl compound (Scheme 3.15).  
 
Scheme 3.15 
 
The increasing demand for optically active compounds has aroused considerable 
interest, since stereogenic centers can be created in the course of the Michael 
reaction. Thus, much effort has been made to develop efficient catalytic 
stereoselective methods. Since chemical transformations that avoid additional 
reagents, waste, and working time are highly desirable, a more promising and atom-
economic strategy would involve direct addition of unmodified carbonyl 
compounds to Michael acceptors. Consequently, aminocatalysis has gained 
considerable attention. The Michael donor can be catalytically activated either 
through enamine or enolate formation for the addition to a Michael acceptor. 
Complementarily, carbonyl-derived Michael acceptors can be activated via 
formation of an iminium species (Scheme 3.16). 
 
 
Scheme 3.16 
 
Although the properly called “Michael Reaction” involves the β-position of an α,β-
unsaturated carbonyl compounds, the term Michael is commonly use to indicate the 
site of attack in a simple addition to α,β-unsaturated compounds, whereby a 
classification based on the nature of the electrophile is useful. 
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Nitroolefins as Michael acceptors 
The enamine-catalyzed Michael addition of carbon nucleophiles to nitroalkenes is a 
useful synthetic method for the preparation of γ-nitrocarbonyl compounds. Owing 
to the various possible transformations 1,4-addition adducts are important 
precursors in organic synthesis.
25
 In organocatalysis, a number of different Michael 
acceptors have already been used. Among them, nitroalkenes are the most 
prominent ones because of their high acceptor reactivity and the possible 
conversion into other useful functionalities.
26
 The first enamine-catalyzed 
asymmetric intermolecular Michael reaction was developed by List in 2001.
27
 The 
addition of unactivated symmetric ketones to nitroolefins was found to proceed in 
the presence of catalytic amounts of (S)-Proline to furnish the desired γ-nitro 
ketones in generally high yields and good diastereoselectivities (syn) but only low 
enantioselectivities (up to 23% ee) (Scheme 3.17).  
 
Scheme 3.17  
 
In general, Proline-catalyzed Michael reactions seem to be highly syn 
diastereoselective but less enantioselective than Mannich or aldol reactions, which 
might be due to less efficient hydrogen bonding between the catalyst and the 
Michael acceptor. 
To explain the syn diastereoselectivity and the absolute configuration observed, 
Enders proposed an acyclic synclinal transition state based on Seebach’s model.28 
Following this model, all bonds around the newly formed bond are staggered, with 
a gauche relationship of the donor and the acceptor π-systems. Additionally, the 
                                                     
25 Ono, N. The Nitro Group in Organic Synthesis; Wiley-VCH: Weinheim, 2005. 
26 Berner, O. M.; Tedeschi, L.; Enders, D. Eur. J. Org. Chem. 2002, 1877. 
27 List, B.; Pojarliev, P.; Martin, H. J. Org. Lett. 2001, 3, 2423. 
28 Enders, D.; Seki, A. Synlett 2002, 26; Seebach, D.; Golinski, J. HelV. Chim. Acta 1981, 64, 1413; 
Blarer, S. J.; Seebach, D. Chem. Ber. 1983, 116, 2250. 
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partially positive nitrogen of the enamine and the partially negative nitro group 
should be situated close to each other, due to favorable electrostatic interactions. A 
hydrogen bond between the carboxylic acid moiety and the nitro group was 
postulated to further fix the conformation (Scheme 3.18). 
 
Scheme 3.18 
 
Further studies to investigate the possibility of an anti diastereoselectivity were 
performed by Alexakis who decided to evaluate nonsymmetrical ketones, in 
particular α-hydroxy and α-alkoxycarbonyl compounds using the pyrrolidine-
derivative 1 as catalyst. Interestingly the expected syn-isomer was only obtained 
using α-metoxyacetone, whereas α-hydroxyacetone yielded mainly the unexpected 
anti-isomer.
29
 This was explained by an additional hydrogen bond between the OH 
group of the substrate and the tertiary amine of the catalyst which led to the cis- 
instead of the trans-enamine (Scheme 3.19) 
 
Scheme 3.19 
                                                     
29 Andrey, O.; Alexakis, A.; Bernardinelli, G. Org. Lett. 2003, 5, 2559. 
129 
 
Concerning steric effects, many studies, done by several groups,
30
 have identified 
the bulk of the catalyst as determinant to have high levels of selectivity. For 
aldehydes, higher enantioselectivities were observed with increasing substituent 
bulk in order Me < Bu < i-Pr but no reaction took place with the sterically more 
congested 3,3-dimethylbutyraldehyde, so steric factors play an important role.  
The same is true for the nitroolefins. Aromatic aldehydes are the most commonly 
used nitro-derivative Michael acceptor, however also aliphatic olefins provide the 
corresponding Michael adducts, although bulky substituents render the reaction 
impossible. 
As already hinted in chapter 1, Wennemers and coworkers have been recently 
reported one of the most efficient examples of enamine-based catalysts with 
nitroolefins as acceptor. The tripeptide Pro-Pro-Asp-NH2 was again found (see 
above) as the best catalyst for this reaction. The reason of the high activity and 
selectivity was deeply investigated using as catalyst a number of derivatives D-Pro-
Pro-AA-NH2 in the conjugate addition of various aldehydes to nitrostyrene. 
Wennemers found that the D-Pro-Pro motif is the major contributor to the high 
stereoselectivities. The C-terminal amide and the spacer to the carboxylic acid in 
the side-chain of the C-terminal amino acid are responsible for the fine-tuning of 
the stereoselectivity.
31
 
 
Scheme 3.20 
 
                                                     
30 Hagiwara, H.; Okabe, T.; Hakoda, K.; Hoshi, T.; Ono, H.; Kamat, V. P.; Suzuki, T.; Ando, M. 
Tetrahedron Lett. 2001, 42, 2705; Hagiwara, H.; Komatsubara, N.; Ono, H.; Okabe, T. J. Chem. Soc., 
Perkin Trans. 1 2001, 316; Betancort, J. M.; Barbas, C. F. Org. Lett. 2001, 3, 3737. 
31 M. Wiesner, M., Neuburger, H., Wennemers, Chem. Eur. J., 2009, 15, 10103. 
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The crystal structure of the tripeptide D-Pro-Pro-Asp-NH2 (Scheme 3.20) clearly 
shows as the global conformation of the molecule is almost independent from the 
nature of the C-terminal amino acid. 
Later a massive study on the exploiting of the tripeptide D-Pro-Pro-Glu-NH2 in the 
conjugate addition of aldehydes to nitroolefins was undertaken obtaining excellent 
results in terms of both stereo- (up to 99:1 syn/anti) and enantioselectivity (up to 
99%) (Scheme 3.21).
32
  
 
Scheme 3.21 
 
α,α-disubstituted aldehydes gave rise to sluggish reactions, while aromatic 
aldehydes proved to be more reactive. Among these aldehydes with bulky 
substituents in the -position, as well as electron-rich aromatic nitroolefins, are 
slightly less reactive compared to the other substrates. 
In addition, no side products, such as homo-aldol condensation products, formed in 
the course of the reaction. Concerning the acceptors, no big differences were 
observed changing the nature of the nitroolefins and the results obtained with 
nitroethylene in terms of ee, were comparable with those obtained with nitrostyrene. 
The reaction proceeds readily in a range of solvents even if highest reactivities are 
observed in alcohols such as isopropanol, whereas the highest stereoselectivities are 
obtained in chloroform. Often, a mixture of these two solvents is an ideal 
                                                     
32 M. Wiesner, H., Wennemers, Synthesis, 2010, 9, 1568. 
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compromise for obtaining both high reactivity and stereoselectivity. In addition, this 
solvent mixture allows good solubility of all the reaction components.
33
 
 
 
α,β-unsaturated carbonyl compounds as Michael acceptors 
In most organocatalytic Michael additions, either highly activated nucleophiles or 
electrophiles have been used. The addition of unactivated carbonyl compounds to 
nitroalkenes, for instance, is well established (section 3.3.1.), whereas fewer 
examples are known dealing with the addition to simple enone acceptors. 
One of the first asymmetric applications was performed by Barbas in the Michael 
addition of acetone to diethyl benzylidene malonate using catalyst 2 with moderate 
yields.
34
 The observed stereochemistry was rationalized with a transition state 
where the alkylidene malonate approaches the enamine from the less hindered re-
face (Scheme 3.22).  
 
Scheme 3.22 
 
As in the case of nitroolefins, the existence of bifunctional catalysts capable of 
interaction with the Michael acceptor can amplify the enantioselection due to the 
steric hindrance of substituents. 
                                                     
33 Wiesner, M.; Revell, J. D.; Wennemers, H. Angew. Chem.Int. Ed. 2008, 47, 1871. 
34 Betancort, J. M.; Sakthivel, K.; Thayummanavan, R.; Barbas, C. F. Tetrahedron Lett. 2001, 42, 
4441. 
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Recently Wang developed a highly enantioselective organocatalytic Michael 
addition of cyclic ketones with with α,β-unsaturated ketones.35 The process was 
catalyzed by sulfonamide 3 which led good selectivities and yields. The system 
resulted to be powerful with a wide range of aliphatic and aromatic cyclic ketones. 
The mechanism reported hypothesizes a bridged H-bond interaction involving 
sulfonamide, carbonyl group and the protic solvent (Scheme 3.23).  
 
 
Scheme 3.23 
 
An interesting, though definitely different, study involving α,β-unsaturated ketones 
that is worth mentioning concerns the enamine-catalyzed asymmetric inverse-
electron-demand hetero-Diels-Alder (HDA) reaction developed by Juhl and 
Jørgensen,
36
 and a plausible catalytic cycle is represented in Scheme 3.24. The 
enamine C, which is generated from the amine catalyst A and the aldehyde B, acts 
as an electron-rich dienophile for the reaction with electron-deficient “diene” D to 
produce the aminal E. Hydrolysis of E gives hemiacetal F and regenerates the 
catalyst. The presence of silica was found to facilitate the hydrolysis step in the 
catalytic cycle. 
                                                     
35 Wang, J.; Li, H.; Zu, L.; Wang, W. AdV. Synth. Catal. 2006, 348, 425. 
36 Juhl, K.; Jørgensen, K. A. Angew. Chem., Int. Ed. 2003, 42, 1498. 
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Scheme 3.24 
 
 
Vinyl sulfones as Michael acceptor 
The reaction of preformed enamines with vinyl sulfones has been known for some 
time.
37
 Although advancement has been made using chiral auxiliaries to develop 
asymmetric conjugate additions to vinyl sulfones,
38
 the direct asymmetric catalytic 
conjugate addition of carbonyl compounds to vinyl sulfones would be desirable. 
Since sulfones are widely useful intermediates of unique synthetic versatility in 
organic synthesis, the desired 1,4-Michael adducts could further react as 
nucleophilic reagents or be involved in reductive alkylations and Julia-type 
reactions, among others. 
                                                     
37 Simpkins, N. S. Tetrahedron 1990, 46, 6951. 
38 Pinheiro, S.; Guingant, A.; Desmae¨le, D.; d’Angelo, J. Tetrahedron: Asymmetry 1992, 3, 1003; 
d’Angelo, J.; Revial, G. Tetrahedron: Asymmetry 1991, 2, 199; Enders, D.; Muller, S. F.; Raabe, G.; 
Runsink, J. Eur. J. Org. Chem. 2000, 879; Sanki, A. K.; Suresh, C. G.; Falgune, U. D.; Pathak, T. Org. 
Lett. 2003, 5, 1285. 
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The first direct catalytic asymmetric Michael addition of aldehydes to vinyl 
sulfones was reported in 2005 by Alexakis using 1,1-bis(benzenesulfonyl)-ethylene 
as Michael acceptor.
39
 As nucleophile, various aldehydes were used and the 
pyrrolidine derivative 1 as catalyst The results proved to be directly correlated to 
the bulk of aldehydes even if α,α-disubstituted aldehydes gave rise to low 
selectivity. The transition state proposed (Scheme 3.25) shows that the steric 
hindrance of bypyrrolidine catalyst is absolutely determinant to the formation of the 
more thermodynamically stable enamine 
 
. 
Scheme 3.25 
 
3.2   Development of the catalytic system  
 
As we showed above in the introductory section, a well-defined structure and 
conformation of the catalyst is mostly important to develop an efficient catalytic 
system (chapter 1).  
Two different strategies can be used for this purpose: the first aims to develop (or 
modify) the structure of a catalytic system to improve its performance. The second 
                                                     
39 Mosse´, S.; Alexakis, A. Org. Lett. 2005, 7, 4361. 
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is based on the use of a backbone having a well-defined conformation, and its 
derivatization with functional groups capable of catalytic activities. 
In our approach we focused on the latter route, using as a platform the expertise of 
our group in the field of diketopiperazines. The idea was to develop a bifunctional 
system having a diketopiperazinic scaffold connected with a proline and a 
carboxylic acid as catalytic centers (Scheme 3.26). 
 
Scheme 3.26 
 
 
2,5-Diketopiperazines as rigid scaffold 
 
2,5.Diketopiperazines are the smallest cyclic peptides composed by two α-amino 
acids and their structure, known since 1938,
40
 is contained in many biologically 
active compounds as antibiotics,
41
 vaccines and anticancer agents.
42
 
 
Scheme 3.27 
 
                                                     
40 R. B. Corey, J. Am. Chem. Soc. 1938, 60, 1598. 
41 Y. Funabashi, T. Horiguchi, S. Iinuma, S. Tanida, S. Harada, J. Antibiot. 1994, 47, 1202; F. Fdhila, 
V. Vazquez, J. L. Sanchez, R. Riguera, J. Nat. Prod. 2003, 66, 1299. 
42 W. A. Loughlin, R. L. Marshall, A. Carreiro, K. E. Elson, Bioorg.Med. Chem. Lett. 2000, 10, 91; B. 
Nicholson, G. K. Lloyd, B. R. Miller, M. A. Palladino, Y. Kiso, Y. Hayashi, S. T. C. Neuteboom, 
Anti-Cancer Drugs 2006, 17, 25. 
136 
 
From a structural and synthetic point of view, 2,5-diketopiperazines are simple 
heterocyclic scaffolds in which diversity can be introduced at up to four different 
positions, and stereochemically controlled at two (Scheme 3.27). Their preparation 
is also feasible from readily available α-amino acids with conventional 
procedures,
43
 solid state,
44
 and microwave-assisted synthesis.
45
 
Our group has recently investigated the conformational properties of 
diketopiperazines with interesting results. In particular, attention has been focused 
on bifunctional diketopiperazines scaffolds 4, formally derived from (S)-aspartic 
acid and either (S)- or (R)-2,3-diaminopropionic acid. 
 
 
These molecules have proven to be useful as β-hairpin inducers46 and efficient 
scaffolds for cyclic peptidomimetics.
47
 In particular product 4a derived from L-
aspartic acid and (S)-2,3-diaminopropionic acid, bears the amino and carboxylic 
acid functionalities in a cis relationship and, as such, can be seen as a -turn mimic 
and promoter of antiparallel -sheet when introduced in peptidic chains.  
                                                     
43 I. L. Rodionov, L. N. Rodionova, L. K. Baidakova, A. M. Romashko, T. A. Balashova, V. T. 
Ivanov, Tetrahedron 2002, 58, 8515; For a review on synthetic approaches to all three DKP isomers 
(2,3-, 2,5-, and 2,6-), see: C. J. Dinsmore, D. C. Beshore, Tetrahedron 2002, 58, 3297, and references 
therein. 
44 W.-R. Li, J. H. Yang, J. Comb. Chem. 2002, 4, 106; P. M. Fischer, J. Pept. Sci. 2003, 9, 9. 
45 A. Lopez-Cobenas, P. Cledera, J. D. Sanchez, P. Lopez-Alvarado, M. T. Ramos, C. Avendano, J. C. 
Menendez, Synthesis 2005, 19, 3412; J. C. O’Neill, H. E. Blackwell, Comb. Chem. High Throughput 
Screening 2007, 10, 857. 
46 A. S. M. Ressurreicao, A. Bordessa, M. Civera, L. Belvisi, C. Gennari, U. Piarulli, J. Org. Chem. 
2008, 73, 652; 
47 A. S. M. Ressurreicao, A. Vidu, M. Civera, L. Belvisi, D. Potenza, L. Manzoni, S. Ongeri, C. 
Gennari, U. Piarulli, Chem. Eur. J. 2009, 15, 12184; A. S. M. Ressurreicao, R. Delatouche, C. 
Gennari, U. Piarulli, Eur. J. Org. Chem. 2011, 217–228. 
137 
 
The synthesis of several peptidomimetics was thus performed by solution phase 
peptide synthesis (Boc strategy). Conformational analysis of these derivatives was 
carried out by a combination of 
1
H-NMR spectroscopy (chemical shift and NOE 
studies), IR spectroscopy, CD spectroscopy and molecular modeling, and revealed 
the formation of -hairpin mimics involving 10- and 18-membered H-bonded rings 
and a reverse turn of the growing peptide chain. The -hairpin conformation of the 
longer derivative was detected also in competitive, dipolar and even protic solvents 
such as dimethylsulfoxide and methanol (Scheme 3.28). 
 
Scheme 3.28 
 
This attitude was further confirmed in the conformational analysis of two oligomers 
by 
1
H NMR, CD spectroscopy and molecular modeling.
48
 
 
Scheme 3.29 
                                                     
48 R. Delatouche, M. Durini, M. Civera, L. Belvisi, U. Piarulli, Tetrahedron Lett. 2010, 51, 4278. 
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In the case of the trimeric structure (Scheme 3.29) the presence of a ribbon was 
proved by NMR which highlighted NOE contacts between distant protons.  
The tetrameric structure was investigated and the predicted conformation obtained 
by molecular modeling was proved by NMR and CD spectroscopy (Scheme 3.30).  
 
 
Scheme 3.30 
 
 3.2.1   Synthesis of catalysts 
 
The synthesis of the diketopiperazine scaffolds 4a and 4b was obtained starting 
from suitably protected N-(tert-butoxycarbonyl)-(2S)-aspartic acid β-allylester and 
either (S) or (R)-N-benzylserine methyl ester with a direct coupling using HATU. A 
closer inspection of the spectroscopic properties revealed that the formation of the 
isopeptide had occurred via the selective acylation of the unprotected β-hydroxy 
group of either (S)- or (R)-N-benzyl serine. (Scheme 3.31). 
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Scheme 3.31 
 
This rather uncommon pathway was studied by NMR spectroscopy and two set of 
signals proved to be diagnostic: i) in the 
1
H NMR spectrum, the O-CH2 protons of 
serine were rather deshielded; ii) in the HMBC spectrum of both compounds, a long 
range coupling (through three bonds) was clearly evident between the O-CH2 
protons of serine and the α-carbonyl carbon of aspartic acid (Scheme 3.32). 
 
Scheme 3.32 
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The cyclization step was also investigated and product 6b was used for the study. 
Since a O,N-acyl transfer should occur to give product 7b upon nitrogen 
deprotection, the Boc group was cleaved by reaction with TFA to obtain a bis-TFA 
salt. 4 equiv. of base were added to provide a complete cyclization and the reaction 
monitored by 
1
H NMR (Scheme 3.33) which clearly showed a decreasing of signals 
belonging to serine (two dd at δ 4.32 and δ 4.45) and concurrent increase of signals 
belonging to diketopiperazines (two dd at δ 3.93 and δ 4.02). 
 
 
Scheme 3.33 
 
Based on these experimental observations, a reasonable mechanistic explanation 
(Scheme 3.34) involves a rate limiting O,N-acyl transfer with immediate ring 
closure to give rise to diketopiperazines with no peptidic intermediate. 
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Scheme 3.34 
 
Products 8 and 9, prepared according to the literature,
8 
were Boc deprotected and 
coupled to either L-Boc-Pro or D-Boc-Pro to give in good yields allylesters 10-13. 
These precursors have been subject to a deallylation reaction to furnish products 14-
17 and Boc deprotection to give catalysts 18-21 which have been stored as 
trifluoroacetic salts (Scheme 3.35). 
 
Scheme 3.35 
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Our idea is based on the fact that the high rigidity of the catalysts would lead the 
two functional groups responsible for the catalytic activity to be in well-defined 
regions of space. 
To bear out this hypothesis, we also synthesized catalysts 22 and 23 to demonstrate 
respectively that steric hindrance of proline and the structure of diketopiperazinic 
backbone are singularly not sufficient to achieve high enantioselectivity. 22a and 
22b should reveal the importance of the presence of a carboxylic functionality on 
the catalyst.   
 
 
Product 23 was synthesized from precursor 12 by direct Boc deprotection whereas 
22a was prepared by simple coupling between commercially available Boc-Proline 
and benzylamine with subsequent Boc deprotection. 
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3.2.2   Catalytic applications and results 
 
Conjugate addition of aldehydes to nitroolefines is among the most widely studied 
reactions concerning proline-based organocatalysts
49
 as well as amine catalysis,
50
 
therefore we chose this reaction to prove the efficiency of our system. 
The enantioselective conjugate addition of n-butanal to β-nitrostyrene was chosen 
as benchmark reaction to screen catalysts and conditions (Scheme 3.36). The 
reactions were performed at 20°C in a different solvents, including CH2Cl2, CHCl3, 
THF and iPrOH, but best results were achieved using a mixture of CHCl3 and 
iPrOH 9:1 and 5 mol-% of catalyst. 
Since catalysts were stored as the corresponding trifluoroacetate salts, one 
equivalent of N-methylmorpholine (with respect to the amount of catalyst) was 
added to free the amino group. 
Good to excellent results were obtained with the catalysts; in particular 18 and 20 
provided quantitative yields as well as excellent diastereoisomeric ratios and 
enantiomeric excesses (Scheme 3.36). The absolute configuration of the product is 
dictated by the configuration of the proline moiety (L or D), whereas the rigid 
diketopiperazinic backbone tunes the degree of selectivity. 
 
 
 
                                                     
49 a) C. Palomo, S. Vera, A. Mielgo, E. Gomez-Bengoa, Angew. Chem. Int. Ed. 2006, 45, 5984; b) M. 
L. Clarke, J. A. Fuentes, Angew. Chem. Int. Ed. 2007, 46, 930; c) X. H. Liu, L. L. Lin, X. M. Feng, 
Chem. Commun. 2009, 6145; d) M. Freund, S. Schenker, S. B. Tsogoeva, Org. Biomol. Chem. 2009, 7, 
4279; e) J. F. Bai, X. Y. Xu, Q. C. Huang, L. Peng, L.X. Wang, Tetrahedron Lett. 2010, 51, 2803; f) J. 
Xiao, F.-X. Xu, Y.-P. Lu, Y.-L. Liu, T.-P. Loh, Synthesis 2011, 1912. 
50 a) R. Husmann, M. Jorres, G. Raabe, C. Bolm, Chem. Eur. J. 2010, 16, 12549; b) Y. Wang, S. Zhu, 
D. Ma, Org. Lett. 2011, 13, 1602; c) C. Luo, D.- M. Du, Synthesis 2011, 1968; d) R. Rasappan, O. 
Reiser, Eur. J. Org. Chem. 2009, 1305; e) H. Uehara, R. Imashiro, G. Hernandez-Torres, C. F. Barbas, 
Proc. Natl. Acad. Sci. USA 2010, 107, 20672; f) A. Lu, T. Liu, R. Wu, Y. Wang, G. Wu, Z. Zhou, J. 
Fang, C. Tang, J. Org. Chem. 2011, 76, 3872. 
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Entry Cat. Yield [%] syn:anti 
ee [%]
 
(syn isomer) 
Abs. Conf. 
1 18 99 40:1 99 (2R, 3S) 
2 19 99 33:1 76 (2S, 3R) 
3 20 96 50:1 92 (2R, 3S) 
4 21 95 33:1 80 (2S, 3R) 
5 L-Pro 85 8:1 39 (2R, 3S) 
6 22a 27 5:1 53 (2R, 3S) 
7 22b 33 4:1 52 (2R, 3S) 
8 23 76 16:1 82 (2R, 3S) 
Scheme 3.36  
 
Beyond the results provided by the catalysts, some important considerations have to 
be done comparing their result with those obtained from reference molecules 22, 23 
and proline. 
Proline itself, which has been widely used as an organocatalyst, afforded only 
moderate reactivity and low diastereo- and enantioselectivity (Scheme 3.36, entry 
5). Prolinamides 22 (22a reacted in presence of a equimolar amount of benzoic 
acid) gave rise to low yields and modest selectivities (Scheme 3.36, entries 6 and 7). 
Ester 23 highlighted the key role of the carboxylic acid in the activation of the 
nitroolefin: despite the same global structure, it provided poorer results in terms of 
both diastereo- and enantioselectivity.  
The substrate scope of catalysts was then investigated using several aliphatic 
aldehydes with β-nitrostyrene under the same reaction conditions (Scheme 3.37). In 
most cases catalyst 20 was the best performing catalyst in terms of 
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enantioselectivity, whereas better diastereoselectivity was usually obtained with 
catalyst 18. 
 
Entry R Cat. Yield [%] syn:anti 
ee [%]
 
(((syn isomer)
 
Abs. 
Conf. 
1 n-C3H7 18 99 11:1 83 (2R, 3S) 
2 n-C3H7 19 98 13:1 66 (2S, 3R) 
3 n-C3H7 20 99 20:1 94 (2R, 3S) 
4 n-C3H7 21
 
99 25:1 82 (2S, 3R) 
5 i-C3H7 18 81 99:1 88 (2R, 3S) 
6 i-C3H7 19 77 50:1 78 (2S, 3R) 
7 i-C3H7 20 40 99:1 92 (2R, 3S) 
8 i-C3H7 21 40 99:1 80 (2S, 3R) 
9 n-C5H11
 
18 99 20:1 97 (2R, 3S) 
10 n-C5H11 19 98 20:1 91 (2S, 3R) 
11 n-C5H11 20 99 8:1 98 (2R, 3S) 
12 n-C5H11 21 95 13:1 95 (2S, 3R) 
13 CH2Ph 18 99 33:1 92 (2R, 3S) 
14 CH2Ph 19 97 20:1 83 (2S, 3R) 
15 CH2Ph 20 94 7:1 98 (2R, 3S) 
16 CH2Ph 21 94 10:1 85 (2S, 3R) 
Scheme 3.37 
 
Catalysts 19 and 21, derived from D-proline, gave the enantiomeric products 
(2S,3R)-24. Remarkably, 19 and 21 parallel the behavior of 18 and 20 in terms of 
performance: catalyst 21 gave better ee values than 19 and, conversely, 19 was 
often more diastereoselective than 21. 
146 
 
Catalysts 20 and 21 have been also tested in the conjugate addition of various 
aldehydes to (E)-2-(furan-2-yl)nitroethene (Scheme 3.38). Good to excellent 
enantio- and diastereoselectivities  were obtained, albeit with moderate conversions, 
which can be attributed to the lower reactivity of the electron-rich substrate. 
 
Entry R Cat. Yield [%] syn:anti 
ee [%]
 
(syn isomer) 
1 n-C2H5 20 66 9:1 93 
2 n-C2H5 21 87 16:1 85 
3 n-C3H7 20 61 13:1 94 
4 n-C3H7 21 64 33:1 78 
5 i-C3H7 20 42 99:1 92 
6 i-C3H7 21 31 99:1 80 
7 CH2Ph 20 97 12:1 95 
8 CH2Ph 21 81 10:1 77 
Scheme 3.38 
 
Making a careful overview of the results, the behavior of products 18 and 20 appear 
quite puzzling. In fact these catalysts, having different stereostructures, yield the 
conjugate addition products with the same absolute configuration and similar 
enantioselectivity. As already published in previous works,
51
 the absolute 
configuration of final product is determined by the configuration of terminal 
proline, however the achievement of the same selectivities is absolutely 
counterintuitive because the relative stereochemistry of the diketopiperazinic unit 
                                                     
51 M. Wiesner, J. D. Revell, H. Wennemers, Angew. Chem. Int. Ed. 2008, 47, 1871 
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DKP-1 and DKP-2 should confer different spatial properties
52
 and consequently 
different relative positions of proline and carboxylic functionality.  
To shed light on the activity of catalysts, we decided to undertake a conformational 
analysis of structures of 18 and 20 by means of computational studies. The 
molecules were subject to an extensive, unconstrained Monte Carlo/Energy 
Minimization conformational search
53
 by molecular mechanics methods using the 
OPLSA-AA force field
54
 and the implicit CHCl3 GB/SA solvent model.
55
 
Comparing the two minimizations (Scheme 3.39), it is possible to observe a similar 
folding of the proline in the direction of carboxylic functionality due to an 
interaction between the proline N-H and the C=O of the acid. 
 
Scheme 3.39 
 
                                                     
52 a) A. S. M. Ressurreicao, A. Bordessa, M. Civera, L. Belvisi, C. Gennari, U. Piarulli, J. Org. Chem. 
2008, 73, 652; b) A. S. M. Ressurreicao, A. Vidu, M. Civera, L. Belvisi, D. Potenza, L. Manzoni, S. 
Ongeri, C. Gennari, U. Piarulli, Chem. Eur. J. 2009, 15, 12184. 
53 G. Chang, W. C. Guida, W. C. Still, J. Am. Chem. Soc. 1989, 111, 4379–4386. 
54 G. A. Kaminski, R. A. Friesner, J. Tirado-Rives, W. L. Jorgensen, J. Phys. Chem. B 2001, 105, 
6474. 
55 W. C. Still, A. Tempczyk, R. C. Hawley, T. J. Hendrickson, J. Am. Chem. Soc. 1990, 112, 6127. 
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This evidence could be considered as a simple speculation since H-bonds are less 
important once the enamine is formed. For this reason we performed an Energy 
Minimizations conformational search also on the enamine intermediate of 20. As 
we expected the conformational equilibrium in the enamine is more complicated 
and features either folded and unfolded geometries. However a low-energy structure 
that superimposes well to the kinked, global minimum of the catalyst gives 
interesting information (Scheme 3.40). In this conformation the re-face of the 
enamine is shielded by the diketopiperazines and benzyl group, leaving the si-face 
exposed to the attack of nucleophilic nitroolefine. The carboxylic group is likely to 
act as H-bond donor, activating the acceptor and directing its approach from the less 
hindered face.     
 
Scheme 3.40  
 
 
3.2.3   Conclusion 
 
In this chapter we have reported the preparation of a new class of peptidomimetic 
organocatalysts starting from two bifunctional diketopiperazines formally derived 
from the head-to-tail cyclization of L-aspartic acid and either (R)- or (S)-2,3-
diaminopropionic acid. The terminal amino group in the DKP scaffold was coupled 
to a L- or D-proline residue giving rise to the four different organocatalysts. These 
were tested in the conjugate addition reaction of several aldehydes to -nitrostyrene 
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and (E)-2-(furan-2-yl)nitroethene with good to excellent diastereo- and 
enantioselectivities. To rationalize the stereoselectivity of these catalysts, a Monte 
Carlo/Energy Minimization (MC/EM) conformational search by molecular 
mechanics methods was undertaken on the four catalysts and their enamine 
derivatives with propanal. The catalysts showed a folded arrangement with the 
COOH pointing towards the proline nitrogen while the enamine derivatives 
revealed conformations where one face of the enamine moiety is shielded by the 
diketopiperazine ring and the carboxylic acid is likely to act as a hydrogen-bond 
donor, activating the nitroolefin acceptor (-NO2) and directing its approach from the 
less hindered enamine face. 
 
 
3.2.4   Experimental Part 
 
General Remarks  
All reactions were carried out in flame-dried glassware with magnetic stirring under 
a nitrogen atmosphere, unless otherwise stated. Dry solvents (over molecular sieves 
in bottles with crown caps) were purchased from Sigma–Aldrich and stored under 
nitrogen. The reactions were monitored by analytical TLC using silica gel 60 F254 
precoated glass plates (0.25 mm thickness). Visualization was accomplished by 
irradiation with a UV lamp and/or staining with a potassium permanganate alkaline 
solution. Flash column chromatography was performed using silica gel 60 Å, 
particle size 40–64 μm, following the procedure reported by Still and coworkers.56 
1
H NMR spectra were recorded with a spectrometer operating at 400.13 MHz. 
Chemical shifts are reported in ppm with the solvent reference relative to 
tetramethylsilane (TMS) employed as the internal standard (CDCl3 δ = 7.26 ppm). 
The following abbreviations are used to describe spin multiplicity: s = singlet, d = 
doublet, t = triplet, q = quartet, m = multiplet, br. = broad signal, dd = doublet of 
doublets. 
13
C NMR spectra were recorded with a 400 MHz spectrometer operating 
                                                     
56 W. C. Still, M. Kahn, A. Mitra, J. Org. Chem. 1978, 43, 2923. 
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at 100.56 MHz with complete proton decoupling. Chemical shifts are reported in 
ppm relative to TMS with the respective solvent resonance as the internal standard 
(CDCl3, δ = 77.23 ppm). Infrared spectra were recorded with a standard FTIR 
spectrometer. Optical rotation values were measured with an automatic polarimeter 
with a 1-dm cell at the sodium D line (λ = 589 nm). HPLC was performed with an 
instrument equipped with a diode array detector using a chiral column. HRMS were 
measured with a Fourier Transform Ion Cyclotron Resonance (FT-ICR) Mass 
Spectrometer APEX II & Xmass software (Bruker Daltonics)–4.7 T Magnet 
(Magnex) equipped with ESI source, available at CIGA (Centro Interdipartimentale 
Grandi Apparecchiature), c/o Università degli Studi di Milano. MS were acquired 
either with a Thermo- innigan LCQ Advantage mass spectrometer (ESI ion source) 
or a VG Autospec M246 spectrometer (FAB ion source). Elemental analyses were 
performed with a Perkin–Elmer Series II CHNS/O Analyzer 2000.  
 
 
Materials  
Commercially available reagents were used as received. Allyl [(3S,6S)-4-benzyl-3-
(tert-butoxycarbonylaminomethyl)-2,5- dioxopiperazin-5-yl]acetate
57
 (8), allyl 
[(3R,6S)-4-benzyl-3-(tertbutoxycarbonylaminomethyl)- 2,5-dioxopiperazin-5-
yl]acetate
18
 (9), and (S)-benzylprolinamide
58
 (22a) were prepared according to 
literature procedures. Spectroscopic and analytical data for the following products 
were determined in agreement with those described in the literature: 2-ethyl-4-nitro-
3-phenylbutanal
59
 (24a), 4-nitro-3-phenyl-2-propylbutanal
59
 (24b), 4-nitro-2-pentyl-
3-phenylbutanal
59
 (24c), 2- isopropyl-4-nitro-3-phenylbutanal
59
 (24d), 2-benzyl-4-
                                                     
57 a) A. S. M. Ressurreicao, A. Bordessa, M. Civera, L. Belvisi, C. Gennari, U. Piarulli, J. Org. Chem. 
2008, 73, 652; b) A. S. M. Ressurreicao, A. Vidu, M. Civera, L. Belvisi, D. Potenza, L. Manzoni, S. 
Ongeri, C. Gennari, U. Piarulli, Chem. Eur. J. 2009, 15, 12184. 
58 D. Gryko, R. Lipinski, Adv. Synth. Catal. 2005, 347, 1948. 
59 M. Wiesner, M. Neuburger, H. Wennemers, Chem. Eur. J. 2009, 15, 10103. 
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nitro-3- phenylbutanal
59
 (24e), 2-ethyl-3-(furan-2-yl)-4-nitrobutanal
60
 (25a), and 3-
(furan-2-yl)-4-nitro-2-propylbutanal
61
 (25b). 
 
 
Synthesis and characterization of catalysts 
 
4-Allyl 1-[(2R)-2-(benzylamino)-3-methoxy-3-oxopropyl] N-(tert-
butoxycarbonyl)-L-aspartate (6b). 
 
To a solution of β-allyl (2S)-N-(tert-butoxycarbonyl) aspartate ester (2.24 g, 8.2 
mmol, 1.1 equiv) in DMF (70 mL), under a nitrogen atmosphere and at 0°C, HATU 
(3.39 g, 8.94 mmol, 1.2 equiv), HOAt (1.21 g, 8.94 mmol, 1.2 equiv) and DIPEA 
(5.1 mL, 29.8 mmol, 4 equiv) were added successively. After 30 min, a solution of 
(R)-N-benzylserine methyl ester (1.56 g, 7.45 mmol, 1 equiv) in DMF (10 mL) was 
added. The reaction mixture was then stirred at 0°C for 1 h and at rt for 24 h. The 
mixture was then diluted with EtOAc (200 mL) and the organic phase was washed 
with 1 M KHSO4 (2x 70 mL), aqueous NaHCO3 (2x 70 mL), and brine (2x 50 mL), 
dried over Na2SO4, and volatiles were removed under reduced pressure. The residue 
was purified by flash chromatography on silica gel (Petroleum ether/EtOAc, 3:1) to 
afford the desired product (6b) as a transparent oil (2.73 g, 72% yield).  
Rf= 0.30 (hexane/EtOAc 6:4); [α]D
20
 +11.0 (CHCl3, c= 1.00); 
1
H NMR (400 MHz, 
CD2Cl2) δ= 1.42 (s, 9H), 2.82 (dd, 1H, J= 17.0, 4.8 Hz), 2.94 (dd, 1H, J= 17.2, 4.68 
Hz), 3.51 (t, 1H, J= 4.74 Hz), 3.70 (d, 1H, J= 13.1 Hz), 3.71 (s, 3H), 3.86 (d, 1H, J= 
13.1), 4.30 (dd, 1H, J= 10.9, 4.8 Hz), 4.39 (dd, 1H, J=10.9, 4.6 Hz), 4.61-4.48 (m, 
                                                     
60 Z. Zheng, B. L. Perkins, B. Ni, J. Am. Chem. Soc. 2010, 132, 50. 
61 D. F. Lu, Y. F. Gong, W. Z. Wang, Adv. Synth. Catal. 2010, 352, 644; 
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3H), 5.34-5.18 (m, 2H), 5.41 (d, 1H, J= 7.8 Hz), 5.95-5.82 (m, 1H), 7.37-7.20 (m, 
5H); 
13
C NMR (100 MHz, CD2Cl2) δ= 28.0, 36.7, 50.0, 51.8, 52.0, 59.1, 65.6, 65.9, 
118.1, 127.1, 128.2, 128.3, 131.9, 139.7, 170.6, 172.4; IR (film): νmax 3362, 2978, 
1740, 1500, 1455, 1368, 1167, 1053; 
HRMS (ESI) m/z calcd for [C23H33N2O8]
+
: 465.22314 [M+H]
+
; found: 465.22267. 
 
 
(2S)-4-(Allyloxy)-1-{[(2R)-2-(benzylammonio)-3-methoxy-3-oxopropyl]oxy}-
1,4-dioxobutan-2-aminium bis(trifluoroacetate) (6B-TFA). 
 
To a solution of 6b (845 mg, 1.82 mmol) in CH2Cl2 (14.4 mL) was added 
trifluoroacetic acid (7.2 mL, 4 mL/mmol). The reaction mixture was stirred for 3 h 
at rt and then concentrated at reduced pressure. The excess TFA was azeotropically 
removed from the residue with toluene. Diethyl ether was added to the residue and 
the resulting suspension was evaporated under reduced pressure to give the 
isopeptide bis-TFA salt (6b-TFA) as a white foamy solid in quantitative yield.  
Rf= 0.37 (DCM/MeOH 95:5); [α]D
32
 -8.7 (CHCl3, c= 1.5); 
1
H NMR (400 MHz, 
CD2Cl2) δ= 3.10 (dd, 1H, J= 18.5, 6.1 Hz), 3.17 (dd, 1H J= 18.3, 3.9 Hz), 3.89-3.81 
(s, 3H), 4.08-4.01 (br, 1H), 4.29 (d, 1H, J= 13.0 Hz), 4.48-4.37 (m, 2H), 4.78-4.59 
(m, 4H), 5.41-5.25 (m, 2H), 6.01-5.86 (m, 1H), 7.59-7.37 (m, 5H); 
13
C NMR (100 
MHz, CD2Cl2) δ= 33.4, 49.4, 50.6, 52.9, 53.2, 53.4, 53.7, 53.9, 56.1, 62.7, 66.5, 
118.9, 129.3, 130.0, 130.5, 131.2, 166.3, 165.9, 170.1; IR (film): νmax 2921, 2850, 
1759, 1681, 1539, 1456, 1392, 1202, 1137; HRMS (ESI) m/z calcd for 
[C18H25N2O6]
+
: 365.17071 [M+H]
+
; found: 365.17033. 
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Allyl [(2S,5R)-4-benzyl-5-(hydroxymethyl)-3,6-dioxopiperazin-2-yl]acetate 
(5b). 
 
The bis-trifluoro acetate salt 6b-TFA (1.08 g, 1.82 mmol, 1 equiv) was dissolved in 
iPrOH (20 mL) and DIPEA (0.9 mL, 5.6 mmol, 4 equiv) was added at rt. The 
reaction was stirred 
for 40 h at rt, monitoring the formation of DKP by TLC (EtOAc/hexane 8:2). The 
solution was then concentrated under reduced pressure and the residue was purified 
by flash chromatography on silica gel (Petroleum ether/EtOAc, 3:1) to afford the 
desired product (5b) as a white foam (514.1 mg, 85% yield).  
Rf= 0.10 (AcOEt/hexane 8:2); [α]D
20
 -35.3 (CHCl3, c = 1.00); 
1
H NMR (400 MHz, 
CD2Cl2) δ= 2.86 (dd, 1H,  J= 17.4, 8.0 Hz), 3.21 (dd, 1H, J= 17.4, 3.9 Hz), 3.81 (br, 
1H), 3.90 (dd, 1H, J= 11.8, 3.0 Hz), 4.01 (dd,1H, J= 11.8, 1.90 Hz), 4.12 (d, 1H, J= 
15.2 Hz), 4.70-4.55 (m, 3H), 5.39-5.20 (m, 3H), 6.02-5.83 (m, 1H), 7.20 (bs, 1H), 
7.43-7.25 (m, 5H); 
13
C NMR (100 MHz, CD2Cl2) δ= 37.1, 47.3, 51.1, 61.6, 61.9, 
65.7, 117.9, 118.3, 127.8, 127.9, 128.8, 131.8, 135.9, 166.6, 168.2, 170.8; IR (film): 
νmax 3364, 3032, 2942, 1738, 1651, 1452, 1383, 1329, 1273, 1183, 1129; HRMS 
(ESI)m/z calcd for [C17H20N2NaO5]
+
: 355.12644 [M+Na]
+
; found: 355.12590. 
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tert-Butyl(2S)-2-[({3S,6S}-6-{2-(Allyloxy)-2-oxoethyl}-4-benzyl-2,5-
dioxopiperazin-3-yl)methylcarbamoyl]pyrrolidine-1-carboxylate (10)  
 
TFA (5 mL) was added dropwise at 0°C to a solution of 7 (170 mg, 0.394 mmol, 
1.0 equiv.) in CH2Cl2 (5 mL) and the reaction mixture was stirred at the same 
temperature for 3 h. Volatiles were evaporated under reduced pressure and the 
residue was treated with Et2O to cause the precipitation of the TFA salt, which was 
isolated by decantation. l-Boc-Proline (93 mg, 0.432 mmol, 1.1 equiv.) was 
dissolved in acetonitrile (4 mL), and HATU (194 mg, 0.510 mmol, 1.3 equiv.) and 
DIPEA (169 μL, 0.985 mmol, 2.5 equiv.) were added at 0 °C under N2. The 
solution was stirred for 30 min before the TFA salt was added, and the mixture was 
stirred for 1 h at 0°C, and overnight at room temperature. The reaction mixture was 
poured into EtOAc (40 mL) and washed with 1M KHSO4 solution (2x 5 mL), satd. 
NaHCO3 solution (2x 5 mL), and brine (1x 5 mL). The organic layer was dried with 
Na2SO4, filtered, and concentrated under reduced pressure. The crude product was 
purified by flash chromatography using 2% MeOH in CH2Cl2 to yield 9 as a white 
solid (164 mg, 0.311 mmol, 79%). Rf = 0.28 (ethyl acetate); m.p. 61–62 °C. [α]20 
D = +6.6 (c = 0.1, CHCl3). 
1
H NMR (400 MHz, CDCl3, 25 °C): δ = 1.45 (s, 9 H), 
1.63 (br., 4 H), 1.87 (br. s, 2 H), 2.82 (m, 1 H), 3.43 (br., 1 H), 3.58 (m, 1 H), 3.79–
3.96 (br., 2 H), 4.17 (d, J = 15.0 Hz, 1 H), 4.25 (br. s, 1 H), 4.47 (m, J = 10.4, 2.6 
Hz, 1 H), 4.66 (m, 2 H), 5.29 (dd, J = 10.3, 1.2 Hz, 1 H), 5.35 (dd, J = 17.2, 1.2 Hz, 
1 H), 5.46 (d, J = 15.0 Hz, 1 H), 5.91 (m, 1 H), 6.61 (br., 1 H), 7.31 (m, 5 H) ppm. 
13
C NMR (100.6 MHz, CDCl3, 25 °C): δ = 24.5, 28.3, 39.5, 40.1, 43.8, 47.1, 52.0, 
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55.8, 57.8, 66.1, 80.6, 119.2, 128.1, 128.6, 129.0, 131.3, 135.2, 164.4 ppm. IR: ν = 
1734, 1662, 1307, 1162, 1124, 970, 842, 723 cm
–1
. C27H36N4O7 (528.60): calcd. C 
61.35, H 6.86, N 10.60; found C 61.03, H 7.18, N 10.22. 
 
 
tert-Butyl(2R)-2-[({3S,6S}-6-{2-(Allyloxy)-2-oxoethyl}-4-benzyl-2,5-
dioxopiperazin-3-yl)methylcarbamoyl]pyrrolidine-1-carboxylate (11) 
 
TFA (5 mL) was added dropwise at 0°C to a solution of 7 (170 mg, 0.394 mmol, 
1.0 equiv.) in CH2Cl2 (5 mL). The resulting solution was stirred at the same 
temperature for 3 h. Volatiles were removed under reduced pressure and the residue 
was treated with Et2O to cause the  precipitation of the TFA salt, which was isolated 
by decantation. D-Boc-Proline (93 mg, 0.432 mmol, 1.1 equiv.) was dissolved in 
CH2Cl2 (4 mL), and HATU (194 mg, 0.510 mmol, 1.3 equiv.) and DIPEA (169 μL, 
0.985 mmol, 2.5 equiv.) were added at 0°C under N2. The solution was stirred for 
30 min before the TFA salt was added, and the mixture was stirred for 1 h at 0°C 
and overnight at room temperature. The reaction mixture was poured into EtOAc 
(40 mL) and washed with 1M KHSO4 solution (2x 5 mL), satd. NaHCO3 solution 
(2x 5 mL), and brine (1x 5 mL). The organic layer was dried with Na2SO4, filtered, 
and concentrated under reduced pressure. The crude product was purified by flash 
chromatography using 2% MeOH in CH2Cl2 to yield 10 as a white solid (183 mg, 
0.346 mmol, 88%). Rf = 0.28 (ethyl acetate); m.p. 63–64 °C. [α]20 D = +29.90 (c = 
0.1, CHCl3). 
1
H NMR (400 MHz, CDCl3, 25°C): δ = 1.44 (s, 9 H), 1.62–1.99 (br., 4 
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H), 3.21–3.67 (br., 4 H), 3.84 (br., 1 H), 3.92 (br., 1 H), 4.13 (d, J = 14.5 Hz, 1 H), 
4.28 (br., 1 H), 4.48 (d, J = 10.7 Hz, 1 H), 4.58–4.70 (m, 2 H), 5.27 (d, J = 10.5 Hz, 
1 H), 5.34 (dd, J = 17.2, 1.3 Hz, 1 H), 5.53 (br. 1 H), 5.91 (m, 1 H), 6.79 (br. s, 1 
H), 7.28–7.34 (m, 5 H) ppm. 13C NMR (100.6 MHz, CDCl3, 25 °C): δ = 24.5, 
28.3, 29.6, 39.4, 43.6, 46.8, 47.2, 52.0, 55.7, 60.1, 66.0, 80.6, 119.1, 128.1, 128.6, 
129.0, 131.4, 135.1, 164.5, 165.5, 171.2, 173.0 ppm. IR: ν = 1740, 1667, 1533, 
1251, 1164, 1127, 970, 849, 723 cm
–1
. C27H36N4O7 (528.60): calcd. C 61.35, H 
6.86, N 10.60; found C 61.21, H 7.14, N 10.25. 
 
 
tert-Butyl(2S)-2-[({3R,6S}-6-{2-(Allyloxy)-2-oxoethyl}-4-benzyl-2,5-
dioxopiperazin-3-yl)methylcarbamoyl]pyrrolidine-1-carboxylate (12) 
 
To a solution of 8 (650 mg, 1.50 mmol, 1.0 equiv.) in CH2Cl2 (19.2 mL) was added 
TFA (19.2 mL) dropwise at 0°C, and the resulting solution was stirred at the same 
temperature for 2 h. Volatiles were evaporated under reduced pressure and the 
residue was treated with Et2O to cause the precipitation of the TFA salt, which was 
isolated by decantation. l-Boc-Proline (355 mg, 1.65 mmol, 1.1 equiv.) was 
dissolved in acetonitrile (15 mL), and HBTU (740 mg, 1.95 mmol, 1.3 equiv.) and 
collidine (0.60 mL, 4.50 mmol, 3.0 equiv.) were added at 0 °C under N2. The 
solution was stirred for 30 min before the TFA salt was added and the mixture was 
stirred for 1 h at 0 °C and at room temperature overnight. The reaction mixture was 
poured into EtOAc (150 mL) and washed with 1M KHSO4 solution (2x 20 mL), 
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satd. NaHCO3 solution (2x 20 mL), and brine (1x 20 mL). The organic layer was 
dried with Na2SO4, filtered, and concentrated under reduced pressure. The crude 
product was purified by flash chromatography using 2% MeOH in CH2Cl2 to yield 
11 as a pale yellow solid (793 mg, 1.50 mmol, 100 %). Rf = 0.26 (ethyl acetate); 
m.p. 57–58 °C. [α]20 D = –3.7 (c = 0.1, CHCl3). 
1
H NMR (400 MHz, CDCl3, 25 °C): 
δ = 1.47 (s, 9 H), 1.88 (br., 2 H), 2.08 (br., 1 H), 2.81 (br., 2 H), 3.22 (dd, J = 17.57, 
3.12 Hz, 1 H), 3.33 (br., 1 H), 3.41 (br., 1 H), 3.58 (br., 1 H), 3.88 (br., 1 H), 3.95 
(br., 1 H), 4.21 (d, J = 15.17 Hz, 1 H), 4.30 (br., 1 H), 4.55–4.63 (m, 3 H), 5.28 
(ddd, J = 30.17, 17.20, 1.16 Hz, 2 H), 5.43 (d, J = 15.16 Hz, 1 H), 5.89 (m, 1 H), 
6.97 (br, 1 H), 7.27–7.35 (m, 5 H), 7.51 (br. m, 1 H) ppm. 13C NMR (100.6 MHz, 
CDCl3, 25 °C): δ = 24.5, 28.4, 28.6, 37.5, 39.2, 47.0, 47.4, 50.6, 59.0, 59.8, 65.8, 
80.6, 118.9, 127.9, 128.4, 128.9, 131.4, 135.6, 164.8, 167.0, 170.6, 173.85 ppm. IR: 
ν = 2360, 1736, 1686, 1532, 1166, 843, 723 cm–1. C27H36N4O7 (528.60): calcd. C 
61.35, H 6.86, N 10.60; found C 60.99, H 6.93, N 10.40. 
 
 
tert-Butyl(2R)-2-[({3R,6S}-6-{2-(Allyloxy)-2-oxoethyl}-4-benzyl-2,5-
dioxopiperazin-3-yl)methylcarbamoyl]pyrrolidine-1-carboxylate (13) 
 
Compound 8 (600 mg, 1.39 mmol, 1.0 equiv.) was dissolved in CH2Cl2 (18 mL), 
and TFA (18 mL) was added dropwise at 0°C. The reaction mixture was stirred at 
the same temperature for 2 h. The solution was evaporated under reduced pressure 
and the residue was treated with Et2O to cause precipitation of the TFA salt, which 
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was isolated by decantation. d-Boc-Proline (329 mg, 1.53 mmol, 1.1 equiv.) was 
dissolved in acetonitrile (14 mL), and HBTU (685 mg, 1.80 mmol, 1.3 equiv.) and 
collidine (0.55 mL, 4.17 mmol, 3.0 equiv.) were added at 0°C under N2. The 
solution was stirred for 30 min before the TFA salt was added and the mixture was 
stirred for 1 h at 0 °C and overnight at room temperature. The reaction mixture was 
poured into EtOAc (150 mL) and washed with 1M KHSO4 solution (2x 20 mL), 5% 
NaHCO3 solution (2x 20 mL), and brine (1x 20 mL). The organic layer was dried 
with Na2SO4, filtered, and concentrated under reduced pressure. The crude product 
was purified by flash chromatography using 2% MeOH in CH2Cl2 to yield 12 as a 
pale yellow solid (734 mg, 1.39 mmol, 100%). Rf = 0.26 (ethyl acetate); m.p. 59–60 
°C. [α]20 D = +18.20 (c = 0.1, CHCl3). 
1
H NMR (400 MHz, CDCl3, 25 °C): δ = 1.46 
(s, 9 H), 1.86 (br., 2 H), 2.34 (br., 1 H), 2.60 (s, 1 H), 2.79 (m, 1 H) 3.26 (dd, J = 
17.52, 1.52 Hz, 1 H), 3.31 3.52 (br., 3 H), 3.86 (br., 1 H), 4.05–4.75 (br., 3 H), 
4.61–4.80 (m, 3 H), 5.28 (m, 2 H), 5.50 (m, 1 H), 5.89 (m, 1 H), 6.72 (br., 1 H), 
7.18 (br., 1 H), 7.25– 7.41 (m, 5 H) ppm. 13C NMR (100.6 MHz, CDCl3, 25°C): δ = 
24.5, 28.4, 28.5, 37.7, 38.6, 39.2, 47.0, 47.3, 50.8, 58.6, 60.3, 65.8, 80.6, 119.0, 
128.0, 128.3, 128.6, 131.4, 135.4, 165.0, 166.6, 170.7, 173.1 ppm. IR: ν = 1733, 
1668, 1164, 1126, 723 cm
–1
. C27H36N4O7 (528.60): calcd. C 61.35, H 6.86, N 10.60; 
found C 61.24, H 7.10, N 10.74. 
 
 
6-[(3S,6S)-4-Benzyl-3-({(2S)-1-(tert-butoxycarbonyl)pyrrolidine-2-
carboxamido}methyl)-2,5-dioxopiperazin-6-yl]acetic Acid (14) 
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To a solution of 9 (75 mg, 0.142 mmol, 1.0 equiv.) in CH2Cl2 (1.2 mL) at 0 °C were 
added pyrrolidine (15 μL, 0.170 mmol, 1.2 equiv.), triphenylphosphane (6.7 mg, 
0.025 mmol, 0.18 equiv.), and tetrakis- (triphenylphosphane)palladium(0) (6.6 mg, 
0.0057 mmol, 0.04 equiv.). The mixture was stirred for 15 min at 0°C and 2 h at 
room temperature, then poured into EtOAc (20 mL) and extracted into satd. 
NaHCO3 solution (3x 3 mL). The organic layers were discarded and the combined 
aqueous phases were acidified to pH 2 with 1M KHSO4 solution. The acidified 
aqueous solution was extracted into CH2Cl2 (3x 5 mL), and the combined organic 
layers were dried with Na2SO4, filtered, and concentrated under reduced pressure. 
The crude product was purified by flash chromatography eluting with 10% MeOH 
in CH2Cl2 to yield the product as a white solid (56 mg. 0.115 mmol, 81 %). Rf = 
0.30 (CH2Cl2/MeOH 9:1); m.p. 128–129 °C. [α]20 D = +57.40 (c = 0.2, CHCl3). 
1
H 
NMR (400 MHz, CDCl3, 25°C): δ = 1.41–1.48 (br., 9 H), 1.83, 2.34 (br., 4 H), 
2.93–3.01 (br., 1 H), 3.10–3.20 (br., 1 H), 3.32–3.63 (br., 4 H), 3.81–3.99 (br., 2 H), 
4.24–4.50 (br., 2 H), 5.51 (m, 1 H), 7.28–7.37 (br., 5 H), 7.50 (br., 1 H) ppm. 13C 
NMR (100.6 MHz, CDCl3, 25°C): δ = 24.4, 28.4, 29.9, 39.8, 40.5, 46.8, 47.2, 52.1, 
57.6, 59.8, 128.1, 128.5, 129.0, 135.0, 155.1, 164.8, 173.3 ppm. IR: ν = 2725, 2676, 
1738, 1666, 1252, 1162, 1126, 969, 849, 724 cm
–1
. C24H33N4O7 (489.55): calcd. C 
59.00, H 6.60, N 11.47; found C 58.97, H 6.55, N 11.64. 
 
 
6-[(3S,6S)-4-Benzyl-3-({(2S)-1-pyrrolidine-2-carboxamido}methyl)-2,5-
dioxopiperazin-6-yl]acetic Acid, Trifluoroacetate Salt (18·TFA) 
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The Boc derivative from the previous reaction was dissolved in CH2Cl2 (1.5 mL), 
TFA (1.5 mL) was added dropwise at 0°C, and the mixture stirred at the same 
temperature for 2 h. The solution was evaporated under reduced pressure and the 
residue was treated with Et2O to cause the precipitation of the TFA salt, which was 
isolated by decantation. 
 
 
6-[(3S,6S)-4-Benzyl-3-({(2R)-1-(tert-butoxycarbonyl)pyrrolidine-2-
carboxamido}methyl)-2,5-dioxopiperazin-6-yl]acetic Acid (15) 
  
To a solution of 10 (75 mg, 0.142 mmol, 1.0 equiv.) in CH2Cl2 (3 mL) at 0°C were 
added pyrrolidine (15 μL, 0.170 mmol, 1.2 equiv.), triphenylphosphane (6.7 mg, 
0.025 mmol, 0.18 equiv.), and tetrakis- (triphenylphosphane)palladium(0) (6.6 mg, 
0.0057 mmol, 0.04 equiv.). The mixture was stirred for 15 min at 0°C and 2 h at 
room temperature, poured into EtOAc (20 mL), and extracted into satd. NaHCO3 
solution (3x 3 mL). The organic layers were discarded and the combined aqueous 
phases were acidified to pH 2 with 1M KHSO4 solution. The acidified aqueous 
solution was extracted into CH2Cl2 (3x 5 mL) and the combined organic layers were 
dried with Na2SO4, filtered, and concentrated under reduced pressure. The crude 
product was purified by flash chromatography eluting with 10% MeOH in CH2Cl2 
to yield the product as a white solid (59.0 mg, 0.120 mmol, 85%). Rf = 0.30 
(CH2Cl2/MeOH 9:1); m.p. 131–132 °C. [α]20 D = +107.60 (c = 0.2, CHCl3). 
1
H 
NMR (400 MHz, CDCl3, 25 °C): δ = 1.44 (s, 9 H), 1.70 (br., 1 H), 1.86 (br., 1 H), 
2.06 (br., 2 H), 2.90 (dd, J = 17.7, 3.2 Hz, 1 H), 3.27 (dd, J = 17.7, 4.1 Hz, 1 H) 
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3.33–3.57 (br., 4 H), 3.76–3.86 (m, 2 H), 4.30–4.40 (m, 3 H), 5.66 (d, J = 15.3 Hz, 
1 H), 7.18 (d, J = 8.7 Hz, 1 H), 7.28–7.38 (m, 5 H), 8.95 (s, 1 H) ppm. 13C NMR 
(100.6 MHz, CDCl3, 25 °C): δ = 24.5, 28.4, 30.3, 35.3, 38.2, 45.6, 47.4, 51.2, 56.4, 
60.1, 81.2, 128.2, 128.6, 129.0, 134.6, 154.9, 165.0, 167.3, 173.0, 173.1 ppm. IR: ν 
= 2726, 1656, 1165, 1123, 723 cm
–1
. C24H33N4O7 (489.55): calcd. C 59.00, H 6.60, 
N 11.47; found C55.91, H 6.54, N 11.58. 
 
 
6-[(3S,6S)-4-Benzyl-3-({(2R)-1-pyrrolidine-2-carboxamido}methyl)-2,5-
dioxopiperazin-6-yl]acetic Acid, Trifluoroacetate Salt (19·TFA) 
  
The Boc derivative from the previous reaction was dissolved in CH2Cl2 (1.6 mL), 
TFA (1.6 mL) was added dropwise at 0°C, and the mixture stirred at the same 
temperature for 2 h. The solution was evaporated under reduced pressure and the 
residue was treated with Et2O to cause the precipitation of the TFA salt, which was 
isolated by decantation. 
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6-[(3R,6S)-4-Benzyl-3-({(2S)-1-(tert-butoxycarbonyl)pyrrolidine-2-
carboxamido}methyl)-2,5-dioxopiperazin-6-yl]acetic Acid (16) 
  
To a solution of 11 (793 mg, 1.50 mmol, 1.0 equiv.) in CH2Cl2 (15 mL) at 0 °C 
were added pyrrolidine (0.149 mL, 1.80 mmol, 1.2 equiv.), triphenylphosphane (77 
mg, 0.3 mmol, 0.2 equiv.), and tetrakis(triphenylphosphane) palladium(0) (87 mg, 
0.075 mmol, 0.05 equiv.). The mixture was stirred for 15 min at 0°C and 2 h at 
room temperature, poured into EtOAc (60 mL), and extracted into satd. NaHCO3 
solution (3x 10 mL). The organic layers were discarded and the combined aqueous 
phases were acidified to pH 2 with 1M KHSO4 solution. The acidified aqueous 
solution was extracted into CH2Cl2 (3x 15 mL) and the combined organic layers 
were dried with Na2SO4, filtered, and concentrated under reduced pressure. The 
crude product was purified by flash chromatography eluting with 10% MeOH in 
CH2Cl2 to yield the product as a white solid (687 mg, 1.40 mg, 94%). Rf = 0.31 
(CH2Cl2/MeOH 9:1); m.p. 117– 118 °C. [α]20 D = –50.16 (c = 0.2, CHCl3). 
1
H 
NMR (400 MHz, CDCl3, 25 °C): δ = 1.33–1.45 (br., 9 H), 1.75–2.40 (br., 4 H), 2.67 
(dd, J = 18.0, 10.4 Hz, 1 H), 3.27–3.96 (br., 6 H), 4.16–4.70 (br., 3 H), 4.33–4.60 
(br., 1 H), 7.23– 7.34 (br., 5 H) ppm. 13C NMR (100.6 MHz, CDCl3, 25 °C): δ = 
24.4, 28.4, 29.1, 31.2, 38.0, 39.3, 47.3, 50.9, 59.1, 59.9, 80.9, 135.6, 155.8, 164.9, 
165.3, 168.3, 168.7, 173.9 ppm. IR: ν = 1737, 1652, 1159, 1072, 723 cm–1. 
C24H33N4O7 (489.55): calcd. C 59.00, H 6.60, N 11.47; found C 59.21, H 6.70, N 
11.80. 
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6-[(3R,6S)-4-Benzyl-3-({(2S)-1-pyrrolidine-2-carboxamido}methyl)-2,5-
dioxopiperazin-6-yl]acetic Acid, Trifluoroacetate Salt (20·TFA) 
 
(5·TFA): The Boc derivative from the previous reaction was dissolved in CH2Cl2 
(18.2 mL), TFA (18.2 mL) was added dropwise at 0°C, and the mixture stirred at 
the same temperature for 2 h. The solution was evaporated under reduced pressure 
and the residue was treated with Et2O to cause the precipitation of the TFA salt, 
which was isolated by decantation. 
 
 
6-[(3R,6S)-4-Benzyl-3-({(2R)-1-(tert-butoxycarbonyl)pyrrolidine-2-
carboxamido}methyl)-2,5-dioxopiperazin-6-yl]acetic Acid (17) 
 
Compound 12 (734 mg, 1.39 mmol, 1.0 equiv.) was dissolved in CH2Cl2 (14 mL), 
and the solution was cooled to 0°C. Pyrrolidine (0.138 mL,1.67 mmol, 1.2 equiv.), 
triphenylphosphane (73 mg, 0.278 mmol, 0.2 equiv.), and 
tetrakis(triphenylphosphane)palladium(0) (80 mg, 0.0685 mmol, 0.05 equiv.) were 
added, the mixture was stirred for 15 min at 0°C and 2 h at room temperature, 
poured into EtOAc (60 mL), and extracted into satd. NaHCO3 solution (3x 10 mL). 
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The organic layers were discarded and the combined aqueous phases were acidified 
to pH 2 with 1M KHSO4 solution. The acidified aqueous solution was extracted into 
CH2Cl2 (3x 15 mL) and the combined organic layers were dried with Na2SO4, 
filtered, and concentrated under reduced pressure. The crude product was purified 
by flash chromatography eluting with 10% MeOH in CH2Cl2 to yield the product as 
a white solid (620 mg, 1.27 mg, 91%). Rf = 0.31 (CH2Cl2/MeOH 9:1); m.p. 111–
112 °C. [α]20 D = +5.50 (c = 0.2, CHCl3). 
1
H NMR (400 MHz, CDCl3, 25°C): δ = 
1.44 (s, 9 H), 1.75–2.15 (br., 4 H), 2.70 (m, 1 H), 3.35–3.55 (br., 3 H), 3.67 (br., 1 
H), 3.82 (br., 1 H), 3.90 (br. s, 1 H), 4.07 (d, J = 14.4 Hz, 1 H), 4.35 (br, 1 H), 4.53 
(d, J = 9.7 Hz, 1 H), 5.48 (d, J = 14.4 Hz, 1 H), 7.25–7.45 (m, 5 H), 7.57 (br, 1 H), 
8.30 (s, 1H) ppm. 
13
C NMR (100.6 MHz, CDCl3, 25 °C): δ = 24.7, 28.4, 29.3, 37.6, 
40.0, 47.1, 47.2, 50.9, 58.4, 59.8, 81.2, 128.1, 128.4, 128.9, 135.3, 155.7, 165.3, 
168.6, 173.7, 174.3 ppm. IR: ν = 1734, 1675, 1163, 1124, 723 cm–1. C24H33N4O7 
(489.55): calcd. C 59.00, H 6.60, N 11.47; found C 59.13, H 6.75, N 11.61. 
 
 
6-[(3R,6S)-4-Benzyl-3-({(2R)-1-pyrrolidine-2-carboxamido}methyl)-2,5-
dioxopiperazin-6-yl]acetic Acid, Trifluoroacetate Salt (21·TFA) 
 
The Boc-protected derivative from the previous reaction was dissolved in CH2Cl2 
(16.5 mL), TFA (16.5 mL) was added dropwise at 0°C, and the mixture stirred at 
the same temperature for 2 h. The solution was evaporated under reduced pressure 
and the residue was treated with Et2O to provide the precipitation of the TFA salt, 
which was isolated by decantation.  
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4-[{(2S)-1-(tert-Butoxycarbonyl)pyrrolidine-2-carboxamido}- methyl]benzoic 
Acid (22b)  
 
Boc-L-Proline (50 mg, 0.23 mmol, 1.0 equiv.) was dissolved in CH2Cl2 (2.5 mL), 
and HATU (88 mg, 0.23 mmol, 1.0 equiv.) and collidine (73 μL, 0.55 mmol, 2.5 
equiv.) were added at 0°C under N2. The solution was stirred for 30 min before 4-
(aminomethyl)benzoic acid (35 mg, 0.23 mmol, 1.0 equiv.) was added, and the 
mixture stirred for 1 h at 0°C and overnight at room temperature. The reaction 
mixture was poured into EtOAc (25 mL) and washed with 1M KHSO4 solution (3x 
15 mL) and brine (1x 20 mL). The organic layer was dried with Na2SO4, filtered, 
and concentrated under reduced pressure. The crude product was purified by flash 
chromatography using 8% MeOH in CH2Cl2 to yield the product as a white-yellow 
solid (52 mg, 0.15 mmol, 65%). Rf = 0.33 (CH2Cl2/MeOH 9:1); m.p. 177–178 °C. 
[α]20 D = –73.43 (c = 0.1, CHCl3). 
1
H NMR (400 MHz, CDCl3, 25 °C): δ = 1.43 (s, 9 
H), 1.82–2.42 (br., 4 H), 3.30–3.55 (br., 2 H), 4.32–4.74 (br., 3 H), 7.30–7.34 (br., 2 
H), 7.88–7.93 (br., 2 H) ppm. 13C NMR (100.6 MHz, CDCl3, 25 °C): δ = 23.7, 24.7, 
28.4, 43.1, 47.2, 60.0, 80.8, 127.3, 128.7, 130.3, 143.9, 155.9, 169.8, 172.5 ppm. 
IR: ν = 1716, 1649, 1562, 1259, 1162, 1022, 923 cm–1. C18H24N2O5 (348.40): calcd. 
C 62.05, H 6.94, N 8.04; found C 61.97, H 6.71, N 7.99. 
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4-{[(2S)-Pyrrolidine-2-carboxamido]methyl}benzoic Acid, Trifluoroacetate 
Salt (22b·TFA) 
  
The compound from the previous reaction was dissolved in CH2Cl2 (1.9 mL), TFA 
(1.9 mL) was added dropwise at 0°C, and the mixture stirred at the same 
temperature for 2 h. The solution was evaporated under reduced pressure and the 
residue was treated with Et2O to cause the precipitation of the TFA salt, which was 
isolated by decantation.  
 
 
(2S)-2-[({3R,6S}-6-{2-(Allyloxy)-2-oxoethyl}-4-benzyl-2,5-dioxopiperazin-3-
yl)methylcarbamoyl]pyrrolidine, Trifluoroacetate Salt (23·TFA) 
 
To a solution of 11 (30 mg, 0.06 mmol, 1.0 equiv.) in CH2Cl2 (0.5 mL) was added 
TFA (0.5 mL) dropwise at 0°C, and the resulting solution was stirred at the same 
temperature for 2 h. Volatiles were evaporated under reduced pressure and the 
residue was treated with Et2O to cause the precipitation of the TFA salt, which was 
isolated by decantation. 
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General Procedure for 1,4-Addition Reactions 
 
To a solution of the catalyst (5.6 mg, 0.011 mmol, 0.05 equiv.) in solvent (500 μL, 
CHCl3/iPrOH, 9:1) was added NMM (1.23 μL, 0.011 mmol, 0.05 equiv.), and the 
solution was stirred for 10 min. The nitroolefin (1 equiv.) and the aldehyde (3 
equiv.) were added and the mixture was stirred for 24 h at 20°C. The reaction 
mixture was purified by flash chromatography on silica gel eluting with a mixture 
of n-hexane and EtOAc. 
 
 
Characterization of 1,4-addition reaction products 
 
3-(Furan-2-yl)-2-isopropyl-4-nitrobutanal (25c)  
 
Synthesized from 2-(2-nitrovinyl)furan and isobutanal according to the general 
procedure. 
The product was purified by flash chromatography (hexane/EtOAc, 9:1). Rf = 0.31 
(hexane/EtOAc, 6:1). 
1
H NMR (400 MHz, CDCl3, 25 °C): δ = 0.89 (d, J = 6.9 Hz, 3 
H), 1.16 (d, J = 7.2 Hz, 3 H), 1.75 (m, 1 H), 2.86 (ddd, J = 9.9, 4.8, 1.8 Hz, 1 H), 
4.05 (m, 1 H), 4.58–4-68 (m, 2 H), 6.22 (dd, J = 3.2, 0.5 Hz, 1 H), 6.31 (dd, J = 3.2, 
1.9 Hz, 1 H), 7.37 (dd, J = 1.9, 0.5 Hz, 1 H) ppm. 
13
C NMR (100.6 MHz, CDCl3, 25 
°C): δ = 17.8, 21.2, 28.0, 35.9, 57.3, 76.6, 109.0, 110.4, 142.6, 150.3, 203.4 ppm. 
IR: ν = 2725, 1715, 1557, 1151, 1015, 731 cm–1 . HRMS (ESI+): calcd. For 
C11H15NO4Na [M + Na]
+
 248.08958; found 248.08933. The enantiomeric excess 
was determined by HPLC using a Chiracel AD-H column (n-hexane/iPrOH, 99:1, 
25 °C) at 0.6 mL/min, UV detection at 212 nm: tR1 (syn) = 27.5 min, tR2 (syn) = 32.0 
min. 
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2-Benzyl-3-(furan-2-yl)-4-nitrobutanal (25d) 
  
Synthesized from 2-(2-nitrovinyl)furan and hydrocinnamaldehyde according to the 
general procedure. The product was purified by flash chromatography 
(hexane/EtOAc, 9:1). Rf = 0.25 (hexane/EtOAc, 6:1). 
1
H NMR (400 MHz, CDCl3, 
25 °C): δ = 2.76 (dd, J = 14.4, 5.6 Hz, 1 H), 2.90 (dd, J = 14.4, 8.8 Hz, 1 H), 3.18 
(dddd, J = 8.8, 7.2, 5.6, 1.6 Hz, 1 H), 4.08 (ddd, J = 8.8, 7.2, 5.2 Hz, 1 H), 4.63, (dd, 
J = 12.8, 5.2 Hz, 1 H), 4.70 (dd, J = 12.8, 8.8 Hz, 1 H), 6.23 (m, 1 H), 6.35, (dd, J = 
3.2, 2.0 Hz, 1 H), 7.12 (m, 2 H), 7.24–7.34 (m, 3 H), 7.41 (dd, J = 2.0, 0.8 Hz), 9.73 
(d, J = 1.6 Hz, 1 H) ppm. 
13
C NMR (100.6 MHz, CDCl3, 25°C): δ = 33.4, 37.2, 
53.8, 75.8, 109.1, 110.6, 127.0, 128.4, 128.9, 137.3, 142.8, 149.9, 202.0 ppm. IR: ν 
= 2728, 1725, 1554, 1496, 1144, 1074, 1017, 969, 918, 738, 701 cm
–1
. HRMS 
(ESI
+
): calcd. for C15H15NO4Na [M + Na]
+
 296.08988; found 296.08933. The 
enantiomeric excess was determined by HPLC using a Chiracel AD-H column (n-
hexane/iPrOH, 99:1, 25°C) at 0.6 mL/min, UV detection at 212 nm: tR1 (syn) = 42.1 
min, tR2 (syn) = 46.7. 
 
 
3.4.3   Computational Studies 
 
All calculations were run using the Schrödinger suite of programs 
(http://www.schrodinger.com) through the Maestro graphical interface. Monte 
Carlo conformational searches of 3–6 and relative enamine derivatives (MCMM,62 
                                                     
62 G. Chang, W. C. Guida, W. C. Still, J. Am. Chem. Soc. 1989, 111, 4379–4386. 
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OPLSA_2005 force field,
63
 implicit CHCl3 GB/SA solvent model)
64
 were 
performed as implemented in the framework of Macromodel version 9.8.
65
 For each 
search, at least 1000 starting structures for each variable torsion angle were 
generated and minimized until the gradient was less than 0.05 kJ/Åmol using the 
truncated Newton–Raphson algorithm.66 Duplicate conformations of ligands and 
those with an energy greater than 6 kcal/mol above the global minimum were 
discarded. 
 
                                                     
63 G. A. Kaminski, R. A. Friesner, J. Tirado-Rives, W. L. Jorgensen, J. Phys. Chem. B 2001, 105, 
6474–6487. 
64 W. C. Still, A. Tempczyk, R. C. Hawley, T. J. Hendrickson, J. Am. Chem. Soc. 1990, 112, 6127–
6129. 
65 MacroModel, version 9.8, Schrödinger, LLC, New York, NY, 2010. 
66 J. W. Ponder, F. M. Richards, J. Comput. Chem. 1987, 8, 1016– 1024. 
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